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Summary 
The present study illustrated a strategy to purify the astrocytes for gene 
expression analysis using FACS, which revealed that TRPC1, TRPC2, TRPC3 
and TRPC4 transcript fragments are expressed in FACS-sorted GLAST-positive 
mouse cortical astrocytes. The full length cDNA of TRPC1 and TRPC3 could be 
amplified from the purified astrocytes. Fura-2 and patch clamp experiments 
were used to characterize TRPC3 in astrocytes, which was found to be involved 
in the DAG- (OAG) mediated Ca2+ entry and not in the ORAI-mediated Ca2+ 
entry. The deletion of the TRPC3 gene resulted in a slower astrocytic migration 
rate measured by the in vitro scratch assay, as well as less astrogliosis and 
cortical edema after brain injury in vivo. TRPC1 exerts negative effect on 
TRPC3 channel activity when co-expressed and astrocytes from TRPC1 gene-
deficient mice revealed a faster in vitro migration rate and an increased in vivo 
astrogliosis and cortical edema. This correlates with the higher TRPC3 channel 
activity measured by Fura-2 in astrocytes isolated from TRPC1 gene-deficient 
mice. The presented results demonstrate an important role of TRPC3 in 
astrocytes Ca2+ signaling in particular after CNS injury as well as of TRPC1 in 
shaping the TRPC3-mediated Ca2+ signals. In the second part of this work, the 
voltage-gated Ca2+ channels (CaVs) in mouse cortical astrocytes were 
investigated. Transcripts of L-, P/Q- and R-type Ca2+ channels as well as CaV 
subunits were found to be expressed in GLAST-sorted mouse cortical 
astrocytes. Patch clamp experiments on cultured cortical astrocytes revealed 
voltage-gated Na+ (NaV) and CaV currents. Using specific blockers, L-type Ca2+ 
channels were found to be the major type contributing to the CaV currents in 
cultured astrocytes, while P/Q-, N- and R-type had minor contributions. Deletion 
of the CaV3 subunit gene in astrocytes did not affect the CaV currents; 
however, the deletion of the CaV2 subunit gene did reduce the CaV currents in 
astrocytes. The presented results leave no doubt that mouse cultured cortical 
astrocytes do express functional voltage-gated Ca2+ channels, and that the 
CaV3 subunit serves functions beyond modulating CaV currents. 
  
Zusammenfassung 
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Zusammenfassung 
Die vorliegende Arbeit beschreibt eine Strategie zur Isolierung von Astrozyten 
für Gen-Expressionsanalysen mithilfe der FACS-Methode. FACS-sortierte 
GLAST-positive kortikale Astrozyten der Maus exprimieren TRPC1, TRPC2, 
TRPC3 und TRPC4 Transkript-Fragmente, und die vollständige cDNS von 
TRPC1 und TRPC3 konnte aus ihnen amplifiziert werden. Mithilfe von Fura-2 
und Patch Clamp Experimenten wurde TRPC3 in kultivierten Astrozyten 
charakterisiert und dessen Beteiligung am DAG (OAG)-vermittelten Ca2+-
Einstrom gezeigt. Am STIM-vermittelten Ca2+ Einstrom ist TRPC3 scheinbar 
nicht beteiligt. Die Deletion des TRPC3-Gens resultiert in einer reduzierten 
Migrationsrate der Astrozyten in vitro, sowie einer geringeren Astrogliose und 
kortikalen Ödembildung nach einer Hirnverletzung in vivo. Die Ko-expression 
von TRPC1 mit TRPC3 hat einen negativen Effekt auf die TRPC3-Aktivität, da 
in TRPC1-defizienten Astrozyten sowohl eine schnellere Migrationsrate in vitro 
als auch eine verstärkte Astrogliose und Ödembildung in vivo beobachtet 
wurden. Dies korreliert mit der in Fura-2 Experimenten gemessenen erhöhten 
TRPC3-Aktivität in TRPC1-defizienten Astrozyten. Die Ergebnisse der 
vorliegenden Arbeit zeigen, dass TRPC3 einen wichtigen Beitrag zu Ca2+-
Signalen in Astrozyten leistet, speziell nach Verletzungen im ZNS, und dass 
TRPC1 die TRPC3-vermittelten Ca2+-Signale moduliert. Im zweiten Teil der 
vorliegenden Arbeit wurden spannungsabhängige Ca2+-Kanäle (CaVs) in 
kortikalen Astrozyten der Maus untersucht. In FACS-sortierten GLAST-positiven 
Astrozyten konnten Transkripte von L-, P/Q-, und R-Typ Ca2+ Kanälen, sowie 
CaVβ Untereinheiten nachgewiesen werden. Patch Clamp Experimente zeigten 
spannungsabhängige Na+- und Ca2+-Ströme in kultivieren Astrozyten. Mithilfe 
spezifischer Blocker konnte der L-Typ Ca2+-Kanal als hauptverantwortlich für 
den CaV-Strom identifiziert werden. P/Q-, N- und R-Typen trugen nur gering 
zum CaV Strom bei. Die Deletion der CaVβ3-Untereinheit hatte keinen Einfluss 
auf den CaV-Strom in den Astrozyten, wohingegen die Deletion der CaVβ2-
Untereinheit den CaV-Strom reduzierte. Die Ergebnisse zeigen, dass kultivierte 
kortikale Astrozyten funktionelle spannungsabhängige Ca2+-Kanäle besitzen, 
und weisen darüber hinaus darauf hin, dass CaVβ3-Untereinheiten neben der 
Modulation von CaV-Strömen noch weitere Funktionen ausüben. 
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1 Introduction 
1.1 Brain injury 
Brain injury is defined as an injury that occurs in the brain affecting a person 
physically, emotionally and behaviorally. Statistics showed that the incidence of 
acute traumatic brain injuries in European countries is about 235 cases per 
100000 inhabitants (Tagliaferri et al., 2006). The brain injuries could happen 
already at birth or later from a disease or trauma and thereby they can be 
classified as traumatic or non-traumatic brain injuries. Traumatic brain injuries 
occur when an external force traumatically injures the brain which includes an 
open head wound, skull fracture or a non-invasive trauma. The non-traumatic 
brain injury involves no external force, but is rather caused by a primary disease 
condition like bleeding, lack of oxygen, tumors, infection or inflammation. Brain 
injuries affect all neuronal and non-neuronal cells in the brain and have different 
effects on the different cell types. Primary cellular injury is followed by a 
secondary response that includes changes in cerebral blood flow, local and 
systemic inflammation, alterations in oxygen delivery and metabolism, and both 
ischemic and apoptotic death of neural cells (Dutton and McCunn, 2003). Like 
any other wound, a scar is generated in the area of the damaged tissue that in 
the brain predominantly consists of astrocytes. Astrocytes, non-neuronal brain 
cells, are known to play an important role after brain injury where they enter into 
a reactive state called astrogliosis (Silver and Miller, 2004). This reactive state 
that astrocytes gain is achieved by the exposure of astrocytes to the damaged 
neuronal tissue on one side, and on the other side to the blood which finds its 
way through the brain due to the disruption of the blood brain barrier. This 
excessive proliferation and migration of reactive astrocytes form what is known 
as the glial scar.  
1.2 Astrocytes 
It is suggested that the total number of cells in the human brain is about 1012, 
where neurons represent 10% whereas 90% of the cells are glial cells of which 
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the astrocytes are the major type (Kimelberg and Nedergaard, 2010). In 1891, 
Mihaly von Lenhossek proposed the name astrocytes for a type of cells which 
were known as neuroglia. The word astrocyte derives from the combination of 
two Latin words, astro “astron” meaning a star, while cyte “kytos” means a 
hollow vessel, later a cell (Parpura and Verkhratsky, 2012). The astrocytes can 
be visualized under the microscope by immunostaining of protein markers such 
as the Glial Fibrillary Acidic Protein (GFAP), Glutamate Aspartate Transporter 
(GLAST), S100 Ca2+-binding protein B (S100B) and Aquaporin 4 (AQP4). 
Astrocytes are coupled via gap junctions which allow to exchange small 
cytoplasmic molecules, such as IP3, ATP, Ca2+ and other ions. They play an 
indispensable role before and after brain development where they guide the 
neuronal migration and serve as source of extracellular matrix and adhesion 
proteins, as well as providing neurotrophic and neurite-promoting factors. The 
central synapses are ensheathed by astrocytes, where they take up 
neurotransmitter molecules clearing the synaptic cleft. They also release 
transmitters itself and thus take part in modulating synaptic signaling and 
regulate the pH, ion concentration and also the osmolarity of the neuronal 
environment. The astrocytes are not only communicating with the nervous 
tissue, but their end-feet cover the entire surface of blood vessels where they 
secrete and take up transmitters and nutriment molecules. This physical 
interaction between astrocytes and blood vessels is found to be necessary for 
angiogenesis in the brain (Maragakis and Rothstein, 2006; Montgomery, 1994). 
Thus astrocytes are considered one of the major cellular component of the 
blood brain barrier (Cabezas et al., 2014). 
1.3 Astrogliosis 
Astrogliosis is a description of astrocytes that became reactive in response to 
CNS damage that could occur via trauma, infection, ischemia, stroke, 
autoimmune reaction and neurodegenerative disease. This reactive state 
causes expressional and morphological changes in astrocytes and 
subsequently increases the proliferation and the migration of astrocytes. 
Astrocytes in this activated state will form a glial scar and could inhibit the 
axonal regeneration in the injury sites (Schachtrup et al., 2010), however other 
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studies have shown otherwise (Anderson et al., 2016; Sofroniew, 2009). 
Traumatic injuries are accompanied in most of the case with tissue and cellular 
damage, blood vessels disruption and subsequent inflammatory reaction. All 
those events lead eventually to the release of different molecules that trigger 
the surrounding cells to react to the injury. For the traumatic brain injuries, it is 
shown that the released molecules after the injury from the damaged tissue and 
the flux of molecules through the damaged blood brain barrier trigger the 
surrounding astrocytes to become reactive (Iglesias et al., 2016). Astrocytes in 
response to those stimuli experience changes in the expression of many genes. 
In this process Ca2+ plays a pivotal role in the signaling cascades downstream 
of the external stimulus. One of the genes which has been always linked to 
astrogliosis is GFAP which is upregulated. The GFAP protein as a marker for 
reactive astrocytes is wildly used in the experimental brain injury animal models 
as well as clinically as a marker for astrogliosis (Anderson et al., 2014). In 
addition to upregulation of the GFAP gene, the genes of chondroitin sulfate 
proteoglycans (CSPGs) are also upregulated. CSPGs are a group of proteins 
that are involved in the cell adhesion, cell growth and cell migration, and which 
are secreted by astrocytes following injuries (Rhodes and Fawcett, 2004). 
Those secreted proteoglycans have been shown to inhibit the axonal growth 
after brain and spinal cord injuries (Schachtrup et al., 2010; Silver and Miller, 
2004). 
 
Figure ‎1-1 Glial scar formation. Representative scheme of traumatic brain 
injury which triggers astrocytes to become reactive and form the glial scar. 
Images of the head adapted from (http://emergencymedicinecases.com). 
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1.4 Calcium (Ca2+) 
Calcium is a chemical element which as Ca2+ is essential for living organisms, in 
particular in cell physiology but also as major component in the mineralization of 
bones and teeth. Within cells, Ca2+ plays an important role in signaling; where it 
acts as a second messenger and regulates neurotransmitters release, muscle 
contraction, enzymatic activities, gene transcription, as well as division, 
differentiation, migration and death of cells. The basal cytoplasmic Ca2+ 
concentration in non-stimulated cells ranges between 50 and 150 nM. Upon 
stimulation, the cytoplasmic Ca2+ can rise to tens of µM leading to activation of 
signaling cascades. The rising in cytoplasmic Ca2+ is caused by Ca2+ release 
from the intracellular Ca2+ stores and/or Ca2+ entry into the cell from the 
extracellular compartment. The intracellular Ca2+ source is represented mainly 
by the endoplasmic reticulum (ER) which can store Ca2+ up to concentrations of 
1 mM, but other organelles like mitochondria and, maybe, lysosome-related 
organelles could also store Ca2+ (Clapham, 2007). The ER Ca2+ is released into 
the cytoplasm upon opening of Inositol 1,4,5-trisphosphate receptor channels 
(IP3Rs) and ryanodine receptor channels. IP3Rs are activated by Inositol 1,4,5-
trisphosphate (IP3) which is mobilized upon activation of Gq-coupled receptors 
or receptor tyrosine kinases: Cleavage of phosphatidylinositol 4,5-bisphosphate 
(PIP2) by phospholipase C (PLC) into IP3 and diacylglycerol (DAG) occurs. The 
ER is equipped with a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 
which ensures the Ca2+ re-uptake into the ER from the cytoplasm. Another 
source of Ca2+ for the cell is the extracellular space that contains Ca2+ at a 
concentration of 2 mM, and Ca2+ enters the cell via selective Ca2+ and non-
selective cation channels (Reuter, 1986). Many selective and non-selective 
cation channels have been suggested to be expressed in astrocytes including: 
Ca2+ release-activated Ca2+ channels (CRAC) (Kraft, 2015), transient receptor 
potential channels (Scimemi, 2013), N-methyl-D-aspartate receptors (NMDA) 
(Conti et al., 1996), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptors (AMPA) (Fan et al., 1999), ionotropic purinergic receptors (Neary and 
Zhu, 1994) and, maybe, voltage-gated Ca2+ channels (Burgos et al., 2007). The 
present work focused on the expression and function of TRP and voltage-gated 
Ca2+ channels. 
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1.5 Transient Receptor Potential (TRP) Channels  
Transient Receptor Potential (TRP) channels represent a large family of ion 
channel proteins located mostly in the plasma membrane. TRP channels were 
first discovered in the Drosophila photoreceptors where a spontaneous mutation 
led to a transient, instead of a sustained receptor potential upon light stimulation 
(Cosens and Manning, 1969). It took then twenty years to identify the gene 
carrying the mutation, the transient receptor potential gene. It was suggested 
that its amino acid sequence forms transmembrane segments (Montell and 
Rubin, 1989). Later in 1995, the first mammalian TRP cDNA, TRPC1, was 
cloned in the laboratory of Prof. Birnbaumer and Prof. Montell (Wes et al., 1995; 
Zhu et al., 1995). Today 28 members have been identified in mammalian 
organisms in which they are expressed in many cell types and tissues. Based 
on the sequence homology, the TRP channels are classified into 6 subfamilies 
(Figure  1-2-a): canonical (TRPC1-7), melastatin (TRPM1-8), vanilloid (TRPV1-
6), ankyrin (TRPA1), mucolipin (TRPML1-3) and polycystin (TRPP2, 3 and 5) 
(Wu et al., 2010). It has been suggested that all TRP members share a similar 
structure of 6 transmembrane spanning segments, including a pore linker 
between the 5th and the 6th segment (Flockerzi, 2007). In December 2013, the 
first crystal structure of TRPV1 was published showing a structure of six 
transmembrane domains and four TRP proteins assembling together in a four-
fold symmetry around the central ion permeation path (Cao et al., 2013; Liao et 
al., 2013). Recently, other groups could show the crystal structures of TRPV1 
(Gao et al., 2016), TRPV2 (Zubcevic et al., 2016), TRPV6 (Saotome et al., 
2016) and TRPA1 (Paulsen et al., 2015). Most of the TRP channels are non-
selective cation channels that are permeable for Ca2+ and Na+, except TRPV5 
and TRPV6 which are highly Ca2+ selective, and TRPM4 and TRPM5 which are 
highly sodium selective, and which are activated by intracellular Ca2+ (Wu et al., 
2010). The TRP channels are weakly voltage-sensitive, but they are activated 
via different mechanism including changes of temperature (heat and cold), pH, 
extra- and intracellular ligands and they are modulated via second messengers 
(Freichel et al., 2012). In the recent years extensive work has been conducted 
to discover modulators for TRP channels i.e., agonists and antagonists, that 
could be used to study those channels. However, the selectivity of these 
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modulators for TRP channels has been always an open debate. On the other 
hand, the emerging of the genetically modified mouse models has given 
significant boost to TRP channel studies. Many laboratories such as the group 
of Professor Flockerzi, Birnbaumer and Freichel extensively contributed in the 
generation of TRP gene-deficient mice and only two TRP channels remained to 
be knocked out, TRPML2 and TRPP5 (Nilius and Flockerzi, 2014). The 
generation of gene-deficient mice offered the opportunity to study selectively 
and accurately the role of TRP channels either in isolated tissues or cells, or in 
the entire animal. Gene-deficient studies have shown that TRP channels are 
involved in many cellular functions. For instance, the deletion of TRPV6 gene or 
the alteration of the TRPV6 channel`s Ca2+ permeability, by a point mutation in 
the pore region of all subunits, led to male infertility (Weissgerber et al., 2012). 
TRPM5 was shown to play a role in insulin secretion, and the TRPM5 gene-
deficient mice exhibited a decreased insulin secretion and reduced glucose 
clearance (Brixel et al., 2010; Colsoul et al., 2010). 
 
Figure ‎1-2 Transient Receptor Potential (TRP) Channel family. (a) 
Evolutionary relation of TRP genes illustrating the 6 subfamilies: TRPC (7 
members), TRPV (6 members), TRPM (8 members), TRPA (1 member), 
TRPML (3 members) and TRPP (3 members). (b) Each TRP protein has 6 
transmembrane domains with intracellular C and N termini, and a pore region 
located between the 5th and the 6th segment which is part of the Ca2+ and Na+ 
permeable pore. (c) Four TRP proteins assemble together to form a tetrameric 
functional channel. 
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1.6 Transient Receptor Potential Canonical Channels (TRPC) 
The TRPC subfamily comprises 7 members that form non-selective cation 
channels permeable to Ca2+ and Na+. It has been shown that TRPC channels 
are activated downstream of phospholipase C (PLC) stimulation, i.e. activation 
of Gq-coupled receptors or receptor tyrosine kinase (Freichel et al., 2012). The 
TRPC channels are subdivided into four groups based on their sequence 
homology TRPC1, TRPC2 which is a pseudogene in humans, TRPC3, TRPC6 
and TRPC7 (also called the DAG-sensitive TRPCs), and TRPC4 and TRPC5, 
however all members have conserved amino acid motifs on the N and C 
terminus. On the N terminus exist the ankyrin repeats, while on the C terminus 
the TRP box (EWKFAR) and the calmodulin and IP3 receptor biding site (CIRB) 
are located, those motifs can be also found in proteins from other TRP 
subfamilies (Clapham, 2003; Tang et al., 2001). 
1.6.1 TRPC1 
The TRPC1 was the first mammalian TRP to be cloned (Wes et al., 1995; Zhu 
et al., 1995); however the mechanism of activation still remains not clear. 
TRPC1 gene is expressed in many tissues and cell lines including kidney, liver, 
skeletal muscle, brain, salivary gland (Nesin and Tsiokas, 2014). Very recently 
Ulrich Wissenbach and Laura Hofmann in our laboratory have identified, in 
parallel with (Ong et al., 2013), a new starting codon CUG instead of AUG, 
which results in an extension of the amino terminal by 82 amino acids. Ong et.al 
have also identified a splice variant TRPC1 that lack 21 nucleotides which has 
a functional implication in the ORAI-mediated Ca2+ entry. Although TRPC1 is 
the founding member of TRPCs, the evidence that this protein could form a 
functional channel by itself is still a matter of debate (Dietrich et al., 2014). 
Nevertheless, TRPC1 has been shown to interact with its closest homologues 
TRPCs, but it also does interact with other TRP proteins and other proteins. For 
instance, the co-expression of TRPC1 with TRPC4 or TRPC5 in HEK293 cells 
did lead to the change of the current voltage relationship of both channels when 
compared to the single TRPC4 or TRPC5, concluding that TRPC1 could form 
functional heteromeric channels with TRPC4 and TRPC5 (Strubing et al., 2001). 
With the DAG-sensitive TRPC channels, TRPC1 was also shown to form 
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heteromeric channels with which were less Ca2+ permeable, but without 
changes in their current voltage relationships (Storch et al., 2012). In addition, 
TRPC1 was shown to interact with ORAI and STIM proteins (Ambudkar, 2014), 
but the role of TRPC1 in ORAI function has always been controversy and 
divides the TRP community. For example, the deletion of TRPC1 gene was 
shown to reduce the Ca2+ entry, upon endoplasmic reticulum Ca2+ depletion, by 
60% in mouse submandibular gland acinar cells (Ambudkar, 2014), and others 
concluded that TRPC1 is a critical component of the store depletion-mediated 
Ca2+ entry in salivary gland acinar cells (Liu et al., 2007). However, Varga-
Szabo et al. reported that platelets isolated from TRPC1 gene-deficient mice did 
exhibit a normal ORAI function (Varga-Szabo et al., 2008). Perhaps it is 
important to consider different roles of TRPC1 in different cell types. 
1.6.2 TRPC2 
TRPC2 is a pseudogene in humans, but it is expressed in rodent vomeronasal 
organ, testis, brain, spleen, heart, thyroid cells and erythroid cell line (Miller, 
2014). This member of TRPC channels is activated via DAG which results from 
the PLC activation (Lucas et al., 2003). TRPC2 has been described to interact 
with one of its closest homologue TRPC6 channels, as well as with other Ca2+ 
release and Ca2+ influx proteins: IP3 receptor, STIM and ORAI (Kiselyov et al., 
2010; Tong et al., 2004). The TRPC2 gene-deficient mice mate normally, 
however males failed to display male-male aggression towards intruder males 
(Stowers et al., 2002). In blood cells it was reported that TRPC2 deletion could 
protect mouse red blood cells from oxidative stress-induced hemolysis 
(Hirschler-Laszkiewicz et al., 2012). 
1.6.3 TRPC3 
TRPC3 was cloned in 1996 by Zhu et al., and it was found to be highly 
expressed in the brain and heart (Camacho Londono et al., 2015; Lichtenegger 
and Groschner, 2014; Zhu et al., 1996). It shares 69% amino acid sequence 
identity with TRPC6 and TRPC7 and also the activation mechanism via DAG 
(Hofmann et al., 1999). TRPC3 was shown to preferentially interact with its 
closest homologues TRPC6 and TRPC7 (Lichtenegger and Groschner, 2014), 
but it was also reported to interact with other Ca2+ channels such as ORAI in 
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heterologous expression (Liao et al., 2007). Lintschinger et al. reported that the 
co-expression of TRPC1 with TRPC3 in HEK cells generated a Ca2+-sensitive 
OAG-activated channel, while TRPC3 alone exhibited minor Ca2+ inhibition 
(Lintschinger et al., 2000). In addition, the Ca2+ selectivity of TRPC3 was 
shown to decrease when TRPC1 is co-expressed (Storch et al., 2012). The 
expression of TRPC3 seemed to coordinate with the expression of its closest 
homologues as shown by Dietrich et al. that TRPC3 gene expression is 
upregulated in TRPC6 gene-deficient smooth muscle cells, suggesting 
compensatory effects of TRPC3 after loss of TRPC6 (Dietrich et al., 2005). 
TRPC3 has been shown to play a role in the mGluR-evoked slow EPSCs in 
mouse cerebellar Purkinje cells (Hartmann et al., 2008). In the peripheral 
organs, TRPC3 was reported to be involved in regulation of the myogenic tone 
of resistance arteries and in controlling arterial blood pressure (Adebiyi et al., 
2010). Interestingly, a mutation in the mouse TRPC3 gene (A1903G) has been 
identified in a mutagenesis screening which led to the replacement of threonine 
residue at position 635 in the mouse TRPC3 amino acid sequence by an 
alanine residue. The homozygous mutant mice are not viable, however the 
heterozygous mutants exhibit motor and coordination abnormalities and loss of 
Purkinje cells, and thus called moonwalker (MWK) mice (Becker et al., 2009). 
This phenotype could be because of the altered TRPC3 (T635A) channel 
gating (Becker, 2014). Like the rest of the TRPC members, TRPC3 is inhibited 
by the general inhibitors of non-selective cation channels like SKF-96365 and 
2-APB (Harteneck and Gollasch, 2011). A selective TRPC3 inhibitor pyrazolium 
3 (Pyr3) has been described to have an inhibitory effect on carbachol-induced 
Ca2+ currents in HEK293 cells overexpressing TRPC3 (Kiyonaka et al., 2009). 
However, Pyr3 also inhibits the ORAI function in astrocytes (own observation, 
(Schleifer et al., 2012)). Schleifer et al. proposed instead another pyrazole 
derivative Pyr 10 which was shown to have higher selectivity for TRPC3 versus 
ORAI. 
1.6.4 TRPC4  
TRPC4 was first cloned in the laboratory of Prof. Flockerzi (Homburg) in 1996 
(Philipp et al., 1996). The closest TRPC homologue to TRPC4 is TRPC5, they 
share 65% amino acid sequence (Philipp et al., 1998). TRPC4 is expressed in 
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many organs including brain, eye, heart, lungs and many others, and it is 
activated downstream Gq/11 and Gi pathways (Freichel et al., 2014). Deletion of 
TRPC4 affects the agonist-dependent vasorelaxation and others suggested that 
TRPC4 is essential in the regulation of blood vessel tone (Freichel et al., 2001). 
In another study, the gene-deficient of both TRPC4 and TRPC1 was shown to 
have a preventive affect against maladaptive cardiac remodeling (Camacho 
Londono et al., 2015). In the brain, the gene-deficient of TRPC4 led to 
decreased anxiety-like behavior and was related to a subsequent decrease in 
Gq-dependent responses (Riccio et al., 2014). A gain of function mutation was 
also described for TRPC4 (TRPC4 G503S) that leads to a constitutive activity of 
the channel (Beck et al., 2013), however the impact of this mutation in vivo has 
not been described yet. Recently, agonist for TRPC4 (and TRPC5) has been 
reported (-)-Englerin A which is able to kill renal cancer cells (Akbulut et al., 
2015). Nevertheless, a proper analysis of the (-)-Englerin A selectivity has to be 
conducted. 
1.6.5 TRPC5 
Almost two years after the cloning of TRPC4, the laboratory of Prof. Flockerzi 
also cloned TRPC5 which, as mentioned above, shares 69% sequence 
homology with TRPC4 (Philipp et al., 1998). TRPC5 is predominantly expressed 
in the central nervous system, however TRPC5 was also detected in other 
tissues (Zholos, 2014). TRPC5 is also activated downstream of G-protein 
coupled receptors and it is potentiated by intracellular Ca2+ (Gross et al., 2009; 
Wu et al., 2010). The TRPC5 gene-deficient mice seem to have reduced 
pilocarpine-induced seizures and subsequent neuronal death (Phelan et al., 
2013). In another study, TRPC5 was suggested to play an essential role in 
amygdala function and fear-related behavior (Riccio et al., 2009). Similar to 
TRPC4, the G504S mutation which was located within the cytoplasmic linker 
between transmembrane domain 4 and 5 led also to TRPC5 gain of function 
(Beck et al., 2013). 
1.6.6 TRPC6 
The first mammalian TRPC6 was cloned in 1997 by the laboratory of Prof. 
Birnbaumer from mouse brain (Boulay et al., 1997). TRPC6 shares high 
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sequence homology with TRPC3 and it is also activated via DAG (Wu et al., 
2010). TRPC6 is expressed in lung, stomach, colon, kidney and other organs 
(Dietrich and Gudermann, 2014). The TRPC6 gene-deficient mice do exhibit a 
reduced angiotensin II-induced albuminuria, but under normal conditions 
(without angiotensin II) TRPC6 gene-deficient mice did have similar albumin 
excretion as wild-type mice (Eckel et al., 2011). Others have shown that TRPC6 
may inhibit seizure susceptibility and neuronal vulnerability in the rat (Kim and 
Kang, 2015). Lysophosphatidylcholine was shown to activate TRPC6 but also 
TRPC5 (Chaudhuri et al., 2003). In addition, the St. John`s wort antidepressant 
molecule Hyperforin was proposed as a TRPC6 specific activator and has been 
used since as one (Leuner et al., 2007). However, we could show that 
hyperforin induces a proton current even totally independent of TRPC6 (Sell et 
al., 2014). Therefore, the use of hyperforin as a selective TRPC6 agonist has to 
be reconsidered. 
1.6.7 TRPC7 
TRPC7 was the last TRPC member to be cloned in 1999 from mouse brain 
(Okada et al., 1999). This channel also belong to the DAG-sensitive TRPC 
channels and shares a high sequence homology with TRPC3 and TRPC6 (Wu 
et al., 2010). TRPC7 was found to be expressed in different tissues including 
heart, lungs, eye, brain, spleen and others (Zhang and Trebak, 2014). A recent 
study using TRPC7 gene-deficient mice showed that TRPC7 is involved in the 
initiation of seizures both in vitro and in vivo, and TRPC7 gene-deficient mice 
seemed to be protected against seizures (Phelan et al., 2014). 
1.6.8 TRPCs in astrocytes 
In the last decade, several studies have been conducted on the role of TRPC 
proteins in astrocytes. Different types of astrocytes from different species have 
been used in those studies including human, mouse and rate astrocytes. All 
members of the TRPC channels were reported to be expressed in rate cortical 
astrocytes, but in the rat spinal cord astrocytes TRPC5 and TRPC7 were not 
detected by PCR (Miyano et al., 2010). TRPC1 was suggested to contribute in 
intracellular Ca2+ dynamics and consequent glutamate release from rat 
astrocytes (Malarkey et al., 2008). In human astrocytoma cells, TRPC3 was 
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found to be associated with thrombin-induced morphological changes (Nakao et 
al., 2008). Another study showed that ATP could induce TRPC3 current in 
cortical astrocytes was slightly blocked by Pyr3, however control experiments 
with knockdown or knockout were missing (Streifel et al., 2014). In an 
intracerebral hemorrhage mouse model, Pyr3 treatment attenuated the 
astrogliosis after cerebral hemorrhage and was linked to inhibition of TRPC3 
(Munakata et al., 2013), however Pyr3 is not a selective TRPC3 blocker 
(Schleifer et al., 2012). TRPC4 was shown to co-localize with the scaffolding 
protein ZO-1 in human fetal astrocytes in culture (Song et al., 2005).  
1.7 Voltage-gated Ca2+ channels (CaVs) 
Voltage-gated Ca2+ channels (CaVs) are a group of highly selective Ca2+ 
channels that open at depolarized membrane potentials. Their genes are 
expressed mostly in excitable cells such as neurons, muscle cells or secretory 
cells. Since the first recording of those channels in 1967 (Reuter, 1967), the 
Cavs are important targets of drugs, the Ca2+ channel blockers, used in the 
treatment of cardiovascular diseases including hypertension, angina and 
arrhythmia, as well as neurological diseases such as pain and seizure. The 
functional CaVs consist of the pore-forming1 subunit which defines the type 
and the pharmacology of the channel, and the other subunits ,2and, 
maybe, as auxiliary subunits which modulate the properties of the channel 
(Catterall et al., 2005; Hofmann et al., 1994). CaVs are classified depending on 
their activation voltages as low voltage activated (LVA) and high voltage 
activated (HVA). The activation potentials of the HVA Ca2+ channels occur 
between -40 to -10 mV while the activation potentials for the LVA channels 
occur between -70 to -60 mV (Nowycky et al., 1985). The CaVs are fast 
activating and inactivating, but not as fast as the voltage-gated sodium 
channels, and the inactivation happens in a Ca2+-dependent manner and / or in 
a voltage-dependent manner (Cens et al., 2006; Ulbricht, 2005; Yue, 2004). The 
activation potentials and the inactivation kinetics are different between the 
diverse subtypes of CaVs and are therefore used to characterize and 
distinguish the different members of the voltage-gated Ca2+ channels. However, 
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the characterization of the CaVs is also performed using specific blockers 
(Olivera et al., 1994; Reuter, 1983). 
 
Figure ‎1-3 Topology of voltage-gated Ca2+ channel. Voltage-gated Ca2+ 
channels subunits including the pore forming 1 subunit and the auxiliary 
subunitsand2. The 1 subunit consists of four homologous repeats, each 
comprising six transmembrane domains (S1 – S6). The channel pore is situated 
between the S5 and S6 domains (PD) of each repeat, and the S4 domains 
represent the voltage sensor (VSD).  
1.7.1 The pore-forming 1 subunits 
The 1 subunit is the main subunit of the voltage-gated Ca2+ channels. It was 
purified and its cDNA cloned for the first time from rabbit skeletal muscle 
(Flockerzi et al., 1986; Tanabe et al., 1987) and consists of four homologous 
domains, each containing six transmembrane segments S1 to S6 (Figure  1-3) 
(Wu et al., 2015). The pore is located between the transmembrane segments 
S5 and S6, and the S4 segment which includes positively charged amino acid 
residues serves as the voltage sensor (Tanabe et al., 1987). Up to date, 10 1 
subunits have been discovered and an alphabetic nomenclature was used to 
classify them. The 1 cloned from skeletal muscle was given the name 1S, 
and the rest were named from 1A to 1F. Similarly to the potassium channels, 
the Ca2+ channels were also given the numerical identifier and Ca was used to 
refer to Ca2+ and V to voltage (CaV). The CaV1.1 to CaV1.4 refer to the L-type 
Ca2+ channels formed by 1S, 1C, 1D and 1F respectively. The CaV2.1, 
CaV2.3 and CaV2.3 refer to the P/Q-type, N-type and R-type Ca2+ channels 
formed by 1A, 1B and 1E respectively. The CaV3.1 to CaV3.3 refer to the T-
type Ca2+ channels formed by 1G, 1H and 1I respectively (Ertel et al., 2000). 
The L-, N-, P/Q- and R-types are considered HVA channels (see  1.7), while the 
Extracellular
Intracellular
N
C
Ca2+ / Na+
TRPC1
TRPC4
TRPC5
TRPC6
TRPC7
TRPC3
TRPC2
TRPM5
TRPM4
TRPM8
TRPM2
TRPM7
TRPM6
TRPM3
TRPM1
TRPV1
TRPV2
TRPV3
TRPV4
TRPV5
TRPV6
TPC1
TPC2
TRPML1
TRPML2
TRPML3
TRPA1
TRPP2
TRPP3 TRPP5
a b
c
Extracellular
Intracellular
N
C
VSD PD
S1 S3S2 S4 S6 S1 S3S2 S4 S6 S1 S3S2 S4 S6 S1 S3S2 S4 S6S5 S5 S5 S5
Introduction 
 
Universität des Saarlandes  14 
 
T-type Ca2+ channels are LVA channels (Lipscombe et al., 2004). The L-type 
Ca2+ channels are blocked by diltiazem, by dihydropyridine derivatives such as 
Amlodipine, Isradipine and Nimodipine and by phenylalkylamine derivatives 
such as Verapamil. The P/Q-type Ca2+ channels are blocked by the funnel web 
spider venom ω-agatoxin IVA, the N-type Ca2+ channels are blocked by the 
cone snail toxin ω-conotoxin GVIA and related cone snail toxins, and the R-type 
Ca2+ channels are blocked by the synthetic peptide toxin SNX-482 derived from 
tarantula venom. For the T-type Ca2+ channels there are no specific blockers 
available so far (Catterall et al., 2005). Gene-deficient mice of the various 1 
subunit genes have been described and most of them exhibit specific 
phenotypes if they are viable. For instance, the CaV1.1 gene-deficient mice, 
which resulted from autosomal recessive mutation in the CaV1.1 α1 subunit die 
at birth because of asphyxiation (Chaudhari, 1992) and CaV1.2 gene-deficient 
mice die on embryonic day 14.5 (Seisenberger et al., 2000), while the CaV1.3 
gene-deficient are deaf (Platzer et al., 2000) and a spontaneous mutation in the 
CaV1.4 gene causes night blindness in mice (Chang et al., 2006). The CaV2.1 
gene-deficient mice exhibit sever ataxia and die few weeks after birth (Jun et 
al., 1999), while the CaV2.2 (Saegusa et al., 2001) and CaV2.3 (Pereverzev et 
al., 2002) gene-deficient mice have mild phenotypes. For the T-type Ca2+ 
channels, the CaV3.1 gene-deficient mice exhibit bradycardia and slow 
atrioventricular conduction (Mangoni et al., 2006), and were also shown to have 
hyperalgesia in response to visceral pain (Kim et al., 2003). The CaV3.2 gene-
deficient mice have abnormal coronary function and focal myocardial fibrosis 
(Chen et al., 2003). However the CaV3.2 gene-deficient mice have neurological 
phenotype characterized by reduced sleep spindles in the thalamus (Astori et 
al., 2011). 
1.7.2 The auxiliary subunits 
The auxiliary subunits of the voltage-gated Ca2+ channels are required for the 
trafficking of the pore-forming 1 subunits to the plasma membrane as well as 
for modulating the gating properties (Arikkath and Campbell, 2003). Those 
subunits are classified in CaV subunits, and CaV2 subunits. The cloning of 
the first CaV subunit cDNA was done in 1989 in Homburg, Germany (Ruth et 
al., 1989), and today four  genes (1 to 4) have been characterized. It has 
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been shown that HVA Ca2+ channels have very small membrane expression 
and subsequently measurable currents in the absence of the  subunits, as 
those subunits translocate the 1 subunits to the plasma membrane (Buraei 
and Yang, 2013). Thus, for the high voltage-gated Ca2+ channels the  subunits 
are indispensable for their cellular function. For instance, the CaV1.1 is 
exclusively associated with the 1 subunit and the deletion of 1 gene in mice 
led to the same phenotype as observed is in the CaV1.1 gene deletion: mice die 
after birth due to asphyxiation (Gregg et al., 1996). The 2 subunit of the CaVs 
plays a vital role in the development of the heart during embryonic phase as 
illustrated by the work of Weissgerber et al. where they show that homozygous 
2 gene-deficient embryos die at embryonic day 10.5 due to heart 
malformation. However, mice were born and could live when the 2 gene is 
deleted in the whole organism except cardiac myocytes (Katiyar et al., 2015; 
Weissgerber et al., 2006). The 3 Gene-deficient mice are viable, but they do 
exhibit a reduced perception of pain. The mechanism behind this phenotype is 
probably due to the reduced expression of the N-type Ca2+ channel in the 3 
gene-deficient spinal cord and subsequent reduction in the Ca2+ currents 
(Murakami et al., 2002). Moreover, those mice do also have an increased 
insulin secretion but the mechanism of this hyperinsulinemia is independent of 
CaVs and rather related to the IP3-induced Ca2+ release from the ER, 
suggesting also Cav-independent functions of the 3 subunits (Berggren et al., 
2004). The 4 gene is not functional in epileptic lethargic mice (lh/lh mice) 
because of a mutation that leads to exon skipping in the 4 gene and induces a 
premature stop codon. Those mice were reported to have ataxia and seizures 
as well as spleen and thymic involution (Burgess et al., 1997). The 2 
subunits are a group of extracellular proteins consisting of four members: 21 
to 24. The 21 cDNA was first cloned in 1988 (Ellis et al., 1988). The 
2and polypeptides are linked to each other by disulfide bonds and it was 
shown that the 2complex is anchored to the plasma membrane via a 
glycophosphatidylinositol (GIP)-anchor at the C-terminal of the(Davies et al., 
2010). The trafficking of the 1 subunits of the HVA Ca2+ channels is mainly 
mediated via the  subunits, however many reports have shown that the co-
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expression of2with the 1 and  subunits enhances the Ca2+ currents 
(Dolphin, 2013). The 21 has been found to be associated with nerve injury-
induced pain where it is upregulated in response to peripheral nerve injury 
(Newton et al., 2001). A mutation in the 22 gene was discovered in the 
“ducky mice” which leads to the loss of the full length mRNA of this gene and 
reduces the Ca2+ currents in the cerebellar Purkinje cells. This mutation has 
been associated with the ducky mouse phenotypes of epilepsy and ataxia 
(Barclay et al., 2001). The 23 gene-deficient mice showed impaired 
transmission of thermal pain-evoked signals from the thalamus to the pain 
center in the brain (Neely et al., 2010). A mutation in the human 24 gene was 
found in patients diagnosed with night blindness suggesting an involvement of 
24 in this disease (Wycisk et al., 2006). However, antibody-based purification 
of CaV channels from brain followed by mass spectrometry analysis revealed 
1 and  subunits but not 2 subunits as part of the channel complex (Muller 
et al., 2010). Among the  subunits, only 1 subunit is associated with 1 
subunit of the CaV1.1 (Chen et al., 2007a; Eberst et al., 1997). Reports have 
shown that in the absence of the subunit the L-type Ca2+ current in skeletal 
muscle cells increases and the inactivation kinetic of the channel is changed 
(Freise et al., 2000). Most of the other subunits interact with the α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and assist the 
trafficking of these receptors to the plasma membrane. They are therefore 
called transmembrane AMPA receptor regulating proteins (TARPs) (Nicoll et al., 
2006). 
1.7.3 CaVs in astrocytes 
The presence of functional voltage-gated Ca2+ channels in astrocytes has been 
always a matter of debate. However, some early reports have shown Ca2+ 
currents in cultured astrocytes (MacVicar and Tse, 1988), which were supported 
by later studies showing mRNA and protein levels of voltage-gated Ca2+ 
channel subunits in cultured astrocytes (Latour et al., 2003). However, 
electrophysiological measurements in situ did not show any Ca2+ currents in 
hippocampal astrocytes (Carmignoto et al., 1998). Apparently, astrocytes 
change gene expression pattern in situ compared to the situation in culture. In 
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addition, the difference between the in vitro and the in situ studies is that the in 
vitro studies have used cortical astrocytes while the in situ study has used 
hippocampal astrocytes. This difference has to be taken into consideration 
since astrocytes from different brain regions could well differ. Up to date, not 
many studies have discussed the role of CaVs in astrocytes. However, Zeng et 
al. reported that the spontaneous Ca2+ oscillations in astrocytes could be 
mediated by voltage-gated Ca2+ channels (Zeng et al., 2009). In a recent study 
(Gurkoff et al., 2013), it was shown that administration of CaVs antagonists to 
rodent models of traumatic brain injury, which involves astrocytes and neurons, 
reduced cell death and improved cognitive function. 
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1.8 Aims 
The aim of the present work was to study the role of TRPC and CaVs channels 
in mouse cortical astrocytes. The following aims will be addressed: 
1. Establishment and characterization of mouse cortical astrocyte cultures.  
2. Expression analysis of TRPC and CaVs channels by the mean of RT-
PCR and mRNA deep sequencing from purified (FACS-sorted) mouse 
cortical astrocytes.  
3. Functional characterization of the expressed TRPC3, TRPC1 and CaVs 
channels by Ca2+ imaging and patch clamp experiments.  
4. Applying in vitro as well as in vivo approaches to investigate the 
physiological role of TRPC3 and TRPC1 in the astrocytes migration and 
astrogliosis after brain injury.  
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2 Materials and Methods 
2.1 Mouse lines 
All animal experiments were performed in accordance with the German 
legislation on the protection of animals and were approved by the local ethic 
committee. New born (day 0-3) or adult mice were used from different gene-
deficient mice and their corresponding wild-types either from C57BL6/N strain 
or 129SvJ/C57Bl6/N (mixed) strains. TRPC1 gene-deficient (Dietrich et al., 
2007), TRPC3 gene-deficient (Hartmann et al., 2008) and TRPC6 gene-
deficient (Dietrich et al., 2005) mice were previously described, the TRPC1/C5 
and TRPC3/C6 double gene-deficient mice was generated in our laboratory by 
crossing the single gene-deficient mice. The gain of function TRPC3 threonine 
to alanine mutation was first identified by Becker et al. from a mutagenesis 
screening (Becker et al., 2009), and heterozygous embryos of this mutation so 
called moonwalker (MWK) mouse were purchased from Harvell Science and 
Innovation (England) and introduced into the animal facility of the Pharmacology 
Department in Homburg by Dr. Petra Weissgerber. Cav2 gene-deficient mice 
(Weissgerber et al., 2006) and Cav3 gene-deficient mice (Murakami et al., 
2002) were generated in the laboratory of Prof. Veit Flockerzi, Pharmacology 
Department in Homburg. 
2.2 Isolation and culture of mouse cortical astrocytes and 
microglia 
The isolation of mouse cortical astrocytes was performed as described before in 
(T. Belkacemi Master thesis 2012). Mice, aged from 0 to 3 days, were sacrificed 
by decapitation using scissors, and the cerebral hemispheres were rapidly 
removed and maintained in a 3.5 cm sterile petri dish containing cold PBS. After 
the separation of the two hemispheres under a stereomicroscope, 
hippocampus, amygdala and thalamus were removed and also the meninges 
were carefully removed in order to avoid fibroblast contamination (Figure  2-1). 
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The isolated cortices were collected in a 50 ml sterile falcon tube filled with 20 
ml of cold DMEM (Dulbecco’s modified Eagle’s medium) medium (Gibco) 
supplemented with 1% GlutaMAX (Invitrogen), 100 U/ml Penicillin and 100 
µg/ml Streptomycin. After isolation, cortices were gently digested using 5 ml 
trypsin (5 g/l) (Sigma) per 10 brains for 15 min at 37°C. The trypsin was then 
inhibited by adding 10 ml DMEM medium supplemented with 10% FCS (Fetal 
calf serum) (Gibco) and centrifuged for 5 min at 200 g. The supernatant was 
removed and cortices were suspended in DMEM medium without FCS. The 
cortices were then triturated by pipetting up and down (10 times) using a 10 ml 
syringe (B. Braun) with a 20G (0,90 x 40 mm) needle (B. Braun). The obtained 
suspension was filtered into a new falcon tube using a 40 µm cell strainer (BD 
Falcon) to get single cells, and centrifuged 5 min at 200 g. Then, cells were 
resuspended in DMEM medium containing 10% FCS, 1% GlutaMAX, 100 U/ml 
Penicillin and 100 µg/ml Streptomycin, and plated as 3 brains in 75 cm2 poly-L-
lysine (P-L-L, 0,1 mg/ml, (Sigma) -coated flasks (BD Falcon) and cultured at 
37°C and 5% CO2 in a humidified incubator (Binder). After 2 to 3 days, the 
medium was changed to remove dead cells and debris, and afterwards the 
medium was changed twice a week until cells reached confluency. Cells from 
single TRPC3 MWK and Cav2 gene-deficient mice were prepared and 
cultured separately until the single mice were genotyped. Microglia cells grow 
on top of the astrocytes and were separated by gently shaking the flask and 
subcultured on P-L-L-coated coverslips for Ca2+ imaging or patch clamp 
experiments. Astrocytes are adherent cells and therefore they were detached 
by first washing the flask (75 cm2) with PBS to remove the medium with FCS 
and then incubated with 3 ml trypsin (5 g/l) for 3 to 5 min. Afterwards, the flask 
was knocked by hand in order to detach the cells, and then cells were 
suspended in 7 ml medium with FCS and plated on P-L-L-coated coverslips for 
Ca2+ imaging or patch clamp experiments.  
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Figure ‎2-1 Isolation procedure of mouse cortices. (a) Open head of a 
newborn mouse showing different parts of the CNS (1: olfactory bulbs, 2: 
cerebral cortices, 3: cerebellum). (b) Extracted brain from the head showing the 
cerebral cortices from the upper side. (c) The upside down view of the brain. (d) 
Brain divided into two hemispheres, the cerebral cortex in the left and the 
hippocampus, amygdala and thalamus in the right. (e) The hippocampus, 
amygdala and thalamus are being separated from the cerebral cortex. (f & g) 
The meninges are being removed from the cerebral cortex. (h) The cerebral 
cortex is separated from the other parts of the brain and ready to be used for 
astrocyte culturing. Photographs were taken by a color camera (AxioCam, 
ZEISS). The figure was adapted from (T. Belkacemi Master thesis 2012). 
2.3 Human embryonic kidney (HEK) 293 cell culture 
HEK-293 cells (ATCC, CRL 1573) are obtained from the American Type Culture 
Collection (ATCC, Manassas, VA, USA), HEK cells stably expressing the 
human cDNA TRPC3 were kindly provided by Dr. M.X. Zhu, University of Texas 
Health Science Center, Houston, HEK cells stably expressing the mouse 
TRPC1 VL and tetracycline-inducible mouse TRPC3 MWK mutation in HEK 
cells were generated in our laboratory. For that purpose, nucleotide A at 
position 1903 was replaced by G in the mouse TRPC3 cDNA and subcloned 
into pCDNA5/FRT/TO vector. Wild-type HEK cells were cultured in MEM 
medium and the others were cultured in DMEM medium, supplemented with 
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10% FCS. The cells were kept in an incubator at 37°C and 5% CO2, and the 
medium was changed every third day. Cells were plated on glass coverslips of 
1 cm in diameter coated with P-L-L. 
2.4 HEK cell transfection 
HEK-293 cells were cultured in 3.5 mm petri dishes until they reached 70% 
confluency. The culture medium was substituted with a fresh medium (MEM 
supplemented with 10% FCS) prior to the transfection. The transfection mixture 
was prepared following the manufacturer recommendation using FuGENE HD 
Transfection Reagent (Promega). For every 3.5 mm petri dish, 2 µg of DNA was 
mixed with 5 µl of Fugene HD reagent and 100 µl of Opti-MEM medium and 
incubated at room temperature for 15 min. The transfection mixture was added 
onto the cells by dropping small droplets all over the petri dish. Afterwards cells 
were incubated at 37°C and 5% CO2 for 24 to 48 h and checked under the 
fluorescence microscope for positive fluorescent cells depending on the 
transfection DNA. Then, cells were plated on glass coverslips coated with P-L-L 
for either patch clamp or Ca2+ imaging experiments and used for experiment up 
to 72 h post transfection. The used eukaryotic expression vectors were 
generated in our laboratory, the full length mTRPC3-pcAGGS-IRES-GFP by 
Stefanie Buchholz and mTRPC1 VL-pcAGGS-IRES-GFP by Laura Hofmann 
and Ulrich Wissenbach. The use of IRES will allow the expression and 
translation of the aimed gene as well as GFP in parallel but separately. 
2.5 Immunocytochemistry 
Mouse cortical astrocytes were plated on P-L-L-coated coverslips and grown 
until almost confluency. Cells were fixed with 4% (w/v) paraformaldehyde (PFA) 
(Sigma) for 15 min at room temperature. After fixation, cells were washed with 
PBS and permeabilized using 0.5% TritonX-100 (Roth) for 15 min at room 
temperature. For blocking the unspecific binding sites, cells were washed with 
PBS and incubated for 60 min at room temperature with 3% Bovine-Serum-
Albumin (BSA) Fraction V (Applichem), 1% (v/v) Normal-Goat-Serum (NGS) 
(Vector) and 0.1% TritonX-100 in PBS solution. Cells were washed and 
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incubated over night at 4°C with the primary antibodies: Anti-GFAP (glial 
fibrillary acidic protein) from rabbit to stain astrocytes (Dianova), anti-CD11b 
(integrin alpha M) (Dianova) from rat to stain microglia. Dilutions (v:v): 1:100 for 
anti-GFAP and anti-CD11b, and 1:10 for anti-GLAST-PE in PBS containing 1% 
(w/v) BSA and 0.05% (v/v) TritonX. Next day, cells were washed with PBS and 
incubated with a fluorescence labeled secondary antibody Goat-Anti-Rabbit-IgG 
dyelight 488 nm, Goat-Anti-Rat-IgG dyelight 594 nm (Dianova) or Goat-Anti-
Rat-IgG dyelight 488 nm (Invitrogen) for 1 hour at room temperature in the dark, 
the secondary antibody was diluted 1:200 in PBS. After 1 hour, cells were 
washed with phosphate-buffered saline (PBS) and the nuclei were stained with 
1 µg/ml 4',6-diamidino-2-phenylindole (DAPI, Sigma) for 10 min at room 
temperature, after that, coverslips were washed with PBS and mounted on 
glass slides covered with mounting medium (Vectashield Vector) and pictures 
were taken with a fluorescence microscope (Axiovert 200M, ZEISS) equipped 
with a camera (AxioCam, ZEISS) and light source (HXP 120), using the 
software AxioVision Rel. 4.7.  
2.6 FACS 
2.6.1 Fluorescence Activated Cell Sorting (FACS) 
Flow cytometry using fluorescent-based separation is a useful scientific 
instrument which offers fast and accurate quantitative analysis of the 
fluorescent-labelled cell. Fluorescence activated cell sorting (FACS) is a type of 
flow cytometry that enables the separation and sorting of different cells into 
separate containers. The sorting of cells is performed according to their light 
scattering and fluorescent characteristics. In 1968, Wolfgang Göhde, from the 
University of Münster, developed the first fluorescence-based device. 
Afterwards, it was manufactured and commercialized by the German developer 
Partec through Phywe AG in Göttingen. 
In a mixture of cells, different types of cells have different surface markers. 
These markers can be specifically labelled using fluorescent labels such as 
fluorescent-coupled antibodies, and thereby become separable FACS. In 
addition, genetically-modified cells expressing fluorescent proteins could also 
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be separated from the non-fluorescent cells by FACS. In principle, Cells loaded 
into FACS will pass through a fast flowing liquid stream for single cells 
separation. Cells will be then presented in droplets, one cell per droplet, using 
vibration. They pass afterwards through a laser beam and the scattered light 
and the fluorescence emissions (upon excitation) of cells are detected. 
According to the scattered light and the fluorescent proprieties of cells, an 
electrical charge is applied to the stream immediately before the droplet tears 
off the stream. The charged droplet falls through an electrostatic deflection 
system that separates them into different containers according to its charge. 
2.6.2 Fixed and permeablized cell preparation for FACS 
Around 1.5 million astrocytes cultured for 2 to 3 weeks were trypsinized and 
suspended into culture medium. Cells were washed with PBS and fixed by 
incubation with 4% (w/v) PFA in PBS buffer for 10 min. Fixed astrocytes were 
centrifuged at 200 g for 7 min to remove the PFA solution and incubated in 
suspension in 0.5% (v/v) TritonX100 in PBS buffer to permeabilize the cells for 
10 min. Afterwards, cells were centrifuged at 200 g for 7 min to remove the 
TritonX100 and resuspended in 0.5% (w/v) BSA in PBS buffer. The cell 
suspension was divided into 4 tubes; the first one was used as the unstained 
control, the second and third were incubated for 10 min in the dark separately 
with anti-GFAP conjugated to Alexa 488 (1:100) (Cell Signaling) or anti-GLAST 
(1:10) (glutamate aspartate transporter) conjugated to Phycoerythrin (PE; 
Miltenyi Biotec). The fourth tube was incubated with both antibodies anti-GFAP-
Alexa488 and anti-GLAST-PE. After 10 min the tubes were centrifuged at 200 g 
for 7 min and washed two times, resuspended in fresh 0.5% BSA in PBS buffer 
and analyzed immediately in the FACS or kept on ice until FACS analysis 
(Moflo, Beckman Coulter). 
2.6.3 Living cell preparation for FACS 
Astrocytes cultured for 2 to 3 weeks after isolation were trypsinized and 
suspended into culture medium. Cells were washed with PBS and resuspended 
in 0.5% BSA in PBS buffer. The cell suspension was divided into several tubes, 
one was kept not stained as a control and the other tubes were used for 
staining of astrocytes and microglia markers. Anti-GLAST-PE (1:10) (Miltenyi 
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Biotec) was used as a surface marker of astrocytes, while anti-CD11b (1:10) 
conjugated to Fluorescein isothiocyanate (FITC) (Miltenyi Biotec) was used as a 
surface marker for microglia. Afterwards, cells were washed with 0.5% (w/v) 
bovine serum albumin (BSA) in PBS and loaded directly into the FACS (Moflo, 
Beckman Coulter). 
The sorter was first loaded with non-stained cells to characterize their size and 
granularity. The results obtained from this step showed that the obtained mouse 
cortical astrocyte culture consisted of two distinct populations in terms of size 
and granularity. Since astrocytes are bigger when examined under the 
microscope, the population which is bigger in size and has more granularities 
was assumed to be the astrocytic population, and the other population would be 
the microglia. Next, stained cells, with either single antibody or both antibodies 
against astrocytes and microglia markers, were analyzed in the FACS. The 
sorting decisions were made from the double stained tubes in respect to three 
parameters; size, granularity and positivity towards the staining. 100 astrocytes 
were sorted from the GLAST-positive CD11b-negative population, which is 
bigger in size and has more granularities, directly into RNase free PCR tubes. 
While 50 microglia cells were sorted from the GLAST-negative CD11b-positve 
population, that is smaller in size and has less granularities, directly into RNase 
free PCR tubes. The PCR tubes were placed immediately in liquid nitrogen and 
transferred to a -80°C freezer until they were used for RT-PCR. 
 
Figure ‎2-2. Fluorescence Activated Cell Sorting (FACS). (a) Scheme of 
forward (FSC) and side scatter (SSC) analysis of astrocytes culture showing the 
bigger cells with more granularity in red (astrocytes) and the smaller cells with 
FSC FITC channel
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less granularity in green (microglia). (b) Scheme of antibody-based 
fluorescence analysis of stained cells with anti-GLAST-PE (astrocytes in red) 
and anti-CD11b-FITC (microglia in green). 
2.7 Polymerase Chain Reaction (PCR) 
In 1971, Dr. Har Gobind Khorana’s group described the idea to amplify a DNA 
(Templeton, 1992). Later on in 1985, Kary B. Mullis invented the Polymerase 
Chain Reaction (PCR) which is used today in different fields, such as scientific 
research, clinical diagnostics and criminal investigations. PCR is a molecular 
biology tool that is used to amplify a fragment of DNA to generate thousands to 
millions of copies. This technique is based on an enzymatic reaction which is 
controlled by thermal cycling, where every cycle consists of heating and cooling 
steps. The generated DNA fragments after every cycle are used as templates 
for the next cycle. This reaction consists of 5 major components: DNA template, 
two primers that are complementary to the 3’ ends of each strand of the double 
strand DNA template, heat-stable DNA polymerase, desoxynucleoside 
trisphosphates (dNTPs) and buffer solution. The PCR is performed in 20 to 60 
cycles. Each cycle consists of 3 temperature steps ensuring different reactions: 
 Denaturation: This step is carried out for 15 – 30 s at 94 – 98°C, causing 
DNA melting by disrupting the hydrogen bonds between complementary 
bases and giving two single DNA strands. 
 Annealing: Depending on the primes, hydrogen bonds are formed 
between the primers and single strands of DNA at 55 to 65°C. This step 
takes around 15-30 s. 
 Elongation: After increasing the temperature to about 70°C for 20 to 40 
s, the DNA polymerase elongate the primers in 5’ - 3’ direction to form 
new DNA strand using dNTPs. 
At the end of the cycles, the reaction is kept for a few minutes at 70 - 75°C 
ensuring a complete extension of any single-stranded DNA. The reaction is 
stopped by applying low temperature of 10°C.  
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2.7.1 Reverse Transcription Polymerase Chain Reaction (RT-
PCR) 
The Reverse Transcription Polymerase Chain Reaction (RT-PCR) is a type of 
PCR which is used to investigate the gene expression. The RT-PCR uses the 
RNA as template to amplify a fragment from the studied transcript, but the PCR 
cannot be done directly on RNA. Thus, a reverse transcription reaction step 
must be done first to synthesize a complementary DNA (cDNA) which then can 
be used in the later PCR as a template. The reverse transcription can be done 
as part of a “RT-PCR” in the PCR tube, which is called one-step RT-PCR, or in 
two-steps in which the first strand cDNA synthesis is done independently, and 
the generated first strand is then used as template for PCR in an independent 
reaction.  
2.7.2 RNA Isolation 
The RNA could be isolated from cells or tissues using phenol–chloroform 
extraction, where proteins and DNA are trapped in the organic phase at pH of 4 
to 6 and the RNA stays in the aqueous phase (Chomczynski and Sacchi, 1987). 
Alternatively, silica-based membranes could be also used in which RNA binds 
specifically and could be eluted after washing out the contaminants i.e. DNA 
and proteins. In this work, the RNA was extracted using silica-based membrane 
method. After having the astrocytes, the total RNA was extracted using RNeasy 
Mini Kit (Qiagen) for samples with more than 5x105 cells, and RNeasy Micro Kit 
(Qiagen) for samples with less than 5x105 cells. All steps were performed at 
room temperature. Cells were disrupted using RLT buffer and the lysate was 
homogenized by centrifugation through a QIAshradder spin column for 2 min at 
17000 g. The flowthrough was mixed with 70% ethanol (equal volume as the 
RLT buffer used), transferred into an RNeasy spin column and centrifuged at 
17000 g for 1 min. After having the flowthrough discarded, RW1 buffer was 
added to the column, centrifuged at 17000 g for 1 min and the flowthrough was 
discarded. The spin column was washed twice with RPE buffer each 
centrifuged at 17000 g for 2 min. The column was centrifuged empty at 17000 g 
for 1 min to remove any residual ethanol. The RNA was eluted by adding 
nuclease-free water to the column and centrifugation of 1 min at 17000 g. The 
yielded RNA was checked by nanodrop (Thermo) and the integrity of the RNA 
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was assessed in the Experion automated electrophoresis station (BioRad). The 
RNA quality indicator (RQI) is assessed by the analysis of the ribosomal RNA 
(rRNA) since it represent more than 80% of the total RNA in the cell and its 
integrity would represent the one of mRNA. Thus 18S and 28S subunits of the 
rRNA are visualized by microcapillary electrophoresis, and the RQI is calculated 
from the 28S, 18S and pre-18S regions. The RQI scores are from 1 to 10, the 
value 1 indicates that the RNA is totally degraded and value 10 indicates that 
the RNA is completely intact (Biorad). 
2.7.3 One-Step Reverse Transcription Polymerase Chain 
Reaction 
One-step RT-PCR was performed on 100 sorted GLAST-positive astrocytes or 
50 sorted CD11b-positive microglia using SuperScriptTM One-Step RT-PCR with 
PlatinumR Taq (InvitrogenR). Each 25 µl reaction contained 12.5 µl 2X Reaction 
Mix (0.4 mM dNTP, 24 mM MgSO4), 0.5 µl RT/Platinum Taq DNA Polymerase, 
0.75 µl forward primer (10 pmol/µl), 0.75 µl reverse primer (10 pmol/µl) and 10 
µl RNase- DNase-free H2O. The thermal cycle profile of the reverse 
transcription and the PCR were done as following: 
1. 1st Strand Synthesis 50°C 30 min 
2.  PCR    94°C  2 min  
     94°C 15 s    1st to 15th cycle 
     62°C 15 s    1st to 15th cycle 
      70°C 20 s    1st to 15th cycle 
      94°C 15 s    16th to 45th cycle 
      62°C 15 s   16th to 45th cycle 
      70°C 20 s + 2 s/cycle  16th to 45th cycle 
      72°C  5 min 
     4°C  
Forward and reverse primers used are specific for mouse TRPC1, TRPC2, 
TRPC3, TRPC4, TRPC5, TRPC6, TRPC7 and HPRT1 DNAs and are shown in 
table 2-1. 
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Table ‎2-1 Exon-spanning oligodeoxynucleotide primers used in RT-PCR 
Gene Forward (5'->3')  Reverse (5'->3') Product size 
TRPC1 TAAAGATTTGCTCGCACA
AGCCC 
TTTGACTGGGAGACAAAC
TCCTTCTGG 
171 bp 
TRPC2 TCTGCCAGCTCACGAATC
GC 
TTTCGTTGAAATTGCCTAG
CTTCTCG 
173 bp 
TRPC3 CAGCATTCTCAATCAGCC
AACACG 
AAGATGGCTAATTCCTCC
GTCGC 
198 bp 
TRPC4 TGAGAAGGAAGCCAGAAA
GCTTCG 
CCTTAACATTCTCCTCCGT
CAAGCC 
168 bp 
TRPC5 GTGGGCGATGCATTACTC
TACGC 
GTGGGCTGCCAACATAAT
GGG 
168 bp 
TRPC6 TCCAGGAAATTGAGGATG
ATGCG 
TTGGAAGCCTTGCTTTTGA
CCC 
197 bp 
TRPC7 AGGCCAAACGCTGTGAAA
ACG 
CCGCTTCATGATCTTCTG
GTATCTGG 
152 bp  
HPRT GTCAACGGGGGACATAAA
AGTTATTGG 
GCTTGCAACCTTAACCATT
TTGGG 
160 bp 
 
2.7.4  Gel Electrophoresis 
Agarose gel electrophoresis was used to separate the DNA frangments by size. 
Hereby, 2% agarose gels were used because the expected size of the amplified 
DNA fragments was around 150 – 200 bp. The agarose gel was prepared by 
dissolving agarose standard (CarlRoth) in Tris/Borate (90 mM) EDTA (2 mM) 
buffer (1X TBE) and boiled for 2 to 3 min in a microwave. After cooling, ethidium 
bromide (0.5 µg/ml) was added and then the agarose loaded onto the gel tray. 
Samples were applied with loading buffer into the gel wells and run at 100 – 150 
V (Consort EV 261 Sigma-Aldrich). The loading buffer (6X) consisted of (w/v) 
15% Ficoll 400 (Sigma), 0.25% Bromophenol blue (Sigma) and 0.25% 
Xylencyanol (Sigma). Bands were visualized using UV light (312 nm) and 
photos were taken using (HeroLab UVT-28 ME-HC) equipped by a camera 
(Herolab B1228-U5). 
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2.8 TRPC1 and TRPC3 Full Length Amplification and Cloning 
2.8.1 Two-Steps Reverse Transcription Polymerase Chain 
Reaction 
Reverse transcription is a reaction that uses the RNA as template to synthesis a 
complementary DNA which then can be used as template in an independent 
PCR experiment. This reaction is carried out in the presence of reverse 
transcriptase, primers that can hybridize on the RNA and dNTPs. 
The first strand cDNA was synthetized from RNA isolated from astrocytes using 
the Maxima first strand cDNA synthesis kit (Thermo Scientific). 734.51 ng of 
RNA (104.93 ng/µl) was mixed with 4 µl 5X Reaction Mix (reaction buffer, 
dNTPs, oligo (dT) and random hexamer primers), 2 µl Maxima Enzyme Mix 
(Reverse Transcriptase and Thermo Scientific RiboLock RNase Inhibitor) and 7 
µl of nuclease-free water. The mixture was incubated for 10 min at 25°C 
followed by 15 min at 50°C. The reaction was terminated by heating the mixture 
at 85°C for 5 min. The generated first strand cDNA was stored at -20°C. 
The PCR was performed using KOD Xtreme™ Hot Start DNA Polymerase 
(Merck Millipore). Every reaction contains 25 µl of PCR mix which consists of 3 
µl cDNA (obtained from reverse transcription of 734.51 ng of RNA, see above), 
12.5 µl 2X Xtreme Buffer, 5 µl dNTPs (0.4 mM), 0.75 µl forward primer (10 
pmol/µl), 0.75 µl reverse primer (10 pmol/µl), 2.5 µl nuclease-free H2O and 0.5 
µl KOD-Xtreme polymerase (1 U/µl). Forward and reverse primers specific to 
full length sequence i.e. the 5’ and 3’ ends of the protein-coding DNAs of mouse 
TRPC1 VL and TRPC3 are shown in table 2-1. The PCR amplification consists 
of 40 cycles, with cycle profile as following: 
    94°C  2 min  
    98°C 10 s   1st to 40th  cycle 
     62°C 30 s   1st to 40th  cycle 
     68°C 3 min   1st to 40th  cycle 
     68°C  5 min 
    4°C  
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Oligodeoxynucleotide Primers used in the PCR reaction were specific for 
mouse TRPC1 VL and TRPC3 and cover the 5’- and 3’-DNA sequence which 
encodes full length of TRPC1 VL and TRPC3, as shown in table 2-2. 
Table ‎2-2 Oligodeoxynucleotide Primers used to obtain full length TRPC 
cDNAs 
cDNA Forward (5'->3') Reverse (5'->3') Product size 
TRPC1 
VL(*) 
[Phos]GATGACGTGAGGAG
AAAGCC 
[Phos]TTAATTTCTTGGATAA
AACATAGC 
2880 bp(*) 
TRPC3 [Phos]ATGTCCACCAAGGTC
AAGAAG 
[Phos]TCACTCACATCTCAG
CACACTG 
2733 bp 
(*) the primers used to amplify TRPC1 VL DNA were 201 nucleotides upstream 
the new start codon CTG. Thus the coding sequence is 2679 bp. 
2.8.2 Gel Extraction and DNA Purification 
Samples were separated by gel electrophoresis (0.8% agarose gel) and DNA 
fragments of the expected sizes were excised from the gel. After that, DNA 
fragments were separated from the gel using Wizard SV Gel and PCR Clean-
Up System (Promega) which uses the ability of DNA to bind to silica 
membranes in the presence of guanidine isothiocyanate. 10 mg of excised gel 
was incubated with 10 µl of membrane binding solution at 50-65°C until the gel 
slice was completely dissolved. The dissolved gel was transformed and 
incubated for 1 min at room temperature into SV Minicolumn and then 
centrifuged at 16000 g for 1 min. The flow-through was discarded and the 
column was washed two times by adding 700 µl of membrane wash solution 
and centrifuged at 16000 g for 1 min. The column was incubated with 50 µl 
nuclease-free water for 1 min followed by centrifugation at 16000 g for 1 min to 
elute the DNA in a new nuclease-free tube. 
2.8.3 Ligation of Fragments into Vectors 
The vector used for ligation was pUC19 which consists of 2686 bp and contains 
an ampicillin resistance gene. The vector was cut using the SmaI restriction 
enzyme which cuts at 5’….CCC/GGG….3’. DNA fragments were incubated 
overnight at 14°C with the vector (ratio sample/vector is 3/1 estimated by 
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running both on an agarose gel) in the presence of 1.5 µl ligase buffer, 1 µl of 
T4 DNA ligase (NEB) and H2O to achieve 15 µl as final volume. 
2.8.4 Transformation  
Transformation was carried out using competent E.coli cells by heat shock. 15 
µl of the ligation reaction of each DNA samples were added to 300 µl of E.coli 
and incubated on ice for 30 min. Mixtures were exposed to heat shock at 42°C 
for 1 min and then chilled on ice for 2 min. Samples were supplemented with 
700 µl of LB medium and incubated at 37°C in a shaker incubator for 1 h. On 
each sample, 200 µl 5-bromo-4-chloro-indolyl-β-D-galactopyranoside (XGal 40 
mg/ml) and 50 µl Isopropyl-β-D-thiogalactopyranosid (IPTG 0.1 M) were added 
and then they were plated onto LB-ampicillin agar plates and incubated at 37°C 
overnight. XGal (colorless) and IPTG were used to distinguish the colonies 
which have been transformed with the DNA fragments from those which have 
not. The E.coli contains lacZΔM15 mutant gene (β-galactosidase is coded by 
lacZ) and the vector contains the complementary α-peptide-coding sequence. 
When the DNA fragment is inserted at the multiple cloning site, the E.coli cells 
are not able to produce the β-galactosidase and therefore are not able to 
hydrolyze the XGal (white colonies). The others, i.e. E.coli carrying empty 
vector or the insertion was not at the multiple cloning site, are able to produce 
functional β-galactosidase and thus the XGal will be hydrolyzed and gives a 
blue color (blue colonies). This is called blue-white selection of colonies.  
2.8.5  DNA Preparation 
Using the Mini prep kit (Sigma - Aldrich), single white E.coli colonies from 
procedure  2.8.4) were inoculated into 5 ml LB-ampicillin medium for each 
colony and incubated overnight at 37°C in a shaker incubator. 1.5 ml of cell 
suspension was spun down at 12000 g for 2 min and the supernatant was 
discarded. Cells were lysed by adding 200 µl of lysis buffer (Sigma - Adrich) and 
gently inverted in the tubes for 6-8 times. 350 µl of neutralization/binding buffer 
was added and samples were centrifuged at 12000 g for 10 min. The 
supernatant was transferred into a Miniprep Binding Column and centrifuged at 
12000 g for 1 min (flow-through liquid was discarded). 500 µl of wash solution 1 
(Sigma - Adrich) was added and samples were centrifuged at 12000 g for 1 min 
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(flow-through liquid was discarded). The previous step was repeated with wash 
solution 2. The column was transferred into a new collection tube, 100 µl of 
elution solution was added to the column and centrifuged at 12000 g for 1 min. 
DNA samples were stored at -20°C. 
2.8.6 Restriction Analysis  
For analyzing the TRPC1 VL and TRPC3 cDNAs in the pUC19 vector using the 
Accelrys Gene software, four restriction enzymes were chosen. For TRPC1 VL, 
Kpnl and Xhol were used; positive clones should yield two distinct bands. In the 
case of sense insertion, 3078 and 2488 bp fragments will be obtained, and in 
the case of antisense 5174 and 392 bp will be obtained for TRPC1 VL. For 
TRPC3, Xbal and PshAl cuts yield in the case of sense insertion, 3690 and 
1729 bp fragments and in the case of antisense 4397 and 1022 bp. The 
restriction reactions were analyzed by gel electrophoresis and positive clones 
were sequenced on both strands by Seqlab sequencing service in Göttingen, 
Germany. 
2.9 Monitoring of Cytoplasmic Ca2+ by Fura-2 
In 1985, Roger Tsien’s group has developed a fluorescent Ca2+ indicator called 
Fura-2 (Grynkiewicz et al., 1985). Since then many other ion selective 
fluorescent dyes have been developed. Today, the most common way to 
measure changes of Ca2+ in the cytoplasm is using fluorescent dyes as e.g. 
Fluo-4 and Fura-2. In the present study, Fura-2 was used to study Ca2+ 
concentration changes in mouse cortical astrocytes. Because Fura-2 is polar 
and thus not membrane permeable, ester form, Fura-2-AcetoxyMethyl (Fura-2-
AM), was used which is membrane permeable (nonpolar). Once it is inside the 
cell it will be de-esterified by intracellular esterases and becomes trapped and 
able to bind free Ca2+ (Figure  2-3). 
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Figure ‎2-3 Loading cells by Fura-2 AM. Fura-2 AM is nonpolar and Ca2+-
insensitive and membrane permeable. Once it is inside the cell, it is hydrolyzed 
by cytoplasmic esterases into the polar, Ca2+-sensitive form. 
Fura-2 is a fluorescent dye changing its excitation spectrum due to the binding 
of Ca2+ ions. Upon Ca2+ binding the excitation peak shifts from 380 nm towards 
340 nm, the emission spectrum stays independent of Ca2+ with a peak at about 
510 nm. At the excitation wavelength of 360 nm, Fura-2 fluorescence intensity 
is Ca2+-independent; this wave length is called isosbestic wavelength. The more 
Ca2+ is bound to Fura-2, the fluorescence emission at 340 nm excitation 
increases and the fluorescence emission at 380 nm decreases (Figure  2-4). 
Thus, Fura-2 is used in a dual excitation system, which measures separately 
the fluorescence emission for both excitation wavelengths, and therefore the 
changes at cytoplasmic Ca2+ concentrations are expressed as the ratio 
F340/F380. Since the F340 increases with Ca
2+ binding and the F380 
decreases, the ratio F340/F380 increases when the cytoplasmic Ca2+ rises 
(Figure  2-4). Therefore, the use of ratiometric measurement eliminates the 
differences in the amount of Fura-2 loading of the different cells. 
Esterase
Ca2+
Fura-2 AM Fura-2
Cell membrane
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Figure ‎2-4 Excitation and emission spectra of Fura-2. The fluorescence 
emission intensity for Fura-2 depends on the excitation wavelengths and on the 
Ca2+ concentration. The excitation peak shifts from 380 nm towards 340 nm 
upon Ca2+ binding. The fluorescence emission at 360 nm stays independent of 
Ca2+ binding is called isosbestic wavelength and is a direct measure of the 
amount of Fura-2 per cell (adapted from Leica). 
2.10 Fura-2 Experiment 
Primary astrocytes, cultured for 2 to 3 weeks, were subcultured for 4 to 6 days 
on glass coverslips coated with P-L-L. Before imaging, cells were loaded for 40 
min with 5 µM Fura-2-AM in medium and incubated in the dark in the presence 
of 5% CO2 at 37°C. Afterwards, cells were washed with 0 or 2 mM Ca
2+-based 
solution (Table  2-3) and the coverslip was fixed in an open or closed chamber 
either for direct application of solutions into the bath or for perfusion, 
respectively. The perfusion system consisted of 8 channels; these channels 
were filled with the appropriate external solutions. Different compounds were 
dissolved in the desired channel, and an aspirating pump was used to generate 
a stable flow of approximately 3 ml/min. The chamber was placed on a 
monochromator (Polychrome V, TILL-Photonics) equipped inverted microscope 
(Axivert S100, Carl Zeiss). Every 2 s Fura-2 was alternately excited at 340 nm 
and 380 nm for 30 ms each and the emitted fluorescence (~510 nm) were 
recorded with a charge-coupled device (CCD) camera (Imago, TILL-Photonics, 
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Germany). Ratio images were calculated from 340 and 380 nm pictures after 
background correction i.e. subtraction of the fluorescence intensity at 340 and 
380 nm excitation of a cell-free region prior to calculate the ratio. Single cells 
were marked as regions of interest and F340/F380 was plotted versus time. The 
monochromator, camera acquisition and analysis were controlled by Till-Vision 
software (TILL-Photonics). 
2.11 Electrophysiological recordings 
The patch clamp technique allows the recording of single or multiple ion 
channels activities in cells. This technique was first developed by Erwin Neher 
and Bert Sakmann, who were awarded the Nobel Prize in Physiology or 
Medicine for his achievement in 1991. Patch clamp recording uses a glass 
micropipette called a patch pipette as a recording electrode, and another 
electrode in the bath around the cell, as a reference ground electrode 
(Figure  2-5). Several configurations could be used to measure ion channels 
including, the cell-attached, the inside-out, outside-out and the whole cell mode. 
In this work, the whole cell mode was employed which allows the recordings 
from all active ion channels in the plasma membrane. The patch pipette is filled 
with a solution of defined ion composition and concentrations depending on the 
aimed ion channel, and contains the measuring electrode as well. To begin the 
measurements, the cytoplasm of the measured cell has to be exchanged by the 
pipette solution allowing access to the measuring electrode which is also used 
to control the membrane potentials. To achieve this configuration, the patch 
pipette is brought in very close contact with the cellular membrane to get a 
gigaseal i.e. the pipette resistance at this stage has gigaohm (GΩ) readings, 
then light sucking is applied to break into the cell. 
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Figure ‎2-5 Whole cell patch clamp recording. Representative schema of the 
whole cell patch clamp shows two electrodes, one as a bath electrode and 
another one as a measuring electrode in the patch pipette. The pipette solution 
replaces the cytoplasm upon break-in and the flow of ions upon channels 
activation is measured as a current. 
2.11.1 TRPC3 currents recording 
Membrane currents were recorded in the tight seal whole-cell patch clamp 
configuration using an EPC-9 amplifier (HEKA Electronics, Lambrecht, 
Germany). Patch pipettes were pulled from glass capillaries GB150T-8P 
(Science Products, Hofheim, Germany) at a vertical Puller (PC-10, Narishige, 
Tokyo, Japan) and had resistances between 2 and 4 MΩ when filled with 
standard internal solution (pipette solution). The different used solutions are 
listed in section (‎2.18). The compounds used for external application were 
diluted into the extracellular solution to achieve the final concentration as 
indicated. All modified solutions were directly applied onto the patch-clamped 
cell via an air pressure-driven application pipette. Osmolarity of all solutions 
were controlled to range between 290 and 310 mOsm. Voltage ramps of 400 
ms duration spanning a voltage range from -100 to 100 mV were applied at 0.5 
Hz from a holding potential (Vh) of 0 mV over the period of the measurements 
using the PatchMaster software (HEKA). All voltages were corrected for a 10 
mV liquid junction potential. Currents were filtered at 2.9 kHz and digitized at 
100 ms intervals. Capacitive currents and series resistance were determined 
and corrected before each voltage ramp using the automatic capacitance 
compensation of the EPC-9. Inward and outward currents were extracted from 
each individual ramp current recording by measuring the current amplitudes at -
80 and +80 mV, respectively, and plotted versus time. Basic currents before an 
Ca / Na
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application were subtracted to get the net developing current. Current-voltage 
(IV) relationships were extracted at indicated time points. Currents were 
normalized to the initial size i.e. capacitance of the cell to obtain current 
densities (pA/pF).  
 
Figure ‎2-6 Voltage ramp protocol for whole cell patch clamp recording. (a) 
Representative scheme of a 400 ms voltage ramp spanning from -100 to 100 
mV from a holding potential (Vh) of 0 mV, used to measure whole cell currents 
by patch clamp experiments. (b) Example trace of a current-voltage relationship 
where inward and outward currents could be extracted at -80 and +80 mV from 
each individual ramp current and plotted versus time. 
2.11.2 CaVs currents recording 
The same setup and general configurations as described for TRPC3 current 
recordings ( 2.11.1) were used to measure the CaVs, however different bath 
solution were employed (Table  2-5 and Table  2-6). Voltage ramps of 50 ms 
duration spanning a voltage range from -100 to 100 mV were applied at 0.5 Hz 
from a holding potential (Vh) of -60 mV over the period of the measurements 
using the PatchMaster software (HEKA). After measuring for 3 to 5 min in the 
ramp protocol, voltage steps of 400 ms duration were applied from -70 to 90 mV 
in 10 mV increase from a holding potential of -60 mV. All voltages were 
corrected for a 5 mV liquid junction potential. Currents were filtered at 2.9 kHz 
and digitized at 100 ms intervals, and linear leak was subtracted by auto-leak 
subtraction feature from PatchMaster software (HEKA). Capacitive currents and 
series resistance were determined and corrected before each voltage ramp 
using the automatic capacitance compensation of the EPC-9. The maximum 
current-voltage (IV) relationships were extracted from the ramp protocol and 
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normalized to the initial size of the cell to obtain current densities (pA/pF). In the 
step protocol, the current-voltage (IV) relationships were constructed from 
plotting the peak currents of each step versus the applied voltages and 
normalized to cell size. In addition, the current of the maximum step was plotted 
versus the step time in ms to obtain the inactivation kinetics. The activation (act) 
and inactivation (inact) kinetics were calculated from the maximum current 
obtained from the step protocol using the following single exponential equation: 
y = 𝑦0 + A
−(𝑥−𝑥0)
𝜏  
 
Figure ‎2-7 Voltage ramp and step protocols for whole cell patch clamp 
recording. (a) Representative scheme of a 50 ms voltage ramp spanning from -
100 to 100 mV from a holding potential (Vh) of -60 mV, used to measure whole 
cell voltage-gated ion currents by patch clamp experiments. (b) Representative 
scheme of voltage steps used to measure whole cell voltage-gated ion currents 
by patch clamp experiments showing steps of 400 ms from -70 to 90 mV (10 
mV increments) and holding potential (Vh) of -60 mV. 
2.12 Migration Assay 
Astrocytes migration was analyzed using a scratch assay in which the migration 
rate of cells is assessed by their speed in covering a defined scratched area on 
a confluent cell layer. Cells were plated in 6-well plates which were previously 
coated with poly-L-lysine and scratched from the outside bottom using a needle 
as an external marker to help taking pictures from the exact same region 
(Figure  2-8 blue lines). All migration experiments were always performed with 
TRPC deficient and the corresponding wild-type astrocytes at the same time. 
Once cells reached confluency, two scratches were performed in every well 
(vertical to the needle scratch) using a 200 µl pipette tip. Wells were washed 
with PBS to remove the detached cells and incubated with 0% FCS medium to 
Vh -60 mV
400 ms
-70 mV
90 mV
0 mV
-100 mV
100 mV
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-60 mVVh
0 mV
a b
Materials and Methods 
 
Universität des Saarlandes  40 
 
inhibit the proliferation at 37°C 5% CO2. At 0, 4, 8 and 24 hours, 4 pictures per 
well (Figure  2-8) were taken from the scratches, at the crossing between the 
scratch line and the external needle scratch, using a phase-contrast light 
microscope (Axiovert 40C, ZEISS) equipped with a camera (AxioCam, ZEISS). 
Migration was quantified as the average of the cell-free scratch areas 
reoccupied by the migrated cells using Image J software. All the measured 
areas were normalized to the 0 hour area (100% cell-free area). 
 
Figure ‎2-8 Migration Assay in 6-well plate. 6-well plate scratched from the 
outside bottom with a needle (green horizontal lines) as markers for pictures. 
The cell scratches on the confluent cell layer were made with 200 µl pipette tip 
(white vertical lines). After the scratches, the 10% FCS medium was substituted 
with a 0% FCS medium to stop proliferation and photos are taken from the area 
where the cell and needle scratches meet (red box). 
2.13 Cortical stab wound surgery 
The cortical stab wound experiment is a surgical technique used to study the 
astrogliosis and glial scar formation in the cortex (Saadoun et al., 2005). All 
experiments were performed in the laboratory of Prof. Frank Kirchhoff under the 
supervision of Dr. Anja Scheller in the Department of Physiology at Saarland 
University. I obtained the approval to perform the stab wound surgery from state 
of Saarland under the name: “Einfluss von TRPC3 Kationenkanälen auf die 
Wundheilung im ZNS” AZ C1-2.4.2.2/11-2015. Mice were anesthetized using 
ketamine (87 mg/kg body weight) and xylazine (13 mg/kg body weight) via 
Outside 
needle scratch 
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scrtach cells cells 
Materials and Methods 
 
Universität des Saarlandes  41 
 
intraperitoneal injection and kept inside cages until the complete loss of 
reflection upon application of presser on the rear feet. Anesthetized mice were 
then transferred onto a stereotaxic instrument equipped with heating plate set at 
35°C to prevent anesthesia-induced hypothermia. After having wiped the top of 
the head with 70% ethanol, a 1 cm long incision in the skin was made in the 
middle of the head following the sagittal plane using a sharp scalpel. The 
membrane which covers the skull was removed with forceps. Using an electric 
drill, the skull was thinned (3 to 4 mm length), in the right hemisphere region 
located 2 mm from the sagittal suture and 4 mm from the olfactory lobe, 
followed by an insertion of a 3 mm wide scalpel in the thinned region 2 mm 
deep into the cortex (Figure  2-10) directed by a stereotactic arm. After cleaning 
the blood, the skin was sutured and animals received buprenorphine (0.05 
mg/kg) via subcutaneous injection to relieve the pain; animals were kept in 
cages on a heating plate until they regained consciousness. Then they were 
transferred in the mice-housing room. Mice were kept and monitored for three 
days; afterwards the following procedure was performed. 
 
Figure ‎2-9 Cortical stab wound surgery. Schematic representation of the 
position of the wound performed on the mouse cerebral cortex of the right 
hemisphere 4 mm away from the olfactory bulb and 2 mm from the sagittal 
suture. The wound is parallel to the sagittal suture and has a length of 3 mm 
and 2 mm in depth. Image adapted from “The Anatomy of the Laboratory 
Mouse” Margaret J. Cook. 
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2.14 Mice fixation with paraformaldehyde (PFA) 
Three days after the surgery, mice were again anesthetized via intraperitoneal 
injection using ketamine (87 mg/kg body weight) and xylazine (13 mg/kg body 
weight) and kept inside cages until the complete loss of reflection upon 
application of presser on the rear feet. Mice were fixed onto a plate and the 
thorax was opened using sharp scissors. Under the hood 30 ml PBS followed 
by 30 ml 4% PFA were perfused by inserting a 25 G needle into the left 
ventricle and opening the right atrium. The perfused brains were removed and 
kept fixed further overnight in 4% PFA solution and used later for 
immunohistochemical analysis. 
2.15 Immunohistochemistry on brain slices 
Brains incubated overnight in 4% PFA were washed with PBS, trimmed with 
scalpel and mounted caudal side-down on a vibratome (Leica) with tissue glue 
(Loctite). 35 µm thick coronal sections were made in the wound region and 4 
representative sections were taken from each brain for immunostaining. Slices 
were placed in 48 well plate and incubated with 3% (v/v) TritonX (Roth) / 5% 
(v/v) donkey serum in PBS to permeablize the tissue and block the unspecific 
binding sites for 1 hour at room temperature. Then the blocking solution was 
removed and replaced by the same solution containing the primary rabbit anti-
GFAP antibody (Dako) (1:1000) and incubated overnight at 4°C. The next day, 
slices were washed 3 times with PBS and incubated at room temperature for 1 
hour with the secondary antibody donkey anti-rabbit Alexa 555 antibody 
(Invitrogene) (1:1000) to visualize the primary anti-GFAP antibody, and 1 µg/ml 
DAPI to stain the nuclei. Then, slices were washed and mounted on glass slides 
with a mounting medium (Thermo) and pictures were taken with a fluorescence 
microscope (Axiovert 200M, ZEISS) equipped with a color camera (AxioCam, 
ZEISS), using the software AxioVision Rel. 4.7 as mosaic images with 10% 
overlap. Images were analyzed with AxioVision by measuring three parameters: 
the area of reactive astrocytes (GFAP-stained cells), cortex edema as the 
increase in the cortex thickness, and distribution of reactive astrocytes 
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measured from the fluorescence intensity of the GFAP staining along the cortex 
(Figure  2-10). 
 
Figure ‎2-10 Cortical stab wound analysis. The cortical wound was analyzed 3 
days after the surgery. As early as possible after immunostaining against GFAP 
(inset), the area of reactive astrocytes i.e. area of GFAP-stained astrocytes 
(orange area) was determined. The cortical edema was measured from the 
increase in the cortex thickness (blue arrows). The distribution of the reactive 
astrocytes is obtained from the GFAP fluorescence intensity of the boxes along 
the cortex (injured and non-injured) after subtracting the background intensity 
(box B). 
2.16 Pharmacological compounds used in Ca2+ imaging and 
patch clamp experiments 
Compound  Provider Used at final 
concentration of 
Thapsigargin (TG) Invitrogen 2 µM 
Cyclopiazonic Acid (CPA) Calbiochem 10 µM 
1-Oleoyl-2-acetyl-sn-glycerol (OAG) Calbiochem 100-300 µM 
Phorbol 12-myristate 13-acetate (PMA) Calbiochem 1 µM 
Nifedipine Sigma-Aldrich 10 µM 
Verapamil Tocris 10 µM 
Isradipine Tocris 1-100 µM 
-Agatoxin-IVA Tocris 2 µM 
-Conotoxin-GVIA Tocris 1 µM 
SNX482 Tocris 300 nM 
Tetrodotoxin (TTX) Tocris 10 µM 
B
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2.17 Statistical Analysis 
Data were analyzed using Till-Vision (Till Photonics), PatchMaster software 
(HEKA), Microsoft Excel, Igor Pro 5.1 (WaveMetrics), AxioVision Rel. 4.7 
(ZEISS) and ImageJ (NIH). Data are shown as mean ± SEM with (xx/y) 
indicating the number of analyzed cells, scratches or mice (xx) per performed 
experiments (y). To estimate the significance of differences, Student’s t-test for 
two groups and one way ANOVA followed by Bonferroni test for more than two 
groups. The difference was found significant if the P-value < 0.05 (*), <0.01 (**) 
or < 0.001 (***). 
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2.18  Solutions for Fura-2 and patch clamp experiments 
All prepared solution were adjusted to a pH of 7.2 with NaOH or CsOH for Na+- 
or Cs+-based solutions respectively, and only solution with an osmolarity 
between 290 to 310 mOsm were used.  
Table ‎2-3 Solutions used in Ca2+ imaging experiments 
 
 
Table ‎2-4 Patch clamp external solutions used for recording of TRPC 
currents 
 
  
Solutions
Compound (mM ) 10 mM Ba2+ 0 mM Ba2+ 0 Na+
NaCl 102 130 0
MgCl2 1 1 1
CsCl 5.4 5.4 107.4
TEACl 20 20 20
HEPES 5 5 5
Glucose 10 10 10
BaCl2 10 0 10
Solutions
Compound (mM ) 2 mM Ca2+ 0 Ca2+ 50 mM  K+ 0 K+
NaCl 140 140 94 140
KCl 4 4 50 0
MgCl2 1 3 1 1
HEPES 10 10 10 10
Glucose 10 10 10 10
CaCl2 2 0 2 2
Solutions
Compound (mM ) 1 mM Ca2+ 0 Ca2+
NaCl 140 140
KCl 0 0
MgCl2 1 3
HEPES 10 10
Glucose 10 10
CaCl2 2 0
Solutions
Compound (mM ) 100 nM Ca2+ 0 Ca2+
CsMs 140 140
NaCl 8 8
MgCl2 1 1
HEPES 10 10
CaCl2 3.1 0
BAPTA 10 10
Solutions
Compound (mM ) 10 mM Ba2+ 0 mM Ba2+ 0 Na+
NaCl 102 130 0
MgCl2 1 1 1
CsCl 5.4 5.4 107.4
TEACl 20 20 20
HEPES 5 5 5
Glucose 10 10 10
BaCl2 10 0 10
Solutions
Compound (mM ) 2 mM Ca2+ 0 Ca2+ 50 mM  K+ 0 K+
NaCl 140 140 94 140
KCl 4 4 50 0
MgCl2 1 3 1 1
HEPES 10 10 10 10
Glucose 10 10 10 10
CaCl2 2 0 2 2
Solutions
Compound (mM ) 1 mM Ca2+ 0 Ca2+
NaCl 140 140
KCl 0 0
MgCl2 1 3
HEPES 10 10
Glucose 10 10
CaCl2 2 0
Solutions
Compound (mM ) 100 nM Ca2+ 0 Ca2+
CsMs 140 140
NaCl 8 8
MgCl2 1 1
HEPES 10 10
CaCl2 3.1 0
BAPTA 10 10
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Table ‎2-5 Patch clamp external solutions used for recording of voltage-
gated Ca2+ currents  
 
 
Table ‎2-6 Pipette solutions used for recording of TRPC and CsVs patch 
clamp experiments 
 
 Ms stands for methanesulfonate. 
 TEA stands for Tetraethylammonium  
 BAPTA stands for 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic 
acid 
 The 100 nM free Ca2+ was calculated with Webmaxc Standard 
(http://web.stanford.edu/~cpatton/webmaxcS.htm). 
 
Solutions
Compound (mM ) 10 mM Ba2+ 0 Ba2+ 0 Na+
NaCl 102 130 0
MgCl2 1 1 1
CsCl 5.4 5.4 107.4
TEACl 20 20 20
HEPES 5 5 5
Glucose 10 10 10
BaCl2 10 0 10
Solutions
Compound (mM ) 10 mM Ba2+ 0 mM Ba2+ 0 Na+
NaCl 102 130 0
MgCl2 1 1 1
CsCl 5.4 5.4 107.4
TEACl 20 20 20
HEPES 5 5 5
Glucose 10 10 10
BaCl2 10 0 10
Solutions
Compound (mM ) 2 mM Ca2+ 0 Ca2+ 50 mM  K+ 0 K+
NaCl 140 140 94 140
KCl 4 4 50 0
MgCl2 1 3 1 1
HEPES 10 10 10 10
Glucose 10 10 10 10
CaCl2 2 0 2 2
Solutions
Compound (mM ) 1 mM Ca2+ 0 Ca2+
NaCl 140 140
KCl 0 0
MgCl2 1 3
HEPES 10 10
Glucose 10 10
CaCl2 2 0
Solutions
Compound (mM ) 100 nM Ca2+ 0 Ca2+
CsMs 140 140
NaCl 8 8
MgCl2 1 1
HEPES 10 10
CaCl2 3.1 0
BAPTA 10 10
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3 Results 
3.1 Characterization of mouse cortical astrocyte cultures 
It is well accepted that primary astrocyte cultures contain noticeable 
percentages of microglia and oligodendrocytes. However the presence of other 
cell types could indicate a contamination from other tissue, for instance the 
presence of fibroblast in the astrocyte culture means that the meninges where 
not completely removed. To estimate the purity of the mouse cortical astrocyte 
culture, confluent cultures in flasks obtained from mouse cortices were plated 
on glass coverslips and stained with antibodies against glial fibrillary acidic 
protein (GFAP), an astrocyte specific marker and CD11b, a microglia specific 
marker. 90% of the cells were GFAP-positive, 9% of the cells were CD11b 
positive and 1% of the cells were neither stained with GFAP nor with CD11b 
antibodies, analyzed from 4 images. There was no co-staining of both 
antibodies in the same cells; however some microglia cells were on top of 
astrocytes which appeared as co-staining but in fact it was not (Figure  3-1).  
 
Figure ‎3-1. Immunocytochemistry of a mouse cortical astrocyte culture. 
Cells are stained with antibodies against GFAP (green) for astrocytes and DAPI 
(blue) to visualize the nuclei, CD11b (red) for microglia. The merge image 
shows no co-staining between the astrocytic and microglia markers, except 
some microglia cells were on top of astrocytes that gave a yellow color. 
3.2 TRPC Expression in mouse cortical astrocyte cultures 
RNA was extracted from three independent astrocyte cultures which were 
shown to contain 90% astrocytes; the extracted RNA was used for RT-PCR. 
Fragments for TRPC1, TRPC2, TRPC3, TRPC4, TRPC6, TRPC7 and HPRT 
transcripts were amplified at the expected sizes except for TRPC5 that revealed 
DAPI GFAP CD11b Merge
20 µm 20 µm 20 µm20 µm
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a band at about 75 bp instead of 168 bp (Figure  3-2). The amplified fragments 
of TRPC transcripts were visualized on 2% agarose gel. Although the astrocyte 
cultures contained around 87% astrocytes, this does not mean that the non-
astrocytic cells will not contribute to the RNA extracted from the cultures. 
Therefore, a second strategy was used to ensure that transcripts are only 
derived from astrocytes.  
 
Figure ‎3-2 TRPC transcripts expression in mouse cortical astrocytes. 
Agarose gels from three independent RT-PCRs performed with RNA extracted 
from enriched astrocyte cultures. DNA-fragments of the expected sizes, were 
amplified by and one-step RT-PCR for HPRT (160 bp), TRPC1 (171 bp), 
TRPC2 (173 bp), TRPC3 (198 bp), TRPC4, (168 bp), TRPC6 (197 bp), TRPC7 
(152 bp), but not for TRPC5 (168 bp) and run on a 2% agarose gel. All three 
RT-PCR gels are shown in supplementary figure S1. 
3.3 Analysis of astrocytes by flow cytometry 
Fluorescence-activated cell sorting (FACS) was used to separate the astrocytes 
from contaminating cells. The fluorescent anti-GFAP antibody cannot be used 
for FACS because GFAP is a cytoplasmic protein and cell permeablization is 
required stain with a specific antibody. The glutamate aspartate transporter 
(GLAST) is localized in the cell membrane and can also be used as an 
astrocytes marker (Jungblut et al., 2012). Thereby, intact living cells can be 
sorted and thereafter be used for RNA extraction or one-step RT-PCR. First we 
check whether the same cell population is stained by the anti-GFAP and the 
anti-GLAST antibodies. After shaking off most of the microglia cells, fixed and 
permeablized astrocytes were stained with anti-GLAST conjugated with PE and 
anti-GFAP conjugated with FITC either separately or combined. Therefore, the 
cells were analyzed by analytical fluorescence-activated cell sorting. The 
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analysis of the forward (FSC) and side scattered (SSC) light (Figure  3-3-a) 
indicates that the fixed and permeablized cells are still intact and not 
fragmented, and the non-stained cells do not exhibit any fluorescence in the 
FITC and PE channels (Figure  3-3-b). Most of the cells stained with anti-GFAP-
FITC shifted towards the FITC channel (R18, Figure  3-3-c); they were spread 
along the channel which indicates differences in the amount of the GFAP 
protein in these cells. The amount of GFAP defines fluorescence intensity. Cells 
stained with anti-GLAST-PE shifted towards the PE channel (R15, Figure  3-3-
d), but under this condition cells accumulated in a small area indicating a more 
homogeneous amount of GLAST than of GFAP in astrocytes. GFAP and 
GLAST are proposed to be astrocyte-specific markers and fixed and 
permeablized astrocytes were stained with both anti-GFAP-FITC and anti-
GLAST-PE antibodies. 96% of the cells shifted towards the right upper corner 
(R16 in Figure  3-3 e) of the flow cytometer analysis window which shows that 
these cells are stained with both antibodies. This result confirms the result 
obtained by the anti-GFAP and anti-CD11b staining of the astrocytes culture 
and the counting under the microscope (Figure  3-1). It also shows that shacking 
off the microglia increases the percentage of astrocytes.  
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Figure ‎3-3 Flow cytometry analysis of the fixed and permeabilized 
astrocytes. (a) Forward (FSC) and side scatter (SSC) analysis of the fixed and 
permeabilized astrocytes showed one population. (b) Analysis of the non-
stained astrocytes on the PE and FITC channels where it shows no reactivity 
from those cells in both channels (R17). (c) Cells stained with only anti-GFAP-
FITC did migrate towards the FITC channel (R18), and (d) cells stained with 
only anti-GLAST-PE did migrate towards the PE channel (R15). (e) 96% of the 
cells stained with both anti-GFAP-FITC and anti-GLAST-PE did migrate toward 
the upper left corner of the analysis window indicating that those cells are 
actually reactive to both channels due to the expression of GFAP and GLAST 
markers (R16). 
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3.4 Sorting astrocytes using preparative FACS 
 
Figure ‎3-4 Preparative FACS of astrocytes and microglia. (a, c, e and g) 
representative experiments from 5 experiments of the forward (FSC) and side 
(SSC) scatter of cells from the staining conditions showed a consistency in 
terms of the existing and the size of two populations. (b) The fluorescence 
analysis of the unstained cells shows no reactivity towards the PE and the FITC 
channels. (d) Staining cells with anti-GLAST-PE led to a shift of 79% of the cells 
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towards the PE channel (R7). The selection of the stained population is based 
on a clear separation from the unstained population. (f) The anti-CD11b-FITC 
staining led to a shift of about 12% of the cells towards the FITC channel (R6). 
(h) The combination of both antibodies anti-GLAST-PE and anti-CD11b-FITC 
led to a clear separation of the cells into two distinct populations with the same 
percentages obtained from the single staining; however, there was a slight 
upper shift in the CD11b population in the presence of anti-GLAST-PE (R4 and 
R6). The sort decision for astrocytes was made from the inner circle of the 
GLAST population (R8), and for the microglia cells from lower right circle which 
has 5% of cells (R6). 
As previously shown in the immunostaining and the flow cytometry analysis the 
astrocyte cultures contained 9% of microglia. These cells will contribute to the 
RNA isolated from the cultures. Therefore, the preparative fluorescence-
activated cell sorting was employed to specifically sort pure astrocytes. To sort 
living cells the anti-GLAST-PE and anti-CD11b-FITC antibodies were used for 
labelling as described above. Unstained astrocytes were first analyzed in terms 
of their size (FSC) and granularity (SSC) which revealed two different 
populations that differ slightly in size and the one that was bigger in size had 
also more granularity (R2 in Figure  3-4-a). The fluorescence analysis of the 
unstained cells showed no signals in the PE channel or in the FITC channel 
(Figure  3-4-b). Cells were then stained with anti-GLAST conjugated with PE. 
The majority of cells did migrate towards the PE channel with 79.33% (R7 in 
Figure  3-4-d) of cells exhibit strong staining and no signal was detected in the 
FITC channel. When cell were stained with microglia marker anti-CD11b 
conjugated with FITC, only 12.52% (R4 in Figure  3-4-f) of the cell migrated 
towards the FITC channel and no signal was seen in the PE channel. In the 
condition where both marker antibodies were used, anti-GLAST-PE and anti-
CD11b-FITC, two distinct populations were observed. However the CD11b 
population did shift slightly towards the center indicating possible week 
unspecific staining by the anti-GLAST antibody, but this population could be 
easily separated from the GLAST-labelled population. For the GLAST-labelled 
population, no shift was observed and the percentage of strongly stained cells 
remained at 79.69% (R7 in Figure  3-4-h). The sorting decision for the astrocytes 
includes cells that showed more granularity and bigger size and which were 
stained by anti-GLAST antibody but not by the anti-CD11b antibody. Astrocytes 
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were sorted in single RNase-free PCR tubes at 100 cells per tube for one-step 
RT-PCR. The remaining astrocytes were sorted in a 14 ml tube to be used for 
total RNA extraction. The microglia cells were defined as the less granular and 
small sized cells labelled by anti-CD11b but not by anti-GLAST antibodies. The 
microglia cells were sorted at 50 cells per tube for RT-PCR.  
3.5 TRPC transcripts expression in the FACS-sorted 
astrocytes and microglia cells 
3.5.1 RT-PCR from FACS-sorted astrocytes and microglia cells 
PCR tubes containing either sorted-astrocytes or microglia cells were stored at -
80°C and the one-step RT-PCR mix were added to the tubes immediately after 
taking them from the freezer. 13 independent RT-PCR from 5 independent 
sortings were performed with astrocytes to check for the expression of TRPC 
transcripts. TRPC1 and TRPC2 were amplified 10 times from 13 PCRs, TRPC3 
was always detected in all 13 PCRs, while TRPC4 was amplified in 11 out of 13 
reactions. The other TRPC members TRPC5, TRPC6 and TRPC7 were not 
detectable in all performed PCRs. The HPRT transcript was used as control. 
The HPRT reaction was always the last one to be pipetted, and the HPRT DNA 
fragment was always amplified (Figure  3-5-a-c). For the microglia 3 
independent RT-PCRs were performed and only TRPC4 was detected in 3 
PCRs, while TRPC2 was detected one time out of 3 PCRs. HPRT was again 
used as control and was always detected (Figure  3-5-b-c). 
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Figure  3-5 TRPC transcripts expression in astrocytes and microglia. (a) 
Example gel from 13 independent RT-PCRs performed from GLAST-sorted 
astrocytes showing the amplification of TRPC1, TRPC2, TRPC3, TRPC4 and 
HPRT DNA fragments of the expected sizes. (b) Example gel from 3 
independent RT-PCRs performed from CD11b-sorted microglia showing the 
amplification of TRPC2, TRPC4 and HPRT fragments. (c) Summery of all RT-
PCR results from the FACS-sorted astrocytes (n=13 reactions) and microglia 
cells (n=3 reactions). All performed RT-PCR gels are shown in supplementary 
figure S2 (astrocytes) and S3 (microglia). 
3.5.2 Transcriptome analysis of TRPCs from GLAST-sorted 
astrocytes by next generation sequencing 
The RNAs used for the transcriptome analysis were extracted from three 
independent FACS sortings i.e. GLAST-positive astrocytes, from three 
independent cultures. The transcriptome analysis was performed in 
collaboration with Prof. Andreas Keller and Dr. Christina Backes from the 
Clinical Bioinformatics department at Saarland University. The samples were 
sequenced in Illumina HiSeq (paired-end, 75 bp) and the obtained reads were 
compared to the mouse genome (NCBI). Ca2+ signaling- and astrocytes-related 
genes were extracted and analyzed, including: TRPC, ORAI, STIM, ITPR, 
AMPA, KAR, NMDA, GRM and astrocyte markers (GFAP, GLAST and S100b) 
genes. TRPC1, TRPC2, TRPC3 and TRPC7 were detected while TRPC4, 
TRPC5 and TRPC6 had very low FPKM (Fragments Per Kilobase of transcript 
per Million mapped reads) values. TRPC1, TRPC2 and TRPC3 were detected 
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with both approaches i.e. RT-PCR and transcriptome, whereas TRPC4 in the 
transcriptome revealed low FPKM value and was detected 10 times from 13 
RT-PCRs. Surprisingly, TRPC7 was never detected in RT-PCR (TRPC7 
primers gave positive band in Figure  3-2) but in the transcriptome analysis it 
was the most expressed among the TRPCs, however, it is unclear yet the exact 
cause behind it.  
 
Figure ‎3-6 Transcriptome anaylsis of TRPCs in cultured cortical 
astrocytes. Bar graph representing transcriptome data, from the GLAST-sorted 
astrocytes RNA, of the TRPC, ORAI STIM, ITPR, AMPA, KAR, NMDA, GRM 
and astrocyte markers. The values are expressed in FPKM (Fragments Per 
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Kilobase of transcript per Million mapped reads) as mean +/- SEM of three 
independent experiments from three independent cultures. The inset illustrates 
the RNA quality anaylsis of the three independ RNA samples from sorted 
astrocytes, showing the 18S and 28S peaks (red trace) and fragments, and 
RNA quality indicator (RQI) number.  
3.5.3 Expression of TRPC3 and TRPC1 full length transcripts in 
GLAST-sorted astrocytes 
The results from the RT-PCR showed that the TRPC3 transcripts are 
consistently amplified from GLAST-sorted astrocyte RNA. TRPC3 fragments 
were amplified in 13 of 13 PCRs. The amplified fragment comprises 198 bp. To 
provide the evidence that the full length transcript of 2733 bp is expressed, 
primers covering the full length TRPC3 transcript were employed. As template, 
the total RNA isolate from the GLAST-sorted astrocytes was reverse 
transcribed into cDNA. The full length of 2733 bp TRPC3 cDNA was amplified 
from the GLAST-sorted astrocytes (Figure  3-7-b). In addition the expression of 
TRPC1 full length cDNA in astrocytes was investigated. The TRPC1 fragments 
was identified in 10 out of 13 PCRs and it is shown to interact with TRPC3, 
TRPC4 and other TRP proteins (Storch et al., 2012). Laura Hofmann and Ulrich 
Wissenbach in our laboratory have found that the TRPC1 start codon is CUG 
which is actually 246 bp upstream of the AUG start codon which has been 
published (Wes et al., 1995; Zhu et al., 1995), leading to an extension of the 
amino terminus by 82 amino acids. Because of its extended length this variant 
of TRPC1 was called TRPC1 very long (VL). The primers used to amplify 
TRPC1 VL cover the TRPC1 sequence including the extension. The TRPC1 VL 
cDNA was amplified from the sorted astrocytes; the DNA fragment runs slightly 
lower than the 3000 bp marker which fits to the full length cDNA sequence of 
TRPC1 VL of 2880 bp (Figure  3-7-a). The coding sequence of TRPC1 VL is 
2679 bp, however the used primers initiate the amplification 201 bp upstream 
the new start codon. Ong et al have also shown that TRPC1 starts from another 
start codon upstream the AUG, and they have also discovered a functional 
splice variant which lacks 21 nucleotides and an EcoRV restriction site; they 
called this variant TRPC1 (Ong et al., 2013). After having purified the amplified 
TRPC1 VL DNA (not subcloned), it was incubated with EcoRV and thereafter by 
agarose gel electrophoresis analyzed (Figure  3-7-c-d). Three DNA fragments of 
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2880, 1737 and 1143 bp were identified. Apparently, two variants are present in 
GLAST-sorted astrocytes; the TRPC1 (non-cut) and the TRPC1 VL (two bands 
at 1737 and 1143 bp).  
 
Figure ‎3-7 Full length amplification of TRPC3 and TRPC1 cDNAs from 
cultured and sorted astrocytes. Agarose gel showing TRPC1 VL (a) and 
TRPC3 (b) full length cDNAs amplified from GLAST-sorted astrocytes. (a) For 
TRPC1 VL, the amplified DNA is running between the marker DNA fragment of 
2500 and 3000 bp and corresponds to the full length size of 2880 bp. (b) For 
TRPC3, the amplified DNA is running between the marker DNA of 2500 and 
3000 bp and corresponds to the full length size of 2733 bp. (c) Sequences of 
TRPC1 VL with the 21 nucleotides (including the EcoRV restriction site) and 
absent in TRPC1is shown in bold black. (d) Agarose gel showing the 
restriction cut of TRPC1 VL by EcoRV which resulted in three distinct 
fragments: the first between 2000 and 3000 bp corresponding to TRPC1 (non-
cut), the second between 1650 and 2000 bp and the third between 1000 and 
1650 bp corresponding to the 1737 and 1143 bp fragments of TRPC1 VL.  
In the next step the full length TRPC3 and TRPC1 VL cDNAs were excised from 
the gels purified and subcloned into pUC19. After transformation of E. coli, 
positive colonies were picked; DNA was extracted and analyzed by restriction 
enzymes (Figure  3-8). Xbal and PshAI cut of the TRPC3 cDNA should give two 
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bands running at 1729 bp and 3690 bp for sense orientation, or 1022 bp and 
4397 bp for antisense orientation. Twelve clones were analyzed and all of them 
yield two fragments and the higher one is between 3500 and 4000 bp (3690 
bp). However, clones number 5, 6 and 10 have lower bands running far below 
the 1500 bp DNA marker whereas the rest of clones have the second band 
running at 1729 bp. This suggests that clones 1-4, 7-9, 11 and 12 are correct 
whereas clones 5, 6 and 10 could be splice variants (Figure  3-8-b). Clones 5 to 
10 were send for sequencing on both strands: The sequences of clone 7, 8 and 
9 did correspond to the DNA sequence of mouse TRPC3. Clone 5 consists of 
only the 5’ sequence, clone 6 lacks the last part of the 3’ sequence and clone 
10 lacks the sequence encoding transmembrane domains 2, 3, 4 and part of 5. 
For TRPC1 VL, Kpnl and Xhol enzymes were employed which, in the case of 
sense insertion, should generate two distinct fragments of 3078 and 2488 bp, 
and 5174 and 392 bp in the case of the antisense insertion. Clones 1, 2, 3, 6, 7 
and 8 were sequenced and only clone 2 corresponds to the TRPC1 VL. All 
other clones (1, 3, 6, 7 and 8) lacked exon 3; in addition clones 1, 7 and 8 
lacked the 21 bp containing the EcoRV site. In summary and according to the 
sequence data these full-length TRPC1 cDNA were isolated, cloned and 
sequenced: TRPC1 VL, TRPC1 VL∆exon3 and TRPC∆exon3 (Figure  3-8-a). 
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Figure ‎3-8 Restriction analysis of the TRPC1 VL and TRPC3 full length 
cDNAs in pUC19. (a) Agarose gel showing analysis of 8 clones from TRPC1 
VL in pUC19 digested with Kpnl and Xhol. Clones 1, 3, 6 and 8 show two bands 
which correspond to the fragments obtained from clones in the sense 
oriontation. Clone 2 and 7 also show two bands that have an uper one running 
at less around 5000 bp and a lower one running at around 400 bp which 
correspond to the antisense cut that should results in two bands at 5174 and 
392 bp. (b) Agarose gel of showing analysis of 12 TRPC3 in pUC19 digested 
with Xbal and PshAl. All clones two fragments have been identified that have an 
uper one running at less then 4000 bp and a lower one (except clone 5, 6 and 
10) running between 1500 and 2000 bp which correspond to the sense 
oriontation. Clone 5, 6 and 10 had the second lower band running bellow 1500 
bp. Tables in a and b illustarate the summary of sequencing results from 
TRPC1 VL and TRPC3 cDNA. 
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3.6 TRPC3 in cultured cortical astrocytes 
3.6.1 Role of TRPC3 in astrocytes 
When the intracellular Ca2+ stores of the endoplasmic reticulum (ER) are 
depleted by IP3-induced Ca2+ release, ER STIM proteins assemble, and 
interact with the plasma membrane Ca2+ channels ORAI; these channels open 
and allow Ca2+ influx into the cell. Then the SERCA pump in the membrane of 
the ER pumps Ca2+ back into the ER. Blockers of the SERCA pump, such as 
thapsigargin (TG) or cyclopiazonic acid (CPA) prevent the SERCA activity. 
Because there is a continuous Ca2+ leak from the ER into the cytoplasm which 
is counteracted by consistent Ca2+ uptake via the SERCA pump. This results in 
the depletion of the ER-Ca2+ stores independently of IP3, and thereby ORAI 
channels will be activated as described above. To monitor the cytoplasmic Ca2+ 
changes in astrocytes, Fura-2 was used as an indicator of Ca2+ concentration: 
The Fura-2 F340/F380 ratio is proportional to the Ca2+ concentration in the 
cytoplasm. After applying 2 µM of the SERCA pump blocker thapsigargin in the 
absence of extracellular Ca2+ an increase in the intracellular [Ca2+] was 
observed that is caused by Ca2+ leakage from the ER into the cytoplasm. This 
[Ca2+] decreased overtime because of its transport out of the cell by other 
pumps and exchangers. Upon readdition of extracellular Ca2+, the [Ca2+] 
increased because of the Ca2+ influx through ORAI channels (Figure  3-9-a). 
The fluorescence ratio decreased over time to reach a steady state but does not 
go back to the basic value because the continuous inhibition of the SERCA 
pump which in turn keeps the ORAI channels in an active state. In addition to 
ORAI (Feske et al., 2006), members of the TRPC channel subfamily have been 
suggested to contribute to the Ca2+ entry (Venkatachalam et al., 2002). 
Because cultured mouse cortical astrocytes express the TRPC3 gene, TRPC3 
could contribute to this Ca2+ entry. Therefore astrocytes from wild-type and from 
mice deficient in TRPC3 and TRPC6 genes were used in the following 
experiment (Figure  3-9). The depletion of the ER Ca2+ stores by thapsigargin in 
the absence of extracellular Ca2+ leads to increase of Ca2+ in the cytoplasm. 
When extracellular Ca2+ was readded (5 mM) Ca2+ entry occurs which was not 
different in astrocytes from wild-type or TRPC3/TRPC6 deficient mice. These 
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results suggest that TRPC3 and TRPC6 are not involved in Ca2+ entry by this 
pathway (Figure  3-9 a c).  
 
Figure ‎3-9 Ca2+ entry in cultured cortical astrocytes from wild-type and 
TRPC3/C6 gene-deficient mice. (a) Fura-2 experiments showing changes in 
the cytoplasmic Ca2+ concentration as changes of F340/F380 ratio. In the 
absence of extracellular Ca2+, 2 µM thapsigargin was applied to deplete the ER 
by blocking the SERCA pump. Readdition of 5 mM Ca2+ provokes an increase 
in the Ca2+ signal which is due to Ca2+ entry in wild-type astrocytes (black). 
Astrocytes from TRPC3/TRPC6 gene-deficient mice (red) did behave in the 
same manner as the wild-type cells and showed no difference in terms of 
response to TG or Ca2+ readdition. Summary: Area under the curves of the 
store depletion (100 s to 500 s) (b) and Ca2+ entry (500 s to 1200 s) (c) from 
both genotypes show no significant differences. Results represent mean +/- 
SEM from four (wt) and three (TRPC3/C6 dko) independent measurement with 
144 and 140 cells respectively (ns = not significant). 
3.6.2 OAG-induced Ca2+ release and Ca2+ Influx in cultured 
astrocytes 
TRPC channels have been shown to be activated downstream of PLC 
activation which involves the generation of diacylglycerole (DAG) and inositol 
1,4,5-triphosphate (IP3). TRPC2, TRPC3, TRPC6 and TRPC7 are activated by 
DAG leading to Ca2+ and sodium influx (Hofmann et al., 2000). OAG, an 
analogue of DAG, can be used experimentally to activate the DAG-sensitive 
TRPCs. The application of 100 µM OAG in the presence of 2 mM extracellular 
Ca2+ on astrocytes induced Ca2+ oscillations measured by Fura-2, but no Ca2+ 
signal was observed in microglia (Figure  3-10-a-b). However when the 
extracellular Ca2+ was removed, the astrocytes did still exhibit Ca2+ oscillation 
which were obviously generated from intracellular Ca2+ stores, as the readdition 
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of Ca2+ in absence of OAG led to steep increase in Ca2+ signal (Figure  3-10-c). 
Hisatsune et al., showed that OAG can also activate PLC and thereby leads to 
IP3 production which in turns induces Ca2+ release from the ER (Hisatsune et 
al., 2005). The observed Ca2+ oscillation in the absence of extracellular Ca2+ 
might be caused by the activation of PLC in the presence of OAG which makes 
it difficult to distinguish whether OAG is able to induce any Ca2+ influx via TRPC 
channels in astrocytes. Therefore, a separation of Ca2+ influx into the cytoplasm 
from the extracellular space and the ER Ca2+ release is necessary to 
investigate whether TRPCs are involved in OAG-induced Ca2+ signaling in 
astrocytes. In order to separate the Ca2+ influx from the Ca2+ release induced by 
OAG, the SERCA pump inhibitor cyclopiazonic acid (CPA) was used at a 
concentration of 10 µM in the presence of 2 mM extracellular Ca2+ to deplete 
the internal stores and induce a steady state Ca2+ entry. At this stage the IP3 
will not be able to induce any further Ca2+ release. On top of this protocol, 100 
µM of OAG was applied to directly activate TRPC channels (Figure  3-10-d). 
Since the internal stores were already depleted and Ca2+ entry through ORAI 
reached a steady state, the additional increase of cytoplasmic Ca2+ 
(Figure  3-10-d) is most probably mediated by Ca2+ influx via Ca2+ channels 
activated by OAG. OAG is well known as activator of protein kinase C (PKC) 
(Nishizuka, 1984) as well as of MUCK 13 (Brose and Rosenmund, 2002), which 
imposes the question, whether the observed additional Ca2+ influx in astrocytes 
upon OAG application is mediated via PKC which subsequently activate a Ca2+ 
channel in the membrane or by direct channel activation. Phorbol-12-myristat-
13-acetat (PMA) was used instead of OAG and did not induce any additional 
Ca2+ signal (Figure  3-10-e), which indicates that the OAG-induced Ca2+ influx in 
astrocytes is PKC- and MUN 13-independent. The next experiments were done 
to answer the question whether channel activated by OAG in the above protocol 
is TRPC3. 
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Figure ‎3-10 OAG-induced Ca2+ release and Ca2+ influx in astrocytes from 
wild-type mice. (a) The application of 100 µM OAG in the presence of 2 mM 
extracellular Ca2+ induces Ca2+ oscillations in astrocytes but not in microglia (b) 
measured by Fura-2. (c) In the absence of extracellular Ca2+, 100 µM OAG 
induces also Ca2+ oscillations but the amplitude and frequency of peaks were 
notably less comparing to the experiment in the presence of extracellular Ca2+. 
(d,e) In the presence of 2 mM extracellular Ca2+, Ca2+ release and Ca2+ entry 
are induced in the presence of CPA. Adding OAG on top (d) leads to additional 
Ca2+ oscillations; these oscillations do not occur if PMA is added instead (e). 
Figure a, b and c show numbers of measured cells per number of experiments, 
and figure d and e show example traces from 386/7 and 173/4 wild-type 
astrocytes, respectively. 
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3.6.3 OAG-induced Ca2+ influx is TRPC3-dependent 
As shown in the previous section, OAG increases the astrocytic cytoplasmic 
Ca2+ concentration by Ca2+ influx. This is probably due to the activation of DAG-
sensitive TRPC channels. By PCR, TRPC2 and TRPC3 transcripts were 
amplified from the GLAST-sorted astrocytes; however TRPC7 was only 
detected in the RNA sequencing analysis and not in RT-PCR. Thus those 
channels could be the candidate channels responsible for the OAG-mediated 
Ca2+ influx. I used astrocytes from TRPC channel gene-deficient mice to 
investigate their contribution in the OAG-induced Ca2+ influx. Astrocytes isolated 
from wild-type, TRPC3-, TRPC6- and TRPC3/TRPC6 gene-deficient mice were 
used in the following experiments (Figure ‎3-11). The deletion of the TRPC3 
gene resulted in a significant decrease by about 30% in the number of OAG-
responding astrocytes when compared to wild-type astrocytes in which around 
85% of the cells did respond to OAG (Figure ‎3-11-a-b-e). However, even within 
the OAG-responding astrocytes from TRPC3 gene-deficient mice the oscillation 
frequency was significantly reduced to 1.5 oscillations per cell compared to 
around 3.5 oscillations per astrocytes from wild-type mice within the 700 s of 
OAG application (Figure ‎3-11-a-b-f). Despite the fact that TRPC6 transcripts 
were not identified in the GLAST-sorted astrocytes, astrocytes from TRPC6 
gene-deficient mice were also tested for their OAG response. As expected, 
those astrocytes isolated from TRPC6 gene-deficient mice did not show any 
difference in the OAG response when compared to wild-type astrocytes neither 
in the number of responding cells nor in the oscillation frequency (Figure ‎3-11-
a-c-e-f). On the other hand, the astrocytes originating from TRPC3/TRPC6 
gene-deficient mice show similar response to OAG as in the astrocytes isolated 
from TRPC3 gene-deficient mice in terms of responding cell number and 
oscillation frequency (Figure ‎3-11-b-d-e-f). These results show that cultured 
cortical astrocytes do exhibit a functional TRPC3 channels. 
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Figure ‎3-11 OAG-Induced Ca2+ oscillations in astrocytes are mediated via 
TRPC3. (a, b, c and d) In the presence of 2 mM extracellular Ca2+, Ca2+ release 
and Ca2+ entry are induced in the presence of CPA and OAG was additionally 
applied. 100 µM OAG, on top of CPA, induced Ca2+ oscillations in astrocytes 
isolated from wild-type (a, same as in Figure ‎3-10-d), TRPC3- (b), TRPC6- (c) 
and TRPC3/C6 gene-deficient (d) mice. (e) Summary of the number of OAG 
responding cells shows that only 30% of astrocytes from TRPC3 gene-deficient 
(red) and TRPC3/TRPC6 gene-deficient (violet) mice did respond to OAG 
application while 85% of astrocytes responded in wild-type (black) and TRPC6 
gene-deficient (blue). (f) Summary of the number of oscillations per cell within 
the 700 s of OAG application shows that astrocytes from TRPC3 gene-deficient 
(red) and TRPC3/TRPC6 gene-deficient (violet) mice exhibited 1.5 oscillations 
per cell while astrocytes obtained from wild-type (black) and TRPC6 gene-
deficient (blue) mice revealed around 3.5 oscillations per OAG-responding cell. 
Figure a, b, c and d show example traces, and e and f show mean +/- SEM 
(number of cells/number of experiments) of the percentage of OAG-responding 
cells and number of OAG peaks respectively from wild-type (386/7), TRPC6- 
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(278/5), TRPC3- (424/7) and TRPC3/TRPC6 gene-deficient (330/8) astrocytes. 
Tables in figure e and f reveal the statistical comparison between the different 
genotypes using one way ANOVA followed by Bonferroni test (** for p value ≤ 
0.01, *** for p value ≤ 0.001 and ns for non-significant).  
3.6.4 Electrophysiological characterization of TRPC3 current in 
TRPC3 cDNA expressing HEK293 cells  
TRPC3 is a non-selective cation channel which is permeable to Ca2+ and 
sodium. The activation of TRPC3 can be measured as a current by whole cell 
patch clamp technique. A voltage ramp from -100 mV to 100 mV during 400 ms 
was applied every 2 s from a holding potential (Vh) of 0 mV (Figure  3-12-a). 
External application of 100 µM OAG was used to activate TRPC3 in a HEK 293 
cell line stably expressing the human TRPC3 cDNA. Using 1 mM Ca2+ in the 
extracellular solution and 100 nM free Ca2+ in the patch pipette induced only 
very small whole cell currents during the application of 100 µM OAG 
(Figure  3-12-b-c-d). Several Ca2+ channels are known to inactivate in the 
presence of Ca2+ such as voltage-gated Ca2+ channels or the TRPV6 channel 
(Niemeyer and Lummis, 2001). Therefore, intra- and extracellular Ca2+ 
concentrations were changed in the whole cell patch clamp experiments to 
optimize the condition for TRPC3 current recording. First, the extracellular Ca2+ 
was removed (nominally Ca2+-free) and the intracellular (pipette) Ca2+ was kept 
at 100 nM (buffered with BAPTA). When OAG was applied no obvious increase 
in the current amplitude occurred comparing with the previous condition (1 mM / 
100 nM Ca2+). However, in the presence of 1 mM extracellular Ca2+ and 
buffering the intracellular Ca2+ to zero (1 mM / 0 Ca2+), outward and inward 
currents with a similar current-voltage relationship as the published for TRPC3 
currents were induced in the presence of 100 µm OAG. Interestingly, when both 
the extra- and intracellular Ca2+ were removed (0 mM/ 0 nM), OAG did induce 
even a Larger current compared to the previous condition (Figure  3-12-b-c-d). 
These results strongly suggest that TRPC3 is a Ca2+ sensitive channel that 
could be inhibited by either intracellular and/or extracellular Ca2+. 
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Figure ‎3-12 TRPC3 currents in TRPC3 cDNA expressing HEK293 cells. (a) 
Voltage ramp protocol used to measure TRPC3 cuurents. Voltage ramps were 
applied every 2 s over a duration of 400 ms from -100 to 100 mV from a holding 
potentiel of 0 mV. (b) Currents at -80 and 80 mV and plotted versus time 
showing the current (pA/pF) before, during and after OAG application after 
substracting the basic current i.e. current before application. (c) Current-voltage 
relationships were extracted from the maxiumum current during OAG 
application after substraction the basic current. (d) Summary of the Imax at -80 
and 80 mV during application of 100 µM OAG showing the Ca2+ dependent 
inhibition of TRPC3 currents at different Ca2+ concentrations (external/internal): 
1 mM / 100 nM (green), 0 mM / 100 nM (blue), 1 mM / 0 nM (red) and 0 mM / 0 
nM (black). Figure b and d are mean +/- SEM of the indicated number of 
measured cells. 
3.6.5 TRPC3 currents in cultured mouse cortical astrocytes 
As shown in Figure  3-11, OAG activates TRPC3-dependent Ca2+ entry 
measured by Fura-2. Now, the optimized patch clamp conditions were 
employed to measure the native TRPC3 currents in astrocytes. However, the 
amount of the TRPC3 protein in astrocytes is expected to be much less as 
compared to HEK293 cells expressing TRPC3 cDNA, and therefore the TRPC3 
currents could be much smaller. For this reason, 300 µM OAG was used 
instead of 100 µM OAG to increase the chance to measure the native TRPC3 
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currents in astrocytes. Under this condition, OAG induced inward and outward 
currents in astrocytes and the current-voltage relationship (Figure  3-13-b) was 
very similar to the one of TRPC3 currents in HEK293 cells (Figure  3-12-c). 
Although the current is very small and only in few cells responded to OAG, this 
further proves that TRPC3 is a functional channel in astrocytes. Because of the 
low success rate, comparison with astrocytes from TRPC3 gene-deficient mice 
was not performed. 
 
Figure ‎3-13 TRPC3 currents in astrocytes. (a) Currents mesured in astrocytes 
extracted at -80 and 80 mV and plotted versus time. The application of 300 µM 
OAG led to the developpement of inward and outward currents in astrocyte. (b) 
The current-voltage relationships of the maximum current during the application 
of 300 µM OAG exhibit a similar shape as the one for TRPC3 currents in 
HEK293 cells. 
Expression analysis, Ca2+ imaging and patch clamp experiment provide clear 
evidence that TRPC3 is functionally expressed in cultured mouse cortical 
astrocytes. In response to brain injury, astrocytes become reactive and 
experience increased proliferation and migration (Fawcett and Asher, 1999). 
Ca2+ has been always linked to cellular migration and was shown to be involved 
in the astrocytic migration (Striedinger and Scemes, 2008). In the following 
experiment, role of TRPC3 in astrocyte migration will be addressed.  
3.6.6 Role of TRPC3 in astrocytes migration 
The so called scratch or in vitro wound healing assay is an assay which is used 
to mimic an injury on cultured cells and learn how cells migrate in culture. 
Astrocytes isolated from wild-type and different TRPC gene-deficient mice were 
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transferred into a 6 well plate and cultured until reaching confluency. Afterward, 
the cell monolayer was scratched with a 200 µl pipette tip and pictures were 
taken at 0, 4, 8 and 24 hours after the scratch from the same region. After 
scratching, the culture medium was substituted with an FCS-free medium to 
avoid cell proliferation. Migration was quantified by measuring the area of 
scratch re-covered by migrated cells again at 4, 8 and 24 h, which was 
normalized to the size of the scratch area at 0 hour. 4 hours after the scratch, 
about 10% of all the scratch area was occupied again by astrocytes isolated 
from wild-type mice but only 5% coverage was observed in astrocytes from 
TRPC3 gene-deficient mice. After 8 hours, about 18% of the scratch was 
covered with astrocytes from wild-type mice, and 7% of the scratch was 
covered in astrocytes from TRPC3 gene-deficient mice. At 24 hours, 30% 
coverage was observed in wild-type astrocytes, while astrocytes from TRPC3 
gene-deficient mice covered only 18% of the total scratch area after 24 hours. 
This suggests that TRPC3 and/or Ca2+ influx via TRPC3 plays a role in the 
astrocytic migration. In the Fura-2 experiment, astrocytes from TRPC6 gene-
deficient mice behaved similarly to the wild-type and cells isolated from 
TRPC3/TRPC6 gene-deficient did behave like the TRPC3 gene-deficient. 
Therefore, astrocytes were isolated from TRPC6 and TRPC3/TRPC6 gene-
deficient mice and used for migration assay. As expected, the migration rate of 
astrocytes isolated from TRPC6 gene-deficient mice did not differ from the one 
of wild-type astrocytes after 4, 8 and 24 hours, while the astrocytes from 
TRPC3/TRPC6 gene-deficient mice were very similar to the astrocytes from 
TRPC3 gene-deficient mice after 4, 8 and 24 hours (Figure  3-14). Those results 
prove the role of TRPC3 in the in vitro migration of cortical astrocytes. 
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Figure ‎3-14 Astrocytes migration in vitro. (a) Representative images of the 
astrocytes at 0 and 4, 8 and 24 hours after scrach from wild-type, TRPC3-, 
TRPC6- and TRPC3/TRPC6 gene-deficient mice. (b) Summary of the migration 
data. Scratch area at time “0” is 100%; area recoverd by migrating astrocytes 
after 4, 8 and 24 h are indicated. Different colors are used for each genotype as 
indicated. Data represent mean +/- SEM of the indicated number of scratches 
from number of experiments (scratches/experiments) and table in figure b 
reveals the summary of the different genotypes statistical comparison (*, p 
value ≤ 0.05, **, p value ≤ 0.01, ***, p value ≤ 0.001 and ns for non-significant). 
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The previous experiment showed how the deletion of TRPC3 gene affected 
negatively the in vitro migration of astrocytes; which is more pronounced in the 
astrogliosis state. Thus in the following experiment, the role of TRPC3 in the in 
vivo migration and glial scar formation will be investigated. 
3.6.7 Astrogliosis and glial scar formation in TRPC3 gene-
deficient mice 
In response to brain injury, astrocytes enter into a reactive state leading to the 
formation of the glial scar which involves excessive proliferation and migration 
of astrocytes into the injury site (Saadoun et al., 2005; Silver and Miller, 2004). 
This reactive state leads to the upregulation of the GFAP gene, and thus the 
GFAP protein is used as an indicator for astrogliosis. Experimentally, cortical 
stab wound surgery is used as a model to study the astrogliosis and glial scar 
formation after brain injury. In this work wild-type and TRPC3 gene-deficient 
male mice (8 weeks old) were used to address the role of TRPC3 in astrogliosis 
and glial scar formation. The surgery was performed under anesthesia on the 
right hemisphere of the cerebral cortex and both genotypes (wild-type and 
TRPC3 gene-deficient mice) were used in parallel. 3 days after the surgery 
mice were sacrificed and fixed with 4% PFA and 35 µm coronal sections were 
made from the injured region and stained against GFAP (Figure  3-15-a). The 
analysis of the wound images showed that the absence of TRPC3 led to a 
significant decrease in the GFAP positive area 2.5 mm2 compared to 3.2 mm2 in 
wild-type mice (Figure  3-15-b). This result shows that astrogliosis is less 
pronounced in TRPC3 gene-deficient mice. This was confirmed by the analysis 
of the fluorescence intensity in which the fluorescence intensity of the anti-
GFAP antibody bond was measured from equally sized rectangles placed along 
the injured and non-injured cortex (Figure  3-15-c inset). The results of this 
analysis showed that in the non-injured hemisphere there was no significant 
difference in the GFAP-fluorescence intensity between TRPC3 gene-deficient 
and wild-type mice. However on the injured hemisphere, TRPC3 gene-deficient 
mice exhibited significant reduction in the GFAP-fluorescence intensity when 
compared to the wild-type mice. Even more, the width of the GFAP staining (i.e 
distribution of GFAP staining along the cortex) was much smaller in the TRPC3 
gene-deficient mice compared to the wild-type (Figure  3-15-c). Like in any other 
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injury, an edema was observed in the injured cerebral cortex and was quantified 
by measuring the cortex width of the injured hemisphere and normalized to the 
contralateral side. The TRPC3 gene-deficient mice showed after cortical stab 
injury an increase of about 5% in the cortex size which was significantly smaller 
when compared to the wild-type mice where they had an increase of about 12% 
in the cortex size after brain injury (Figure  3-15-d). This result indicates that 
TRPC3 plays a role in the reactivity of astrocytes as well as in the inflammatory 
reaction following brain injury. 
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Figure ‎3-15 Cortical stab wound. (a) Example images of the cortical stab 
injury from wild-type and TRPC3 gene-deficient mice as 35 µm sections stained 
anti-GFAP antibody to visualize the reactive astrocytes. (b) Summary of the 
area of reactive astrocytes (in mm2) showing significant smaller area of GFAP 
staining in TRPC3 gene-deficient mice (red) compared to wild-type (black). (d) 
Analysis of the cortical edema after brain injury measured from the cortical 
width where the TRPC3 gene-deficient mice had less cortical edema compared 
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to wild-type mice. (c) Diagram showing the distribution of the reactive astrocytes 
obtained (inset) from measuring the anti-GFAP fluorescence intensities of 
rectangles along the cortex. Data shows again the TRPC3 gene-deficient mice 
had less intensity and distribution of astrocytes compared to wild-type. Data 
represent mean +/- SEM from 7 wild-type mice (13 sections) and TRPC3 gene-
deficient mice (14 sections) (* for p value ≤ 0.05, and *** for p value ≤ 0.001). 
 
3.7 TRPC3 T to A mutation and moonwalker mice (MWK) 
3.7.1 Expression of the TRPC3 MWK mutant cDNA in HEK 293 
cells 
As already described in the introduction and material and methods 
(sections  1.6.3 and  2.3), I refer to the TRPC3 A1903G mutation, which is a 
TRPC3 gain of function mutation, as TRPC3 MWK in this study. The 
overexpression of the TRPC3 MWK cDNA in HEK 293 cells lead to cell death 
(observed in our laboratory) due probably to the increase of the cytoplasmic 
Ca2+ concentrations to a level beyond the cellular counterregulatory 
mechanisms. Therefore, a HEK cell line was generated in which the expression 
of TRPC3 MWK cDNA is induced in the presence of tetracycline (see 
section  2.3). Already 2 hours after induction by 1 µg/ml tetracycline, currents 
could be measured in whole cell patch clamp experiments upon break-in using 
the same ionic conditions than outlined in (Figure  3-12). The outward current at 
80 mV after break-in was ~20 pA/pF (Figure  3-16-a-b inset) and currents kept 
increasing over time reaching ~60 pA/pF after 150 seconds (Figure  3-16-a-b). 
The current-voltage relationship shows an inward and an outward current which 
has some similarity with the one of wild-type TRPC3 (Figure  3-12) and the 
shape of the current did not change over time (Figure  3-16-b). In Fura-2 
experiments (Figure  3-16-c), the readdition of 2 mM Ca2+ induced an increase 
in the F340/F380 ratio already 2 hours after induction of TRPC3 MWK cDNA 
expression also indicating that the mutation rendered the TRPC3 open 
(Figure  3-16-c). The previous experiments were performed 2 hours after 
tetracycline treatment, however increasing the time after tetracycline addition 
led to a strong decrease in the number of surviving cells to about 70% after 6 
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hours (observed during Fura-2 measurement), indicating that the cells dye due 
to the constitutive Ca2+ influx and Ca2+ overload (Figure  3-16-d). 
 
Figure ‎3-16 Constitutive channel activity of the TRPC3 MWK in HEK293 
cells. (a) Currents at -80 and +80 mV versus time showing constitutive currents 
which were already present upon break-in in absence of any agonist. Current-
voltage relationships of the break-in current (b inset) and the current after 150 s 
(b) showing a similar shape as the TRPC3 wild-type current (Figure ‎3-12). (c) 
Fura-2 experiment shows after adding tetracycline cells were kept in 0 
extracellular Ca2+, after 100 s 2 mM Ca2+ was added to the bath leading to Ca2+ 
entry. (d) Cells stained with Fura-2 observed under the microscope and 
counted. Times after adding tetracycline are indicated. The data represent 
mean +/- SEM of the number of cells in patch clamp and number of cells per 
number of experiments in Fura-2. 
3.7.2 Astrocytes from moonwalker mice 
Because TRPC3 gene is expressed in mouse cortical astrocytes, astrocytes 
from heterozygous MWK mice were isolated and analyzed (will be referred as 
MWK astrocytes). These astrocytes exhibit a higher basal Ca2+ levels in the 
presence of 2 mM extracellular Ca2+ when compared to the astrocytes isolated 
from their wild-type littermates mice (Figure  3-17-a). In the Ca2+ readdition 
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protocol (Figure  3-17-b), the MWK astrocytes did have a higher basal Ca2+ level 
which was dropping to the wild-type levels in the absence of extracellular Ca2+. 
Upon readdition of 2 mM Ca2+, mutant astrocytes revealed a significant 
increase of the F340/F380 ratio compared to the wild-type astrocytes which 
showed a rather small Ca2+ increase if at all (Figure  3-17-b). 
 
Figure ‎3-17 Ca2+ imaging in astrocytes from heterozygous MWK mice. (a) 
Fura-2 experiment in the presence of 2 mM Ca2+ showing the increased basal 
Ca2+ level in the astrocytes from MWK (red) compared to cell from wild-type 
mice (black). (b) Readdition of 2 mM Ca2+ led to an increase in the Ca2+ signal 
in astrocytes isolated from MWK mice (red) compared to cell from wild-
typelittermates (black). Data represent mean +/- SEM of the indicated number 
of cells per number of experiments.  
3.7.3 Astrocytes reactivity in non-injured MWK mouse brain 
As shown in Figure  3-14 and Figure  3-15, the deletion of TRPC3 gene led to 
reduction in the reactivity of astrocytes and the size cortical edema after brain 
injury. We asked the question could the constitutively open TRPC3 has an 
astrocytic effect, i.e. it leads to astrogliosis even without injury? To address this 
question wild-type and MWK mice were analyzed for astrogliosis without stab 
wound surgery by sectioning their brains and staining them anti-GFAP antibody. 
Images from the GFAP staining showed that there is no obvious difference 
between TRPC3 MWK and wild-type mice in terms of GFAP staining 
(Figure  3-18). This suggests that only activation of TRPC3 alone is not sufficient 
to trigger astrogliosis without injury. 
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Figure ‎3-18 GFAP staining of coronal sections from MWK and wild-type 
mice. Brain coronal section obtained from heterozygous TRPC3 MWK and wild-
type mice stained with anti-GFAP in red to visualize the reactive astrocytes. No 
obvious difference in GFAP staining could be observed in the cortex. Those 
images are obtained from one mouse from each genotype and representative 
sections are shown.  
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3.8 TRPC1 in cultured cortical astrocytes 
3.8.1 Role of TRPC1 in astrocytes 
TRPC1 has been repeatedly reported to be associated with STIM and ORAI 
which are expressed in astrocytes (see Figure  3-6) (Brechard et al., 2008; 
Dietrich et al., 2007; Liu et al., 2007). Therefore, astrocytes from TRPC1 gene-
deficient mice were used in Fura-2 experiments. Intracellular Ca2+ stores were 
depleted in the presence 10 µM CPA that leads to a transient increase in the 
cytoplasmic Ca2+ due to the continuous Ca2+ leak out of the ER which is not 
reversed by the SERCA pump because it is blocked. Comparing astrocytes 
from wild-type and TRPC1 gene-deficient mice revealed that TRPC1 deficient 
astrocytes had significantly smaller Ca2+ release from the ER upon CPA 
treatment in the absence of extracellular Ca2+ (Figure  3-19-a-b). Upon 
readdition of 2 mM extracellular Ca2+, the cytoplasmic Ca2+ increases because 
of ORAI-dependent Ca2+ influx. When applying the same protocol on astrocytes 
isolated from TRPC1 gene-deficient mice no obvious difference was observed 
when looking at the Fura-2 traces. However, when analyzing the area under the 
curve of the traces obtained in the presence of 2 mM Ca2+ TRPC1 gene-
deficient astrocytes had slightly larger area under the curve as compared to the 
wild-type astrocytes (Figure  3-19-a-c). Those observations in TRPC1 deficient 
astrocytes upon CPA treatment indicate that TRPC1 could have an ORAI/STIM-
independent effect in astrocytes.  
 
Figure ‎3-19 Ca2+ entry in cultured cortical astrocytes from wild-type and 
TRPC1 gene-deficient mice. (a) Fura-2 experiment showing changes in the 
cytoplasmic Ca2+ concentration recorded as F340/F380 ratio. In the absence of 
extracellular Ca2+, 10 µM CPA was applied to deplete the ER which led to an 
increase in Ca2+ because of the Ca2+ leak out of the ER. Readdition of 2 mM 
0.9
0.8
0.7
0.6
0.5
0.4
F
3
4
0
/F
3
8
0
12008004000
time (s)
2 mM Ca10 µM CPA
wt (206/6)
Trpc1 ko (266/6)
a
***
0
10
20
30
40
50
60
wt Trpc1 ko
TG-dependent Store depletion
A
U
C
  ?
 F
3
4
0
/F
3
8
0
 .s
b
206
(6)
266
(6)
**
0
20
40
60
80
100
120
140
160
wt Trpc1 ko
Ca entry upon store depletion
A
U
C
  ?
 F
3
4
0
/F
3
8
0
 .s
c
206
(6)
266
(6)
a
1.2
1.0
0.8
0.6
0.4
F
3
4
0
/F
3
8
0
12008004000
time (s)
5 mM Ca
wt (144/4)
Trpc3/c6 dko (140/3)
b
TG-dependent Store depletion
0
10
20
30
40
50
60
wt Trpc3/c6 dko
A
U
C
  ?
 F
3
4
0
/F
3
8
0
 .s
ns
144
(4)
140
(3)
c
Ca entry upon store depletion
A
U
C
  ?
 F
3
4
0
/F
3
8
0
 .s
0
20
40
60
80
100
120
140
160
wt Trpc3/c6 dko
ns
144
(4)
140
(3)
2 µM TG
Results 
 
Universität des Saarlandes  79 
 
Ca2+ induced an increase in the cytoplasmic Ca2+ due to ORAI-dependent Ca2+ 
entry in wild-type astrocytes (black). TRPC1 deficient astrocytes (green) did 
exhibit a smaller response to CPA; however the ORAI-dependent Ca2+ seemed 
to be similar to wild-type cells. (b) Bar graphs of the area under the trace of 
Ca2+ release  shows a significant reduction in the store depletion of TRPC1 
deficient astrocytes compared to wild-type. (c) Bar graphs of the area under the 
trace of Ca2+ entry from both genotypes showing a slight significant increase in 
TRPC1 deficient astrocytes compared to the wild-type cells. Data represent 
mean +/- SEM of the indicated number of cells per number of experiments (* for 
** for p value ≤ 0.01 and *** for p value ≤ 0.001 and). 
3.8.2 Impact of TRPC1 VL on TRPC3 currents in HEK 293 cells  
In the current work TRPC1 and TRPC3 were shown to be expressed in 
astrocytes and TRPC3 could be activated by OAG, however TRPC1 has so far 
no specific agonist or even a clear mechanism of activation. Nevertheless, it 
has been shown that TRPC1 could interact with other TRP proteins to form 
heterotetrameric channels. In some cases those heterotetrameric could show 
different currents and/or different selectivity towards Ca2+ and sodium when 
compared to the homomeric channels (Strubing et al., 2001). I studied by whole 
cell patch clamp whether TRPC1 could interact with TRPC3 by co-expressing 
the TRPC3 and TRPC1 VL cDNAs in HEK 293. First, I measured TRPC3 
currents in HEK cells expressing only the TRPC3 cDNA. In contrast to 
Figure  3-12, where I studied the function of human TRPC3, in this new 
experiment the mouse TRPC3 cDNA was expressed. The reason for switching 
to the mouse cDNA is that we are studying the TRPC channels in mouse and 
we do want to be as close to the in vivo situation as possible. Currents were 
measured in the whole cell patch clamp configuration with voltage ramp from -
100 mV to 100 mV. The application of 100 µM OAG did induce inward and 
outward currents similar than in Figure  3-12 and not in non-transfected HEK 
293 (Figure  3-20-a-b-c-d). When the mouse TRPC3 cDNA was co-
overexpressed in HEK cells stably expressing the mouse TRPC1 VL cDNA, 
OAG induced significantly reduced currents when compared to TRPC3 cDNA 
expression alone (Figure  3-20-a-b). However, the current-voltage relationship of 
this current was similar to the one obtained from cells expressing the TRPC3 
cDNA alone. The application of OAG on TRPC1 VL cDNA expressing cells did 
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not induce any currents (Figure  3-20-e-f). These results show a negative effect 
of TRPC1 VL on TRPC3 activity. 
 
Figure ‎3-20 TRPC3 and TRPC3/TRPC1 VL currents in HEK293 cells. (a) 
Currents at -80 and 80 mV plotted versus time showing current before, during 
and after OAG application of TRPC3 currents in HEK cells transiently 
transfected with TRPC3 cDNA (black) and TRPC3/TRPC1 VL currents in 
TRPC1 VL-stably expressing HEK293 cells transfected with TRPC3 cDNA 
(red). (b) Current-voltage relationships were extracted from the maxiumum 
current during OAG application after having substracted the basal current befor 
application. HEK 293 cells (c,d) and TRPC1 VL HEK293 cells (e,f) did not show 
any OAG-induced currents. Data represent mean +/- SEM of the indicated 
number of measured cells. 
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3.8.3 Role of TRPC1 in OAG-induced Ca2+ oscillations in 
cultured cortical astrocytes 
Following the findings from the patch clamp experiments where TRPC1 VL was 
found to have a negative effect on TRPC3 currents (Figure  3-20), and from the 
PCR results that both TRPC3 and TRPC1 VL transcripts are expressed in 
culture cortical astrocytes (Figure  3-5-a), the question came up whether the 
deletion of the TRPC1 would enhance the TRPC3 activity in astrocytes. In Fura-
2 experiments, astrocytes isolated from TRPC1 gene-deficient mice were tested 
using the OAG protocol described before. After having the intracellular Ca2+ 
stores depleted (10 µM CPA in the presence of 2 mM extracellular Ca2+) 100 
µM OAG was applied on top of the steady state ORAI-dependent Ca2+ entry. 
Astrocytes isolated from TRPC1 gene-deficient mice showed a significant 
increase in the number of OAG-responding cells (Figure  3-21-a-b-c) and 
moreover the number of oscillations within the responding cells was also 
significantly increased as compared to the wild-type (Figure  3-21-a-b-d). These 
results show that deletion of TRPC1 did potentiate the OAG-induced Ca2+ influx 
via TRPC3 in astrocyte, and together with the patch clamp results hints for a 
possible interaction of TRPC1 with OAG-sensitive TRPC channels, i.e. TRPC3. 
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Figure ‎3-21 Deletion of TRPC1 increases the OAG-induced Ca2+ 
oscillations in astrocytes. Example traces (Fura-2 F340/F380) from the OAG 
response as established Figure ‎3-10 in astrocytes isolated from wild-type (“a” 
identical with Figure ‎3-10-d) and TRPC1 gene-deficient (b) mice. (c) The 
statistical analysis of the number of responding cells shows that almost all the 
cell from TRPC1 gene-deficient mice (green) did respond to the OAG 
application while around 85% of astrocytes from wild-type mice (black) 
responded to OAG. (d) Summary of the number of oscillations per cell shows 
~5.5 oscillations per TRPC1 deficient astrocytes within the 700 s of OAG 
application and ~3.5 oscillations per OAG-responding astrocytes from wild-type. 
Data in c and d represent mean +/- SEM; from number cells per number of 
experiments (* for p value ≤ 0.05). 
3.8.4 Impact of TRPC1 VL on the constitutive TRPC3 MWK 
The data so far show that TRPC1 reduces TRPC3 currents in HEK293 cells, 
whereas in astrocytes isolated from TRPC1 gene-deficient mice revealed 
enhanced OAG-mediated TRPC3 dependent Ca2+ oscillations. To further 
investigate the effect of TRPC1 on TRPC3 activity, the TRPC1 VL cDNA was 
co-expressed in the tetracycline inducible TRPC3 MWK HEK cell line, using the 
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patch clamp technique under the same conditions as described above 
(Figure  3-12) for the optimum TRPC3 measurement. TRPC1 VL (48 h after 
transfection its cDNA) was found to significantly reduce the constitutive TRPC3 
MWK (2 h on tetracycline induction) currents compared to control cell (only 
TRPC3 MWK). Co-expression of the TRPC3 cDNA in TRPC3 MWK inducible 
cells led also to a significant reduction of constitutive TRPC3 MWK currents 
(Figure  3-22-a-b-c). Similar results were obtained by Fura-2 measurement 
(Figure  3-22-c-d). The basal Ca2+ levels in TRPC3 MWK cells in the absence of 
extracellular Ca2+ were significantly reduced in the presence of TRPC1 VL 
overexpression but not in the presence of TRPC3. Upon readdition of 2 mM 
extracellular Ca2+, the cytoplasmic Ca2+ increased under all these conditions. 
The steady state F340/F380ratio, i.e. 5 min after Ca2+ readdition, was lowest in 
TRPC1 VL/TRPC3 MWK cells and TRPC3/TRPC3 MWK cells and the highest 
in TRPC3 MWK cells (Figure  3-22-d-e). These results confirm the previous 
finding that TRPC1 VL suppresses the TRPC3 activity, and that also co-
expression of the wild-type TRPC3 cDNA reduces the TRPC3 MWK activity. 
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Figure ‎3-22 Effects of TRPC1 VL and TRPC3 on the constitutive TRPC3 
MWK currents in HEK 293 cells. The expression of the TRPC3 MWK was 
induced by tetracycline 2 h befor the measurement. The TRPC1 VL (green) and 
TRPC3 (red) cDNAs were transiently transfected 48 h prior to the measurement 
in TRPC3 MWK cell line. (a) Currents at -80 and +80 mV versus time showing 
that TRPC1 VL (green) and TRPC3 (red) reduced the TRPC3 MWK currents 
compared to control cells (black, identical as in Figure ‎3-16). (b) Summary of 
the currents at 80 mV and -80 mV at 150 s, and inset: showing current-voltage 
relationships of the currents in a 150 s after break-in. (d) Fura-2 experiment of 
TRPC3 MWK cells (black, identical as in Figure ‎3-16) plus TRPC1 VL (green) 
and TRPC3 (red) in the absence of extracellular Ca2+ and after application of 2 
mM Ca2+. Ca2+ readdition led to an increase in the F340/F380 ratio which was 
highest in TRPC3 MWK cells and lowest in TRPC1 VL/TRPC3 MWK cells. (d) 
Summary of the F340/F380 ratio in the absence of Ca2+ (basal Ca2+ at 40 s) 
and after readdition of 2 mM Ca2+ (400 s). Mean +/- SEM with number of cells in 
patch clamp and number of cells per number of experiments in Fura-2 (* for p 
value ≤ 0.05, ** for p value ≤ 0.01, *** for p value ≤ 0.001 and ns for non-
significant) 
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3.8.5 Role of TRPC1 in astrocytes migration 
 
Figure ‎3-23 In vitro migration of astrocytes from TRPC1 gene-deficient 
mice. (a) Representative images of astrocytes at 0 and 4, 8 and 24 hours after 
scrach from wild-type (shown already in Figure ‎3-14) and TRPC1 gene-deficient 
mice. (b) Summary of the migration data. Scratch area at time “0” is 100%; area 
recoverd by migrating astrocytes after 4, 8 and 24 h are indicated from wild-type 
(black) and TRPC1 deficient (green) astrocytes. Data represent mean +/- SEM 
of the indicated number of scratches per experiments (*** for p value ≤ 0.001). 
Since the deletion of the TRPC3 led to a reduced in vitro migration and because 
TRPC1 had a negative effect on TRPC3 channel activity, we investigated the 
effect of TRPC1 deletion on astrocyte migration. Astrocytes isolated from wild-
type and TRPC1 gene-deficient mice were transferred into a 6-well plate and 
cultured until reached confluency. Thereafter, the cell monolayer was scratched 
as described in the methods and in Figure  3-14. The analysis of the migration 4 
hours after the scratch revealed that astrocytes from TRPC1 gene-deficient 
mice have occupied around 17% of the scratched area, whereas wild-type cells 
(shown already in  3.6.6) occupied 10% of the scratched area. After 8 hours, 
~28% of the scratch was covered by TRPC1 deficient astrocytes, and 18% of 
the scratch was covered by astrocytes from wild-type mice. At 24 hours, 65% 
was covered by TRPC1 deficient astrocytes and 30% by wild-type astrocytes 
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(Figure  3-23). These results and the results from patch clamp and Fura-2 
experiments show that TRPC1 decreases TRPC3 function. If TRPC1 is absent, 
the TRPC3 activity increases, as a result migration is increased, and currents 
and Ca2+ entry are increased as well. Thus TRPC1 could have a significant 
impact on the astrogliosis after brain injury which is shown in Figure  3-15 to 
depend on the presence of TRPC3. 
3.8.6 Astrogliosis and glail scar formation depends on TRPC1 
gene-deficient mice 
Next we studied the role of TRPC1 in astrogliosis and glial scar formation after 
brain injury. Because of the lack of TRPC1 gene-deficient mice at the time of 
the experiments and the consistent absence of TRPC5 transcripts in the PCR 
analysis of astrocytes (see  3.5), available TRPC1/TRPC5 gene-deficient mice 
were used for this experiment which was performed as described in the 
methods and Figure  3-15. 3 days after injury, mice were sacrificed and fixed 
with 4% PFA and 35 µm coronal sections were made from the injured brain 
region and stained for GFAP. Inspection of the GFAP-stained slices showed 
that the deletion of TRPC1/TRPC5 led to a significant increase in the area of 
reactive astrocytes, i.e. the GFAP positive area (3.8 mm2) as compared to the 
corresponding wild-type mice (3 mm2). This was further confirmed by the 
analysis of the anti-GFAP antibody fluorescence intensity which was measured 
from equally sized rectangles placed along the injured cortex (normalized to the 
contralateral). This analysis showed that a significant increase in the anti-GFAP 
antibody fluorescence intensity from injured hemisphere compared to the wild-
type mice. Moreover, the width of the GFAP staining (i.e distribution of GFAP 
staining along the injured cortex) was wider in the TRPC1/TRPC5 gene-
deficient mice compared to the wild-type. The analysis of the edema, quantified 
by measuring the cortex width of the injured hemisphere and normalized to the 
contralateral side, showed more cortical edema in the gene-deficient mice 
~17%, while wild-type mice had ~10% increase of the cortex width 
(Figure  3-24). These results indicate that deletion of TRPC1 suppresses the 
reactivity of astrocytes as well as in the inflammatory reaction following brain 
injury. It is to note that the independent groups of wild-type animals taken as 
controls for the TRPC3 gene-deficient mice and the TRPC1/TRPC5 gene-
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deficient mice showed no significant difference in the analyzed parameters of 
the cortical stab wound protocol (n=7 for control1 and control2 respectively). 
 
Figure ‎3-24 Cortical stab wound in TRPC1/TRPC5 gene-deficient mice. (a) 
Example images of the cortical stab injury from wild-type and TRPC1/TRPC5 
gene-deficient mice as 35 µm sections stained anti-GFAP antibody to visualize 
the reactive astrocytes. (b) Summary of the area of reactive astrocytes (in mm2) 
showing significant larger area of GFAP staining in TRPC1/TRPC5 gene-
deficient mice (green) compared to wild-type (black). (d) Analysis of the cortical 
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edema after brain injury measured from the cortical width where the 
TRPC1/TRPC5 gene-deficient mice had more cortical edema compared to wild-
type mice. (c) Diagram showing the distribution of the reactive astrocytes 
obtained (inset) from measuring the anti-GFAP fluorescence intensities of 
rectangles along the cortex and normalized to the contralateral. Data shows 
again the TRPC1/TRPC5 gene-deficient mice had more intensity and 
distribution of astrocytes compared to wild-type. Data represent mean +/- SEM 
from 7 wild-type mice (14 sections) and 6 mice TRPC1/TRPC5 gene-deficient 
mice (12 sections) (** for p value ≤ 0.01, and *** for p value ≤ 0.001).  
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3.9 Voltage-gated Ca2+ channels (CaVs) in astrocytes 
3.9.1 Expression of CaVs subunits in cultured mouse cortical 
astrocytes  
Astrocytes are generally considered to not express functional voltage-gated 
Ca2+ channels CaVs, even though many studies have shown that astrocytes do 
express mRNA of CaV subunits (Latour et al., 2003). In the present study 
transcriptome analysis from GLAST-sorted cultured mouse cortical astrocytes 
showed that indeed astrocytes do express various CaV1 subunit genes. In 
addition, CaV subunit genes, but not CaV1 subunit gene, CaV22 and 
CaV24 subunit genes were detectable (Figure  3-25). 2 to 8 are no CaV 
channel subunits but are involved in AMPA-receptor trafficking and therefore 
called transmembrane AMPA receptor regulating proteins (TARPs) (Nicoll et al., 
2006). In addition, the FPKM values of 2 to 8 transcripts are higher than the 
CaV1 subunit transcripts, but could correlate with the FPKM values of the 
AMPA transcripts shown in Figure  3-6. Interestingly, there are in sum more 
transcripts for the four CaV genes than for CaV1 subunit genes or CaV2 
subunit genes. This finding might indicate that in addition to the assumed 1:1:1 
stoichiometry of CaV1:CaVCaV2, additional functions and roles for Cav 
may be independent of the channel subunit function exist. However the mRNA 
levels do not necessarily reflect the functional presence of the channels. 
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Figure ‎3-25 Expression anaylsis of voltage-gated Ca2+ channel subunit 
genes in cultured cortical astrocytes. Bar graph represents transcriptome 
data obtained from the GLAST-sorted astrocytes RNA, of the CaV1 subunits, 
CaV subunit, CaV2 subunit, CaV1 subunit and TARP 2 to 8 subunit 
genes. The values are expressed in Fragments Per Kilobase of transcript per 
Million mapped reads FPKM as mean +/- SEM of three independent RNA 
sequencing experiments from three independent FACS-sorted astrocyte 
cultures. 
3.9.2 High potassium depolarization in astrocytes 
CaVs are Ca2+ selective channels and their activity could be measured using 
Fura-2-based Ca2+ imaging. The CaVs are activated upon depolarization of the 
membrane potential which could be achieved by increasing the extracellular 
potassium concentrations. In Fura-2 experiments, the potassium concentration 
is set to 4 mM in which is not sufficient for depolarization needed to open CaVs. 
Increasing the potassium concentration to 50 mM led to a fast transient 
increase in the cytoplasmic Ca2+ which maybe mediated by voltage-gated Ca2+ 
channel opening (Figure  3-26-a). As shown by others (Beck et al., 2004), the 
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removal of extracellular potassium also causes cytoplasmic Ca2+ increase in 
astrocytes. This was explained that the potassium channels become Ca2+ 
permeable in the absence of potassium and is supposed to be specific 
mechanism for astrocytes. Microglia showed no response to neither potassium-
free condition nor to the high potassium (Figure  3-26-b). 
 
Figure ‎3-26 Ca2+ influx induced by high potassium induced-depolarization 
in astrocytes. (a) Fura-2 Ca2+ measurement (F340/F380) in astrocytes. 
Application of 50 mM cytoplasmic potassium led to subsequent Ca2+ influx, and 
removal of extracellular potassium also induced Ca2+ increase. Similar protocol 
was applied on microglia (b) did not lead to any Ca2+ increase. Data represent 
mean +/- SEM of the indicated number of cells per number of experiments. 
3.9.3 Electrophysiological characterization of voltage-gated 
Ca2+ and Na+ channels in cultured cortical astrocytes 
The Fura-2 experiment showed that voltage-gated Ca2+ channel activity might 
be present in astrocytes upon potassium depolarization Patch clamp 
experiments offer the opportunity to characterize the CaVs in a more reliable 
manner. Due to the inhibitory effect of intracellular Ca2+ on the CaVs, the patch 
clamp experiments were carried out using an intracellular solution with Ca2+ 
buffered to 0 by BAPTA and extracellular Ca2+ was substituted by 10 mM 
barium (Ba2+) since under this condition Ca2+-dependent inactivation of CaV 
currents should be absent. 
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Figure ‎3-27 Voltage-gated cation channels in astrocytes. Scheme of the 
voltage ramp protocol (a) and step protocol (b) used to measure CaVs activity. 
Voltage ramps were applied every 2 s over a duration of 50 ms from -100 to 100 
mV from a holding potentiel of -60 mV. The step protocol consist of voltage 
steps from -70 to 90 mV applied over a duration of 400 ms with 10 mV 
increment from a holding potential of -60 mV. (c) Current-voltage relationships 
extracted from the maximum current during the voltage ramp mesurements in 
102 mM Na+ (Black), 0 Na+ (substituted with cesium) (red) and the readditon of 
102 mM Na+ (green). Currents extracted from the 400 ms voltage step 
mesurements at -20 mV (red) and at 10 mV (black) during 102 mM Na+ (d), 0 
Na+ (e) and after the readditon of 102 mM Na+ (f). 
After break-in, astrocytes were clamped to -60 mV and voltage ramps from -100 
to+100 mV of 50 ms duration were applied every 2 s (Figure  3-27-a). Under this 
condition, the astrocytes showed two distinct inward currents with a maximum 
at approximately -20 and +10 mV (Figure  3-27-c-black). To learn more about 
those currents, a step protocol was applied from -70 mV to +90 mV where every 
step last for 400 ms and steps escalated by 10 mV (Figure  3-27-b). This 
protocol showed that there are two different types of currents easily 
distinguishable by their peak voltage and their inactivation kinetics. The first 
type of currents had maximum amplitude at -20 mV and exhibited fast 
inactivation kinetics, while the second one had its maximum at +10 mV and 
showed a much slower inactivation. The shape of the current with its maximum 
at -20 mV strongly reflects the shape of a voltage-gated Na+ channel, and the 
one at +10 mV rather indicates a voltage-gated Ca2+ channel (Figure  3-27-d). 
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Within the same cell, the extracellular Na+ was substituted by cesium which 
does not pass Na+ channels. As expected the current at -20 mV disappeared 
and only the current at +10 mV was present (Figure  3-27-c-red), in addition the 
step protocol showed no Ba2+ current with fast inactivation at -20 mV but the 
current at +10 mV did not change which strongly suggest that the first current 
was a voltage-gated Na+ current (Figure  3-27-e). Readdition of extracellular Na+ 
led to the reappearance of the Na+ current, however the current amplitude was 
much smaller due to the duration of the measurement (Figure  3-27-c-green, f). 
Analyzing the transcriptome data obtained from the RNA extracted from the 
GLAST-sorted astrocytes, several transcripts of voltage-gated Na+ 1 and  
subunit genes were found to be expressed. The detectable members were the 
NaV 1.1, 1.2, 1.3, 1.5 and 1.6 with the 1.2 and the 1.5 transcripts showed the 
highest levels, while all NaV subunit genes were detectable with NaV1 and 
4 subunit were the highest (Figure  3-28).  
 
Figure ‎3-28 NaVsubunit 1 and  transcripts of voltage-gated Na+ channels 
in cultured cortical astrocytes. Bar graph represents transcriptome data 
obtained from the GLAST-sorted astrocytes RNA, of the NaV1 and NaV 
subunit genes. The values are expressed in Fragments Per Kilobase of 
transcript per Million mapped reads FPKM as mean +/- SEM of three 
independent RNA sequencing experiments from three independent FACS-
sorted astrocyte cultures. 
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Tetrodotoxin (TTX) is a potent blocker of NaV channels; it is commonly used to 
block the NaVs when measuring CaVs activity. Using the same experimental 
conditions as before, but with addition of 10 µM TTX to the extracellular 
solution, the ramp protocol showed only one inward current which was almost 
completely blocked when the bath solution was replaced by a Ba2+/Ca2+-free 
solution (Figure  3-29-a). Analyzing the maximum current from the step protocol 
revealed a current-voltage relationship which is typical for CaVs (Figure  3-29-b). 
Its maximum was at 10 mV and the current trace obtained by the depolarization 
at 10 mV showed the typical CaVs inactivation kinetics (Figure  3-29-c).  
 
Figure ‎3-29 CaVs currents in cultured cortical astrocytes. (a) Current-
voltage relationships extracted from the maximum current during the voltage 
ramp mesurements of wild-type astrocytes in the presence of 10 mM Ba2+ and 
10 µM TTX  showing an inward current (black) which disapeared in the absence 
of Ba2+ (grey). (b) Current-voltage relationships extracted from the voltage steps 
mesurements in 10 mM Ba2+ showing a current of -5 pA/pF at 10 mV 
depolarization. (c) Current induced by depolarizing to 10 mV for 400 ms shows 
the typical activation and inactivation kinetics of the CaV channels. 
3.9.4 Impact of CaV3 deletion on CaVs activity in astrocytes 
Cav subunits are associated with the pore forming CaV1 subunit and they 
are involved in CaV1 trafficking to the plasma membrane and also in channel 
gating properties. The deletion of CaV3 subunit gene was shown, in a previous 
paper from our laboratory, to shift the Ca2+ current to more depolarized 
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potentials in dorsal root ganglion neurons (Murakami et al 2002). Astrocytes 
were isolated from CaV3 gene-deficient mice and used for electrophysiological 
measurements of dorsal root ganglion neurons currents. CaV3 deficient 
astrocytes exhibited similar CaV inward currents when compared with the 
corresponding wild-type cells in terms of current amplitude as well as activation 
and inactivation potentials (Figure  3-30-b-d). No significant difference could be 
identified, but a slightly higher but not significantly different current at -30 and -
20 mV steps were observed in astrocytes CaV3 deficient astrocytes 
(Figure  3-30-b). The maximum currents (Imax) were achieved at 10 mV in both 
genotypes, and after normalizing the currents from the voltage steps to the 
maximum amplitude, CaV currents of CaV3 deficient astrocytes showed no 
difference in their activation and inactivation kinetics as compared to the 
corresponding currents of wild-type astrocytes (Figure  3-30-e-f). Thus the 
CaV3 subunit does not seem to play a role in the function of the CaV current in 
cultured cortical astrocytes. 
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Figure ‎3-30 CaV currents in CaV3 deficient astrocytes. (a) Current-voltage 
relationships extracted from the current obtained by the voltage ramp protocol 
of wild-type astrocytes (black) and astrocytes from CaV3 gene-deficient mice 
(green). (b) Current-voltage relationships extracted as maximum current 
amplitudes from the voltage steps measurements of astrocytes from wild-type 
(black) and CaV3 gene-deficient mice (green). (c) Currents at 10 mV including 
as inset normalized currents to the maximum amplitude from both gentotypes. 
(d) Maximal current density (Imax) of the current at 10 mV from wild-type 
astrocytes (black) and CaV3 gene-deficient astrocytes (green). Analysis of the 
activation (e, act) and inactivation (f, inact) kinetics of the currents at 10 mV from 
wild-type astrocytes (black) and CaV3 gene-deficient astrocytes (green). Data 
represent mean +/- SEM of the indicated number of measured cells (ns for non-
significant). 
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3.9.5 Impact of CaV2 deletion on CaVs activity in astrocytes 
Similarly to CaV3, the deletion of CaV2 subunit was also shown to shift the L-
type Ca2+ currents to more depolarizing potentials in embryonic 
cardiomyocytes, and in addition the amplitude of the current was reduced 
(Weissgerber et al., 2006). In the present work, astrocytes were also isolated 
from the extra-cardiomyocyte CaV2 gene-deficient mice generated in our 
laboratory. These mice carry a functional CaV2 gene in cardiomyocytes and 
are CaV2 gene-deficient in all other cell of their body (Katiyar et al., 2015). 
Ba2+ currents were measured using ramp protocols from -100 to +100 mV and 
step protocols from -70 to +90 mV with 10 mV increment as shown in 
Figure  3-27-a-b. The current amplitude in CaV2 deficient astrocytes was 
significantly reduced by ~40% compared to the corresponding wild-type cells 
(Figure  3-27-d). Moreover the activation curve tended to shift, but not 
significantly, towards more depolarized potentials in astrocytes isolated from 
CaV2 gene-deficient mice. The activation kinetics obtained from current at 10 
mV showed no difference when CaV2 was deleted in astrocytes, but the 
inactivation kinetic at 10 mV current was significantly faster in CaV2 deficient 
astrocytes (Figure  3-31-e-f). Thus, in contrast to CaV3 the CaV2 has an 
impact on the CaV currents in cultured cortical astrocytes. The characteristics of 
the CaV currents were not significantly different in the two wild-type astrocytes 
used as a control for CaV3 and the CaV2 deficient astrocytes (black traces in 
Figure  3-30 and Figure  3-31).  
Results 
 
Universität des Saarlandes  98 
 
 
Figure ‎3-31 CaV currents in CaV2 deficient astrocytes. (a) Current-voltage 
relationships extracted from the current obtained by the voltage ramp protocol 
of wild-type astrocytes (black) and astrocytes from CaV2 gene-deficient mice 
(emc2 ko red). (b) Current-voltage relationships extracted as maximum current 
amplitudes from the voltage steps measurements of astrocytes from wild-type 
(black) and CaV2 gene-deficient mice (red). (c) Currents at 10 mV including as 
inset normalized currents to the maximum amplitude from both gentotypes. (d) 
Maximal current density (Imax) of the current at 10 mV from wild-type astrocytes 
(black) and CaV2 gene-deficient astrocytes (red). Analysis of the activation (e, 
act) and inactivation (f, inact) kinetics of the currents at 10 mV from wild-type 
astrocytes (black) and CaV2 gene-deficient astrocytes (green). Data represent 
mean +/- SEM of the indicated number of measured cells (* for p value ≤ 0.05, 
** for p value ≤ 0.01 and ns for non-significant). 
-5
-4
-3
-2
-1
1 pA/pF
-100 -50 50 100
mV
-6
-4
-2
pA/pF
-100 -50 50 100
mV
* *
*
*
b
d
a
c
*
-6
-5
-4
-3
-2
-1
0
wt ecm 2 ko
I
 a
t 
1
0
 m
V
 (
p
A
/p
F
)
m
a
x
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
a
c
t 
(m
s
)
ns
wt ecm 2 ko
0
20
40
60
80
100
120
140
160
180
i
n
a
c
t 
(m
s
)
**
wt ecm 2 ko
10 mV
50 ms
1 pA/pF
50 ms
wt (7)
ecm 2 ko (11)
wt (7)
ecm 2 ko (11)
wt (7)
ecm 2 ko (11)
dc
7 11 7 11
7 11
Results 
 
Universität des Saarlandes  99 
 
3.9.6 Pharmacological characterization of CaVs in astrocytes 
 
Figure ‎3-32 Pharmacological characterization CaVs in astrocytes. Current-
voltage relations extracted from the Imax (black) and after (grey) the application 
of nifedipine (a), verapamil (b), -agatoxin-IVA (c),-conotoxin-GVIA (d), SNX 
482 (e), all agents (without nifedipine and NiCl2) (f) and NiCl2 (g). (h) Summary 
of mean +/- SEM with from the indicated number of measured cells. 
The CaV Imax measured in cultured mouse cortical astrocytes was obtained at 0 
to 10 mV which indicates a contribution of high voltage-activated (HVA) CaVs 
rather than low voltage-activated (LVA) CaVs. These results are in good 
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agreement with the transcriptome data that shows the P/Q- and L-type channels 
to be expressed more prominently than the LVA CaVs (Figure  3-25-a). It is 
difficult to discriminate between the HVA CaVs in a cell that expresses a 
mixture of those channels by analyzing the current-voltage relationship. 
However, blockers of CaVs have been developed and tested, and some such 
as nimodipine and verapamil are in use to treat patients for more than 50 years. 
A set of different blockers of HVA CaVs were used in whole cell patch clamp 
experiments of astrocytes (Figure  3-32). The measurement started in the 
standard extracellular solution and after having the Ba2+ currents recorded for 2 
min, blockers were applied, either separately or in combination, with an 
application pipette onto the measured cell. The percentage of blockage was 
calculated by dividing the decrease in the Imax after blocker application by the 
Imax before application ((Imax - Imax blocker)*100/ Imax). Application of 10 µM 
nifedipine, an L-type CaV blocker, led to a reduction of about 27% in the current 
(Figure  3-32-a), whereas another L-type blocker verapamil (10 µM) led to even 
higher blockage of about 56% (Figure  3-32-b). This indicates that many L-type 
Ca2+ channels are contributing to the astrocytic inward Ba2+ current. -agatoxin-
IVA, a CaV2.1 blocker, was also used since there was a prominent expression 
of CaV2.1 RNA in the transcriptome, however only 5% blockage was observed 
using 2 µM (Figure  3-32-c). A CaV2.2 blocker, -conotoxin-GVIA, was also 
used, but 1 µM was able to block only 3% of the CaV current in astrocytes 
(Figure  3-32-d). The last HVA Ca2+ channel to be tested is the CaV2.3 channel 
using its specific blocker SNX 482, which blocks 12% of the current 
(Figure  3-32-e). The summed percentages of blockage from the different 
blockers resulted in 76% which reflects a residual current of 24% that was not 
blocked. Nevertheless, a cocktail of blockers was used including verapamil, -
agatoxin-IVA,-conotoxin-GVIA and SNX 482 with same concentrations that 
were previously used. Again this cocktail was not able to fully block the inward 
current measured in astrocytes and resulted in a blockage of only 65% 
(Figure  3-32-f). Whereas NiCl2, a non-specific Ca
2+ channels blocker at 
concentration of 2 mM, blocked almost completely the inward current (around 
94%) (Figure  3-32-g). This finding indicates that maybe higher concentration of 
the CaV blockers have to be used to completely block all the CaVs.  
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In the transcriptome analysis of astrocytes, only CaV1.2 and CaV1.3 among the 
L-types were prominently expressed but the CaV1.3 transcripts were 10-fold 
higher than the CaV1.2. Therefore, a more sensitive CaV blocker was used. 10 
µM of isradipine was able to block about 52% of the astrocytic inward current 
(Figure  3-33-b) which was very similar to what was obtained in the presence of 
10 µM verapamil. When the concentration of isradipine was increased to 100 
µM ~82% of the current was blocked (Figure  3-33-c), while 1 µM isradipine 
blocked ~25% of the current (Figure  3-33-a). Taken the summed percentages 
of inhibition by 100 µM isradipin (82%), -agatoxin-IVA (5%),-conotoxin-GVIA 
(3%) and SNX 482 (12%) revealed blockage of 102% of the Ca2+ current 
measured in astrocytes. 
 
Figure ‎3-33 Block of CaV currents in astrocytes in the presence of 
increasing concentrations of isradipine. Current-voltage relationships 
extracted from the maxiumum current before (black) and during (grey) the 
application of isradipine 1 µM (a), 10 µM (b) and 100 µM (c). (d) Summary of 
means +/- SEM of the percentage of inhibition from the indicated number of 
measured cells. 
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4 Discussion 
4.1 Characterization of cultured astrocytes and their transcript 
expression pattern 
Astrocyte cultures obtained from the cerebral cortex of new born mice consist 
mainly of astrocytes and a very low number of microglia cells that grow on top 
of the astrocytes. Microglia cells can be removed by shaking the culture flask, 
but this procedure does not lead to full removal of the microglia. Such a culture 
is called enriched astrocytes culture. Using specific antibodies for astrocytes 
(anti-GFAP) and microglia (anti-CD11b) did reveal that a few cells of the 
enriched astrocyte culture were still positively labelled with the microglia marker 
but most of the cells were GFAP-positive. Most of the published studies, which 
used cultured astrocyte, have employed the enrichment method leading to more 
than 90% purity (Grimaldi et al., 2003; Yi et al., 2016). PCR analysis using RNA 
isolated from such astrocyte enriched cultures revealed that all the TRPC 
transcripts, except that of TRPC5, could be identified (Figure  3-2). These results 
are in agreement with results have been published by several groups on rat 
embryonic cortical astrocytes (Grimaldi et al., 2003; Liang et al., 2014). In 
addition, several groups have reported by the mean of western blot that 
astrocytes do express TRPC1, TRPC3, TRPC4 and TRPC6 (Grimaldi et al., 
2003; Linde et al., 2011). However, the specificity and the sensitivity of the 
antibodies used in those studies against the TRPC proteins have not been 
shown. RT-PCR is a very sensitive technique where an RNA contamination 
from another cell type could easily lead to amplification of contaminating 
transcripts even if the number of contaminating cells is very low. In the case of 
the astrocyte cultures, which are contaminated by microglia cells, it is therefore 
very difficult to rely on the PCR results from the enriched culture. For this 
reason, isolation of pure astrocytes before any gene expression analysis is 
essential. Separating cells by fluorescence-activated cell sorting (FACS) is a 
technique which can be used to separate astrocytes from microglia cells. To 
sort living cells, surface markers which are labelled with fluorescent antibodies 
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are needed. The astrocytic marker GFAP is a cytoplasmic marker, and 
therefore using this marker to sort living cells is not possible. Alternatively, the 
glutamate aspartate transporter (GLAST) has been suggested to be an 
astrocytes marker protein which is located in the plasma membrane (Schmitt et 
al., 1997). Flow cytometry analysis of fixed and permeablized cells from 
astrocyte cultures stained with both anti-GFAP-FITC and anti-GLAST-PE, 
revealed that the same cells were stained with both antibodies (Figure  3-3). 
Similarly as has been described (Jungblut et al., 2012). We therefore used anti-
GLAST-PE antibody to sort pure living astrocytes for transcriptome analysis by 
next generation sequencing and RT-PCR. In addition, anti-CD11b-FITC 
antibody was used to label the microglia. Astrocytes were sorted for PCR 
analysis as GLAST-positive / CD11b-negative, and microglia as CD11b-positive 
/ GLAST-negative (Figure  3-4). By RT-PCR using 100 sorted astrocytes, not all 
TRPC transcripts were amplified. Only TRPC3 was amplified in 13 independent 
PCRs from 5 independent sortings of 5 independent cultures, whereas TRPC1, 
TRPC2, TRPC4 were amplified more than 10 (TRPC1 and TRPC2) and 11 
(TRPC4) times from the 13 performed PCRs (Figure  3-5-a). The difference in 
the expression pattern from the enriched and FACS-sorted astrocytes shows 
clearly how few contaminating cells could change the expression pattern of 
astrocytes. The RT-PCR results using 50 sorted microglia cells per reaction, 
showed that only TRPC4 was consistently amplified in the 3 performed PCRs 
(Figure  3-5-b). The expression patterns of the sorted astrocytes and microglia 
together do not fit the PCR results of the enriched astrocyte culture i.e. 
astrocytes and microglia are not the TRPC6- and TRPC7-expressing cells. This 
indicates that there is one (or more) other cell type (s) in the astrocyte cultures 
which could be the source of the TRPC6 and C7 detection. The FACS analysis 
revealed a third population of unstained cells i.e. GLAST-negative and CD11b-
negative. Oligodendrocytes have been always reported to be present in the 
astrocytes culture in a low number (Chen et al., 2007b), and therefore 
oligodendrocytes could be the third cell population in the astrocytes cultures. In 
addition, a previous work has reported that TRPC6 is expressed in 
oligodendrocytes (Paez et al., 2011) which favor the possibility that 
oligodendrocytes are the (at least) TRPC6-expressing cells. However, this has 
to be further proved and confirmed by sorting separately the oligodendrocytes 
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and having them analyzed by PCR. Interestingly, comparing the RT-PCR 
results with the transcriptome data obtained from the GLAST-sorted astrocytes 
revealed more or less the same tendency, i.e. TRPC1. TRPC2 and TRPC3 
were commonly detected with both methods (Figure  3-6). However, TRPC7 was 
detected in the transcriptome but not in the RT-PCR, even though the TRPC7 
primers did amplify TRPC7 fragment using the enriched culture RNA which rule 
out the problem of primers (Figure  3-2). The reason behind this discrepancy is 
not clear yet. In addition, the expression levels of TRPC transcripts are 
comparable with the transcripts of other genes which are already described to 
play a role in Ca2+ signaling of astrocytes such as type 2 IP3R (Kanemaru et al., 
2013), like TRPC1 and TRPC3 (Figure  3-6) 
The present work focused on TRPC3 as I always could detect its transcripts in 
all performed RT-PCR from the GLAST-sorted astrocytes. In addition, TRPC1 
was detected more than 10 times in a total of 13 PCRs. However, the amplified 
fragments in the RT-PCR are only 200 bp, therefore the full length cDNAs of 
TRPC3 and TRPC1 cDNAs were amplified from astrocytes, subcloned in 
pUC19 and sequenced (Figure  3-7). The sequencing of the TRPC1 clones 
revealed the presence of the extended TPRC1 variant, so called TRPC1 very 
long (VL), and a splice variant which has been published by Ong et al. (Ong et 
al., 2013) called TRPC1 lacking an EcoRV restriction cite due to the absence 
of 21 bp fragment in exon 5. However, the TRPC1 identified in astrocytes 
(Figure  3-7) lacks also the exon 3. In addition to the TRPC1 VL and 
TRPC1∆exon3 variant, the TRPC1 VL∆exon3 was identified. The presence of 
these TRPC variants in astrocytes could play a role in the Ca2+ homeostasis 
mediated by TRPC and ORAI channels. 
4.2 Roles of TRPC1 and TRPC3 proteins in astrocytes 
Upon a decrease in the ER Ca2+ concentrations, STIM proteins in the ER 
membrane assemble and interact with ORAI channels in the plasma membrane 
leading to Ca2+ influx into the cell from the extracellular space. Several TRPC 
channels have been discussed to be involved in the process (Venkatachalam et 
al., 2002). In pancreatic and salivary gland cells, the knockdown of TRPC3 
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gene expression reduced significantly Ca2+ entry when ER Ca2+ stores are 
depleted (Kim et al., 2011). Similarly, knockdown of TRPC3 gene expression in 
dorsal root ganglion cells gave similar results (Alkhani et al., 2014). In salivary 
gland acinar cells isolated from TRPC1 gene-deficient mice exhibited impaired 
Ca2+ entry (Liu et al., 2007). In the present work, astrocytes isolated from wild-
type mice showed a prominent Ca2+ entry after store depletion with the SERCA 
pump blockers thapsigargin or cyclopiazonic acid followed by Ca2+ readdition 
(Figure ‎3-9). However, Ca2+ entry induced by store depletion / Ca2+ readdition 
protocol was not affected in astrocytes isolated from TRPC3/TRPC6 gene-
deficient mice. On the other hand, astrocytes isolated from TRPC1 gene-
deficient mice did have a reduced Ca2+ release in the presence of SERCA 
pump blocker and slightly increased Ca2+ entry (Figure ‎3-19). These results 
clearly indicate that TRPC3 plays no role in the ORAI-dependent Ca2+ entry in 
cultured mouse cortical astrocytes. However TRPC1 seem to affect negatively 
the ORAI-dependent Ca2+ entry in astrocytes, and moreover, the deletion of 
TRPC1 gene reduced the Ca2+ release in the presence of SERCA pump 
inhibitor. A Similar tendency was also observed in TRPC1 siRNA-treated SH-
SY5Y cells where a smaller Ca2+ release after thapsigargin treatment was 
observed (Selvaraj et al., 2012). The reduction of Ca2+ release from the ER in 
TRPC1 deficient astrocytes (Figure ‎3-19) could indicate a possible role of 
TRPC1 in the Ca2+ homeostasis of the endoplasmic reticulum. Accordingly, my 
observation in the astrocytes could fit with what has been previously reported 
on TRPC1 by Berbey at al. that it localizes in the ER membrane of skeletal 
muscle cells and acts as a leak channel (Berbey et al., 2009).  
4.3 Dissection of OAG-induced Ca2+ signals in astrocytes 
DAG is an endogenous activator for TRPC2, TRPC3, TRPC6 and TRPC7 
leading to the opening of these channels and a subsequent Ca2+ influx 
(Hofmann et al., 1999). DAG is formed by activation of PLC after activation of 
Gq protein coupled receptors or receptor tyrosine kinases. The DAG analogue 
OAG is an exogenous activator for DAG-sensitive TRPC channels (Hofmann et 
al., 1999), and it can be used externally in experiments. The application of 100 
µM OAG on wild-type astrocytes led to Ca2+ oscillations in the presence of 
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extracellular Ca2+ (Figure  3-10-a). However, when extracellular Ca2+ was 
removed, OAG was still able to induce Ca2+ oscillations with smaller amplitudes 
(Figure  3-10-c). Hisatsun et al. suggested that the increase in cytoplasmic Ca2+ 
concentration observed after OAG stimulation in the absence of extracellular 
Ca2+ is mediated by the activation of PLC by OAG. Eventually, the activation of 
PLC leads to the cleavage of PIP2 into DAG and IP3 which then induces Ca2+ 
release from the ER via IP3-receptor channels (Hisatsune et al., 2005). The 
question to be answered in my experiment was: Are the Ca2+ oscillation, in the 
presence of extracellular Ca2+ in cultured astrocytes, deriving from IP3-induced 
Ca2+ release and subsequent Ca2+ influx through ORAI channels, or in addition 
to the IP3/ORAI pathways, through TRPC channels? To exclude intracellular 
Ca2+ release as source for the OAG-mediated Ca2+ oscillations, intracellular 
Ca2+ stores were permanently emptied by blocking the SERCA pump, which 
also leads to constitutive activation of ORAI. Application of OAG on top of this 
condition led eventually to an additional Ca2+ influx (Figure  3-10-d), which was 
not mediated via PKC since the PMA, a PKC activator, had no influence 
(Figure  3-10-e). In the current study, several TRPC gene-deficient mice have 
been used to dissect the role of TRPCs in astrocytes and whether they are the 
target of OAG. In the RT-PCR from the GLAST-sorted astrocytes only TRPC2 
and TRPC3 were detected from the TRPC members which can be activated via 
DAG or experimentally via OAG. Therefore the main focus was on TRPC3. 
Application of OAG protocol on astrocytes isolated from TRPC3 gene-deficient 
mice revealed a significant reduction in the number of responding cells as well 
as the number of oscillation per responding cell (Figure  3-11-b). The same was 
seen in astrocytes isolated from TRPC3/TRPC6 gene-deficient 
mice(Figure  3-11-d), whereas Ca2+ signals in astrocytes isolated from TRPC6 
gene-deficient mice did not differ from those of wild-type astrocytes 
(Figure  3-11-c). However, in good agreement with the PCR results revealing no 
TRPC6 expression, the OAG-mediated Ca2+ signals were not affected in 
astrocytes from TRPC6 deficient mice. Thus the major Ca2+ influx mediated by 
OAG is TRPC3-dependent. The residual OAG-mediated Ca2+ oscillations in 
astrocytes from TRPC3 gene-deficient mice might have been mediated via 
TRPC2. A study on rat astrocytes showed that OAG induced Ca2+ signals in 
astrocytes, and TRPC3 was suggested to be involved (Grimaldi et al., 2003). 
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However, the efficiency of the siRNA used in this study was never shown. To 
further confirm the presence of a functional TRPC3 in astrocytes, whole cell 
patch clamp technique was employed. Before trying to isolate TRPC3 currents 
in astrocytes, the experimental conditions to record these currents were 
optimized in HEK293 cells expressing TRPC3 cDNA. Under conditions of 1 mM 
extracellular Ca2+ and 100 nM in the patch pipette, the OAG was not able to 
induce any measurable currents (Figure  3-12) even though many published 
work have been using those conditions (Trebak et al., 2003). Only after omitting 
the intra- and extracellular Ca2+, OAG was able to induce consistently TRPC3 
currents (Figure  3-12). This suggests that TRPC3 channel activity is highly Ca2+ 
sensitive and Ca2+ shows a negative feedback on TRPC3 activity which is more 
pronounced from the cytoplasmic side. A similar observation was reported for 
TRPC3 (Lintschinger et al., 2000) describing that TRPC3 activity depends on 
extracellular Ca2+. Using our optimized conditions (0 Ca2+ intra- and 
extracellular) in whole cell patch clamp, OAG also induced currents in 
astrocytes (Figure  3-13) which revealed very similar current-voltage relation 
compared to the one from TRPC3 channel in HEK cells. However, the success 
rate is low. Endogenous TRP currents are very small, and in most measured 
astrocytes chloride currents were present which rendered the characterization 
of the endogenous TRPC3 current difficult. A complementary approach, 
astrocytes isolated from moonwalker (MWK) mice. They are heterozygous for a 
gain of function mutation in TRPC3 gene. Interestingly astrocytes isolated from 
these mice showed a higher basal Ca2+ levels and exhibited higher Ca2+ influx 
after readdition of extracellular Ca2+ (Figure  3-17). The observation that 
astrocytes from MWK mice have higher basal Ca2+ levels further confirms the 
fact that TRPC3 is functionally expressed in astrocytes. 
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Figure ‎4-1 OAG/DAG-dependent cation entry. Representation of the possible 
OAG pathways, including: 1) OAG induces Ca2+ (and Na+) influx via DAG-
sensitive TRPC channels similar to DAG (DAG results from the activation of 
PLC by Gq proteins). 2) OAG could activate the PLC which leads to IP3-
induced Ca2+ release which in turn activates ORAI. 3) OAG activates PKC 
which most probably has no effect of TRPC channels in astrocytes. 
4.4 Role of TRPC1 in the OAG-induced TRPC3 channel activity 
Although TRPC1 was the first mammalian TRP to be cloned; its mechanism of 
activation remains unclear. However, many reports have shown that TRPC1 
could interact with TRPCs, and also with many other TRP and ORAI proteins 
(Dietrich et al., 2014). The well characterized interaction partners of TRPC1 are 
TRPC4 and TRPC5 at least in cell culture where TRPC1, if forming 
heterotetramers with TRPC4 or TRPC5, changes the current-voltage 
relationships (Strubing et al., 2001). TRPC1 has been shown to also interact 
with TRPC3 in skeletal muscle cells using co-immunoprecipitation (Cheung et 
al., 2011). In HEK cells TRPC1 did not change the current-voltage relationship 
of TRPC3 but shifted the reversal towards negative potentials and thus they 
concluded that it reduces its Ca2+ permeability (Storch et al., 2012). In the 
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current work, TRPC1 VL cDNA expressing cells did not show any currents 
when stimulated with OAG (Figure  3-20-e). However, when the TRPC3 cDNA 
was co-transfected with TRPC1 VL cDNA in HEK, the TRPC3 currents were 
significantly smaller compared to the pure TRPC3 current (Figure  3-20-a). 
Despite the reduction in the TRPC3 currents in presence of TRPC1 VL, the 
current-voltage relationships of TRPC3 with TRPC1 VL did not differ from the 
TRPC3 alone. This was further confirmed when TRPC1 VL cDNA was co-
expressed with the TRPC3 MWK in HEK cells, where the constitutive TRPC3 
MWK currents as well as the basal Ca2+ levels were reduced (Figure  3-22-a-c). 
Storch et al. observed only a slight decrease in the inward currents and a slight 
increase in the outward currents after co-transfection of TRPC1 and TRPC3 
cDNAs, in contrast to the inhibitory effect of TRPC1 VL on TRPC3 channel 
activity presented in this work (Figure  3-20-a). The TRPC1 VL variant which 
includes a 5’ extension and a new start codon CUG that adds 82 amino acids to 
the known sequence was used. The additional amino acid sequence of TRPC1 
VL could be responsible for the effect on the TRPC3 current observed in this 
study. Astrocytes do express the TRPC1 VL variant, and in addition the TRPC1 
VL∆exon3 variant and TRPC1∆exon3 variant, which is a very long TRPC1 
variant lacking exon3 and 21 bp within exon5 (Figure  3-7). The effect of TRPC1 
VL was studied on the OAG-induced Ca2+ oscillations in astrocytes, in which 
TRPC3 was found to be involved. The results obtained from the OAG protocol 
in astrocytes isolated from TRPC1 gene-deficient mice showed that significantly 
more cells respond to OAG and more oscillations could be detected per cell 
when compared to wild-type astrocytes (Figure  3-21-b). This observation further 
enforces the fact that TRPC1 VL exerts a negative effect on TRPC3 activity. 
The exact mechanism of the TRPC1 effect is not clear yet, but several 
scenarios could be proposed. Since physical interaction of TRPC1 VL with 
TRPC3 was shown by co-immunoprecipitation (results from Laura Hofmann in 
our laboratory), it could be that: 1) both proteins form a heteromeric channel 
that is less active than the homomeric TRPC3, 2) TRPC1 VL acts as an 
additional non-conducting “beta” subunit for the homomeric TRPC3 channel and 
modulates its gating properties, or 3) TRPC1 VL reduces the membrane 
expression of TRPC3. All those possibilities have to be addressed with proper 
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biochemical techniques to have a deeper understanding on the TRPC1-TRPC3 
interaction. 
4.5 Role of TRPC1 and TRPC3 in astrocytes migration and 
astrogliosis 
In healthy brain, astrocytes play critical roles in energy supply, homeostasis of 
ions and transmitters, synapse function, synaptic remodeling and blood flow. 
Astrocytes could enter into a reactive state called astrogliosis which is an 
abnormal increase in the migration and proliferation of astrocytes due to the 
damaged neurons (Silver and Miller, 2004). Moreover, traumatic brain injury 
results in the destruction of the brain-blood barrier which leaves the neurons 
and astrocytes exposed, in addition to molecules released from dead cells, to 
the blood fluid and blood cells. Many large and small molecules are involved in 
triggering the astrogliosis including cytokines and growth factors (Il6, LIF, 
CNTF, IL1, Il10, TGFβ, TNFα, INFγ), mediators of innate immunity (LPS and 
other Toll-like receptor ligands), neurotransmitters and modulators (glutamate, 
noradrenalin), small molecules released by cell injury (ATP), and molecules of 
oxidative stress (nitric oxide, reactive oxygen species) (Sofroniew, 2009). Most 
of these molecules are modulators of the G protein coupled receptors which 
could involve an increase in the cytoplasmic Ca2+ concentration and therefore 
Ca2+ is closely related in the mechanism underlying the astrogliosis and glial 
scar formation after brain injury. As shown by Gao et al. that BAPTA-AM, a Ca2+ 
chelator, reduces the GFAP expression and the glial scar formation after brain 
injury, and concluded that the traumatic brain injury triggers Ca2+ influx which 
mediates in the end the astrogliosis (Gao et al., 2013). In the present study, 
several TRPC channels, which are activated downstream of Gq-coupled 
activation, are shown to be expressed in astrocytes. The deletion of TRPC3 
gene resulted in reduced OAG- mediated Ca2+ influx in astrocytes, but deleting 
TRPC1 gene enhanced this Ca2+ influx (Figure  3-11 and Figure  3-21). 
Therefore, we investigated the role of TRPC3 and TRPC1 in astrocytes 
migration and astrogliosis. A scratch assay as an in vitro experiment for cell 
migration was applied as cells might behave similar in this in vitro experiment as 
they do after injury in vivo. Astrocytes isolated from TRPC3 gene-deficient mice 
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had a significant reduction in the migration rate as compared to wild-type 
astrocytes (Figure  3-14). However, astrocytes isolated from TRPC1 gene-
deficient mice exhibited a significant increase in the migration rate as compared 
to wild-type astrocytes (Figure  3-23). The astrocytes migration results seem to 
correlate with the changes in the Ca2+ influx observed in TRPCs deficient 
astrocytes, i.e. the TRPC3 deficient astrocytes have less OAG-induced Ca2+ 
influx and less migration rate, and vice versa, TRPC1 deficient astrocytes have 
more OAG-induced Ca2+ influx and more migration rate. In the in vivo brain 
injury, the TRPC3 gene-deficient mice exhibited a significantly reduced area of 
astrogliosis (measured as area of GFAP-positive cells) and reduced cortical 
edema (Figure  3-15). Again the TRPC1/TRPC5 gene-deficient mice showed the 
opposite effects i.e. an increased astrogliosis area and increased cortical 
edema as compared to wild-type mice (Figure  3-24). This consistency observed 
in the TRPC3 and TRPC1 gene-deficient mice, repectively, strongly suggests 
that the Ca2+ influx via TRPC3 plays a critical role in the Ca2+ signaling required 
for astrogliosis. This Ca2+ influx is enhanced when TRPC1 is deleted and 
thereby astrogliosis is increased. The relation of Ca2+ signaling and astrogliosis 
was also reported by Kanemaru et al. where they showed that type 2 IP3 
receptor gene-deficient mice had impaired reactive astrogliosis and concluded 
that the Ca2+ signaling via IP3 receptor type 2 is required for astrogliosis 
(Kanemaru et al., 2013). Next, we asked the question whether Ca2+ influx by 
itself could lead to astrogliosis without brain injury? To answer this question, we 
used the MWK mice, since astrocytes from these mice have increased basal 
Ca2+ (Figure  3-17). The analysis of non-injured brain slices from MWK mice did 
not show any signs of spontaneous astrogliosis when stained with anti-GFAP 
(Figure  3-18). Hence that Ca2+ influx alone is not sufficient to induce 
astrogliosis, but an injury is required to initiate the process. The findings of the 
current work strongly suggest that in particular TRPC3 channel is responsible 
for Ca2+ entry during brain injuries, and therefore is involved in the astrogliosis 
and glial scar formation after brain injury. Controlling the intensity of astrogliosis 
could help to ameliorate the outcome after brain injuries and TRPC channels 
could therefore be targeted to control astrogliosis.  
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4.6 Voltage-gated Na+ (NaV) and Ca2+ (CaV) channels in 
astrocytes 
Transcripts of genes encoding NaVs and CaVs have been identified in 
astrocytes by RNA sequencing (Figure  3-25 and Figure  3-28). Many transcripts 
from the genes encoding the ion conduction genes of L-type CaVs (CaV1.2 and 
CaV1.3) and P/Q-type CaV (CaV2.1) were identified, as well as transcripts of 
the CaV and CaV2 genes (Figure  3-25). In rat astrocytes, only members of 
the CaV1 subunit genes have been investigated, but no functional analysis 
have been conducted in that study (Latour et al., 2003). Regarding the other 
auxiliary subunits, , and2subunits, little is known about their presence and 
function in astrocytes. The current study provides a complete overview about 
the expression pattern and expression levels of auxiliary CaV of the  and2 
subunit genes in mouse cortical astrocytes. The first evidence for the presence 
of functional CaVs was obtained after increasing the extracellular [K+] 
concentration that leads to cell depolarization and CaVs should be activated. 
This is in fact the case as shown in Figure  3-26-a. Astrocytes used in this study 
exhibited Ca2+ response towards potassium depolarization in Fura-2 experiment 
which was absent in microglia cells. This type of astrocytic response to high 
potassium has been reported previously in brain slices but it was attributed to 
glutamate released by depolarized neurons which subsequently activates Ca2+ 
signals in astrocytes (Beck et al., 2004; Carmignoto et al., 1998). Neurons do 
not survive in the astrocyte culture within the first week of culturing (Schildge et 
al., 2013), and most of the conducted experiments were performed two to three 
weeks after the isolation. Therefore, it is highly unlikely that the Ca2+ signals 
observed in astrocytes after high potassium depolarization depend on neurons. 
To further investigate the source of the potassium-induced Ca2+ influx in 
astrocytes, whole cell patch clamp experiments were performed with conditions 
allowing to measure CaVs currents. As expected from the transcriptome 
analysis, inward Ba2+ (used instead of Ca2+) currents were observed in 
astrocytes isolated from new born mice cortices. However, two types of inward 
currents were observed; one has maximum amplitude at -20 mV and the other 
one at 10 mV. When analyzing the currents at different voltage steps, the 
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current with a maximum at -20 mV had the typical shape of a voltage-gated Na+ 
current with fast inactivation kinetics, and the one at 10 mV had slow 
inactivation kinetics which is characteristic for the voltage-gated Ca2+ channels. 
Moreover, the current at -20 mV did disappeared when Na+ was replaced by 
cesium which does not permeate NaVs, and the 10 mV current persisted under 
this condition (Figure  3-27). Additionally, the use of TTX, a specific blocker of 
the NaVs, did abolish the Na+ current in cultured astrocytes. The removal of 
extracellular barium abolished the CaVs current (Figure  3-29). Those results 
correlate nicely with the transcriptome data from astrocytes where NaV1 and 
NaV subunit genes were identified. In 1983, Nowak and colleagues have 
found evidence of Na+ channels in cortical astrocytes using patch clamp 
experiments and specific activators like veratridine and scorpion toxin (Nowak 
et al., 1984). In 1987, the same group have shown again in a follow up study 
that the Na+ currents measured in cortical astrocytes are TTX-sensitive but 
require a concentration more than 1 µM to achieve a complete block (Nowak et 
al., 1987). Later, another study showed the presence of the Na+ channel genes 
in rat cortical astrocytes (Gautron et al., 1992). Despite the early discovery of 
Na+ channels in astrocytes, very few studies have been conducted towards their 
functional role. Black et al. have shown that the NaV1.5 protein is upregulated 
in astrocytes from post-mortem multiple sclerosis patients (Black et al., 2010). 
Apparently, NaVs in astrocytes are also relevant under pathological conditions. 
The HVA Ca2+ channels consist of L- (CaV1.1, CaV1.2, CaV1.3 and CaV1.4), 
P/Q- (CaV2.1), N- (CaV2.2) and R- (CaV2.3) types, and the LVA consists 
mainly of the T-type Ca2+ channels. However, the L-type CaV1.3 Ca2+ channel 
is activated at more negative potential than CaV1.2, therefore shares some 
proprieties with CaV3 channels (Koschak et al., 2001). The Ca2+ currents 
measured in this work from cortical astrocytes did open at -50 mV but had a 
maximum at 0 to 10 mV (Figure  3-29). This corresponds to the LVA channels 
on one hand since they open at a voltage less than -40 mV, and to HVA 
channels on the other hand because they had a maximum at positive potentials 
which is characteristic for the HVA members. This indicates that the Ca2+ 
currents in astrocytes are composed of more than one channel and most 
probably from CaV1.2, CaV1.3 and CaV2.1. In the transcriptome data, mainly 
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CaV1.2, CaV1.3 and CaV2.1 are detectable (Figure  3-25). Most probably the 
first component of the astrocytic Ca2+ current is maybe contaminated with some 
CaV3 channels. The second component could be Cav1.2 and / or Cav2.1. 
Specific Ca2+ channel blockers were employed to distinguish the currents, 
although for the CaV3 channels there are no specific antagonists available. 2 
µM -agatoxin-IVA (CaV2.1) and 1 µM -conotoxin-GVIA (CaV2.2) blocked 5% 
and 3% respectively, while the CaV2.3 blocker SNX482 (300 nM) did block 12% 
and the L-type blocker verapamil (10 µM) blocked 56% of the Ca2+ current in 
astrocytes from wild-type mice. The combination of all blockers as one cocktail 
led to 65% blockade of the current; the residual current behaved similar in terms 
of current-voltage relationship which may indicate that no saturating 
concentrations of blockers were used. Although considerable CaV2.1 
transcripts were identified, CaV2.1 seems to not contribute much to the overall 
current. On the other hand the L-type Ca2+ channel blocker verapamil blocked 
more than 50% of the current, while nifedipine (another L-type blocker) blocked 
less than 30%. isradipine, another L-type blocker, was used leading to 25% 
inhibition at 1 µm and 52% inhibition at 10 µM. However, at 100 µM isradipine 
blocked 82% of the current. The need of high isradipine concentrations to block 
the CaV currents is astrocytes suggests that CaV1.3 is one of the main 
functional CaVs in astrocytes, which correlates with the transcriptome data that 
CaV1.3 is highly expressed in astrocytes. The sensitivity of CaV1.3 towards the 
dihydropyridine derivatives is shown to be 20 fold less compared to CaV1.2 
when nimodipine was used (Xu and Lipscombe, 2001). Summing up, the 82% 
isradipine block with the block by -agatoxin-IVA, -conotoxin-GVIA and 
SNX482, results in a complete block of CaV current in astrocytes, very similar to 
the block by the non-specific blocker Ni2+. In summary, the different approaches 
suggest that CaV currents in cortical astrocytes are derived from mainly L-type 
Ca2+ channels (CaV1.2 and CaV1.3) and minor contribution of P/Q- (CaV2.1) 
and maybe R- /CaV2.3) types. This was seen differently by Burgos et al. 
(Burgos et al., 2007) who observed that the main CaV in the astrocytes is the 
P/Q-type (CaV2.1) (about 60%) and L-type (about 40%) Ca2+ channels.  
CaV1, CaV2, CaV3 and CaV4 subunit genes of the voltage-gated Ca2+ 
channels were detected in the transcriptome from GLAST-sorted astrocytes. 
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Since CaVsubunits are shown to be associated with the HVA pore forming 1 
subunits (Dolphin, 2003) and involved in its trafficking to the plasma membrane 
and also gating properties. As mentioned above that the main component of the 
CaV currents in astrocytes is mediated via the L-type Ca2+ channels (CaV1.2 
and CaV1.3). Thus the role of CaV2 subunit in CaV currents in astrocytes 
were addressed since it is shown to associate preferentially with the L-type 
channels (Campiglio and Flucher, 2015). The role CaV3 subunit in the 
astrocytic CaV current was also analyzed, as it might preferentially associate 
with the CaV2 channels (Berrou et al., 2005). CaV current in astrocytes isolated 
from CaV3 gene-deficient mice did not show any significant difference as 
compared to the corresponding wild-type astrocytes in terms of amplitude and 
inactivation kinetics (Figure  3-30). In contrast, the astrocytes isolated from the 
CaV2 gene-deficient mice did have significantly reduced CaV current 
amplitude as well as significantly faster inactivation kinetics compared to 
astrocytes from wild-type mice (Figure  3-31). This fits with results from 
Weissgerber and colleagues (Weissgerber et al., 2006) in embryonic 
cardiomyocytes. They showed that the current amplitude was reduced and was 
faster inactivated in cells from CaV2 gene-deficient mice. The CaV current in 
astrocytes could have an impact on the physiological role of astrocytes either in 
healthy or in pathological conditions, similar to the effect of Ca2+ influx via 
TRPC3. Ca2+ has been suggested to play an important role in the traumatic 
brain injury where it accumulates in the astrocytes via the different cellular Ca2+ 
sources and causes cell death and dysfunction (Gurkoff et al., 2013). However, 
clinical trials in the early nineties on patients with acute traumatic brain injury 
showed modest improvement of the outcome after treating the patients with the 
L-type Ca2+ blocker nimodipine (Bailey et al., 1991), but those effect are in 
dispute (Vergouwen et al., 2006). On the other hand nimodipine is still approved 
for treatment of ischemic deficits following aneurysm hemorrhage in the brain 
(Fachinformation Nimodipin 2014). In the current work, the L-type CaVs were 
shown to contribute essentially to CaV currents in astrocytes. Under injury 
conditions gene expression and channel activity could become different than in 
healthy conditions and therefore other CaVs could be recruited in astrocytes. 
The blockers for CaV2.1, CaV2.2 and CaV2.3 are snail and spider toxins and 
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they are proteins. These properties limit their therapeutic use. Hopefully, small 
molecules will be developed, which do block these CaV2 channels and which 
may offer an option for treatment in traumatic brain injury.  
References 
 
Universität des Saarlandes  117 
 
5 References  
1. Adebiyi, A., Zhao, G., Narayanan, D., Thomas-Gatewood, C.M., 
Bannister, J.P., and Jaggar, J.H. (2010). Isoform-selective physical 
coupling of TRPC3 channels to IP3 receptors in smooth muscle cells 
regulates arterial contractility. Circ Res 106, 1603-1612. 
2. Akbulut, Y., Gaunt, H.J., Muraki, K., Ludlow, M.J., Amer, M.S., Bruns, A., 
Vasudev, N.S., Radtke, L., Willot, M., Hahn, S., et al. (2015). (-)-Englerin 
A is a potent and selective activator of TRPC4 and TRPC5 calcium 
channels. Angew Chem Int Ed Engl 54, 3787-3791. 
3. Alkhani, H., Ase, A.R., Grant, R., O'Donnell, D., Groschner, K., and 
Seguela, P. (2014). Contribution of TRPC3 to store-operated calcium 
entry and inflammatory transductions in primary nociceptors. Mol Pain 
10, 43. 
4. Ambudkar, I.S. (2014). Ca2+  signaling and regulation of fluid secretion in 
salivary gland acinar cells. Cell Calcium 55, 297-305. 
5. Anderson, M.A., Ao, Y., and Sofroniew, M.V. (2014). Heterogeneity of 
reactive astrocytes. Neurosci Lett 565, 23-29. 
6. Anderson, M.A., Burda, J.E., Ren, Y., Ao, Y., O'Shea, T.M., Kawaguchi, 
R., Coppola, G., Khakh, B.S., Deming, T.J., and Sofroniew, M.V. (2016). 
Astrocyte scar formation aids central nervous system axon regeneration. 
Nature 532, 195-200. 
7. Arikkath, J., and Campbell, K.P. (2003). Auxiliary subunits: essential 
components of the voltage-gated calcium channel complex. Curr Opin 
Neurobiol 13, 298-307. 
8. Astori, S., Wimmer, R.D., Prosser, H.M., Corti, C., Corsi, M., Liaudet, N., 
Volterra, A., Franken, P., Adelman, J.P., and Luthi, A. (2011). The 
Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in 
thalamus. Proc Natl Acad Sci U S A 108, 13823-13828. 
9. Bailey, I., Bell, A., Gray, J., Gullan, R., Heiskanan, O., Marks, P.V., 
Marsh, H., Mendelow, D.A., Murray, G., Ohman, J., et al. (1991). A trial 
of the effect of nimodipine on outcome after head injury. Acta Neurochir 
(Wien) 110, 97-105. 
10. Barclay, J., Balaguero, N., Mione, M., Ackerman, S.L., Letts, V.A., 
Brodbeck, J., Canti, C., Meir, A., Page, K.M., Kusumi, K., et al. (2001). 
Ducky mouse phenotype of epilepsy and ataxia is associated with 
mutations in the Cacna2d2 gene and decreased calcium channel current 
in cerebellar Purkinje cells. J Neurosci 21, 6095-6104. 
11. Beck, A., Nieden, R.Z., Schneider, H.P., and Deitmer, J.W. (2004). 
Calcium release from intracellular stores in rodent astrocytes and 
neurons in situ. Cell Calcium 35, 47-58. 
12. Beck, A., Speicher, T., Stoerger, C., Sell, T., Dettmer, V., Jusoh, S.A., 
Abdulmughni, A., Cavalie, A., Philipp, S.E., Zhu, M.X., et al. (2013). 
Conserved gating elements in TRPC4 and TRPC5 channels. J Biol 
Chem 288, 19471-19483. 
13. Becker, E.B. (2014). The Moonwalker mouse: new insights into TRPC3 
function, cerebellar development, and ataxia. Cerebellum 13, 628-636. 
References 
 
Universität des Saarlandes  118 
 
14. Becker, E.B., Oliver, P.L., Glitsch, M.D., Banks, G.T., Achilli, F., Hardy, 
A., Nolan, P.M., Fisher, E.M., and Davies, K.E. (2009). A point mutation 
in TRPC3 causes abnormal Purkinje cell development and cerebellar 
ataxia in moonwalker mice. Proc Natl Acad Sci U S A 106, 6706-6711. 
15. Berbey, C., Weiss, N., Legrand, C., and Allard, B. (2009). Transient 
receptor potential canonical type 1 (TRPC1) operates as a sarcoplasmic 
reticulum calcium leak channel in skeletal muscle. J Biol Chem 284, 
36387-36394. 
16. Berggren, P.O., Yang, S.N., Murakami, M., Efanov, A.M., Uhles, S., 
Kohler, M., Moede, T., Fernstrom, A., Appelskog, I.B., Aspinwall, C.A., et 
al. (2004). Removal of Ca2+  channel beta3 subunit enhances Ca2+ 
oscillation frequency and insulin exocytosis. Cell 119, 273-284. 
17. Berrou, L., Dodier, Y., Raybaud, A., Tousignant, A., Dafi, O., Pelletier, 
J.N., and Parent, L. (2005). The C-terminal residues in the alpha-
interacting domain (AID) helix anchor CaV beta subunit interaction and 
modulation of CaV2.3 channels. J Biol Chem 280, 494-505. 
18. Black, J.A., Newcombe, J., and Waxman, S.G. (2010). Astrocytes within 
multiple sclerosis lesions upregulate sodium channel Nav1.5. Brain 133, 
835-846. 
19. Boulay, G., Zhu, X., Peyton, M., Jiang, M., Hurst, R., Stefani, E., and 
Birnbaumer, L. (1997). Cloning and expression of a novel mammalian 
homolog of Drosophila transient receptor potential (Trp) involved in 
calcium entry secondary to activation of receptors coupled by the Gq 
class of G protein. J Biol Chem 272, 29672-29680. 
20. Brechard, S., Melchior, C., Plancon, S., Schenten, V., and Tschirhart, 
E.J. (2008). Store-operated Ca2+ channels formed by TRPC1, TRPC6 
and Orai1 and non-store-operated channels formed by TRPC3 are 
involved in the regulation of NADPH oxidase in HL-60 granulocytes. Cell 
Calcium 44, 492-506. 
21. Brixel, L.R., Monteilh-Zoller, M.K., Ingenbrandt, C.S., Fleig, A., Penner, 
R., Enklaar, T., Zabel, B.U., and Prawitt, D. (2010). TRPM5 regulates 
glucose-stimulated insulin secretion. Pflugers Arch 460, 69-76. 
22. Brose, N., and Rosenmund, C. (2002). Move over protein kinase C, 
you've got company: alternative cellular effectors of diacylglycerol and 
phorbol esters. J Cell Sci 115, 4399-4411. 
23. Buraei, Z., and Yang, J. (2013). Structure and function of the beta 
subunit of voltage-gated Ca2+ channels. Biochim Biophys Acta 1828, 
1530-1540. 
24. Burgess, D.L., Jones, J.M., Meisler, M.H., and Noebels, J.L. (1997). 
Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with 
ataxia and seizures in the lethargic (lh) mouse. Cell 88, 385-392. 
25. Burgos, M., Pastor, M.D., Gonzalez, J.C., Martinez-Galan, J.R., Vaquero, 
C.F., Fradejas, N., Benavides, A., Hernandez-Guijo, J.M., Tranque, P., 
and Calvo, S. (2007). PKCepsilon upregulates voltage-dependent 
calcium channels in cultured astrocytes. Glia 55, 1437-1448. 
26. Cabezas, R., Avila, M., Gonzalez, J., El-Bacha, R.S., Baez, E., Garcia-
Segura, L.M., Jurado Coronel, J.C., Capani, F., Cardona-Gomez, G.P., 
and Barreto, G.E. (2014). Astrocytic modulation of blood brain barrier: 
perspectives on Parkinson's disease. Front Cell Neurosci 8, 211. 
References 
 
Universität des Saarlandes  119 
 
27. Camacho Londono, J.E., Tian, Q., Hammer, K., Schroder, L., Camacho 
Londono, J., Reil, J.C., He, T., Oberhofer, M., Mannebach, S., Mathar, I., 
et al. (2015). A background Ca2+ entry pathway mediated by 
TRPC1/TRPC4 is critical for development of pathological cardiac 
remodelling. Eur Heart J 36, 2257-2266. 
28. Campiglio, M., and Flucher, B.E. (2015). The role of auxiliary subunits for 
the functional diversity of voltage-gated calcium channels. J Cell Physiol 
230, 2019-2031. 
29. Cao, E., Liao, M., Cheng, Y., and Julius, D. (2013). TRPV1 structures in 
distinct conformations reveal activation mechanisms. Nature 504, 113-
118. 
30. Carmignoto, G., Pasti, L., and Pozzan, T. (1998). On the role of voltage-
dependent calcium channels in calcium signaling of astrocytes in situ. J 
Neurosci 18, 4637-4645. 
31. Catterall, W.A., Perez-Reyes, E., Snutch, T.P., and Striessnig, J. (2005). 
International Union of Pharmacology. XLVIII. Nomenclature and 
structure-function relationships of voltage-gated calcium channels. 
Pharmacol Rev 57, 411-425. 
32. Cens, T., Rousset, M., Leyris, J.P., Fesquet, P., and Charnet, P. (2006). 
Voltage- and calcium-dependent inactivation in high voltage-gated Ca2+ 
channels. Prog Biophys Mol Biol 90, 104-117. 
33. Chang, B., Heckenlively, J.R., Bayley, P.R., Brecha, N.C., Davisson, 
M.T., Hawes, N.L., Hirano, A.A., Hurd, R.E., Ikeda, A., Johnson, B.A., et 
al. (2006). The nob2 mouse, a null mutation in Cacna1f: anatomical and 
functional abnormalities in the outer retina and their consequences on 
ganglion cell visual responses. Vis Neurosci 23, 11-24. 
34. Chaudhari, N. (1992). A single nucleotide deletion in the skeletal muscle-
specific calcium channel transcript of muscular dysgenesis (mdg) mice. J 
Biol Chem 267, 25636-25639. 
35. Chaudhuri, P., Colles, S.M., Damron, D.S., and Graham, L.M. (2003). 
Lysophosphatidylcholine inhibits endothelial cell migration by increasing 
intracellular calcium and activating calpain. Arterioscler Thromb Vasc 
Biol 23, 218-223. 
36. Chen, C.C., Lamping, K.G., Nuno, D.W., Barresi, R., Prouty, S.J., Lavoie, 
J.L., Cribbs, L.L., England, S.K., Sigmund, C.D., Weiss, R.M., et al. 
(2003). Abnormal coronary function in mice deficient in alpha1H T-type 
Ca2+ channels. Science 302, 1416-1418. 
37. Chen, R.S., Deng, T.C., Garcia, T., Sellers, Z.M., and Best, P.M. 
(2007a). Calcium channel gamma subunits: a functionally diverse protein 
family. Cell Biochem Biophys 47, 178-186. 
38. Chen, Y., Balasubramaniyan, V., Peng, J., Hurlock, E.C., Tallquist, M., 
Li, J., and Lu, Q.R. (2007b). Isolation and culture of rat and mouse 
oligodendrocyte precursor cells. Nat Protoc 2, 1044-1051. 
39. Cheung, K.K., Yeung, S.S., Au, S.W., Lam, L.S., Dai, Z.Q., Li, Y.H., and 
Yeung, E.W. (2011). Expression and association of TRPC1 with TRPC3 
during skeletal myogenesis. Muscle Nerve 44, 358-365. 
40. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA 
isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. 
Anal Biochem 162, 156-159. 
References 
 
Universität des Saarlandes  120 
 
41. Clapham, D.E. (2003). TRP channels as cellular sensors. Nature 426, 
517-524. 
42. Clapham, D.E. (2007). Calcium signaling. Cell 131, 1047-1058. 
43. Colsoul, B., Schraenen, A., Lemaire, K., Quintens, R., Van Lommel, L., 
Segal, A., Owsianik, G., Talavera, K., Voets, T., Margolskee, R.F., et al. 
(2010). Loss of high-frequency glucose-induced Ca2+ oscillations in 
pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- 
mice. Proc Natl Acad Sci U S A 107, 5208-5213. 
44. Conti, F., DeBiasi, S., Minelli, A., and Melone, M. (1996). Expression of 
NR1 and NR2A/B subunits of the NMDA receptor in cortical astrocytes. 
Glia 17, 254-258. 
45. Cosens, D.J., and Manning, A. (1969). Abnormal electroretinogram from 
a Drosophila mutant. Nature 224, 285-287. 
46. Davies, A., Kadurin, I., Alvarez-Laviada, A., Douglas, L., Nieto-Rostro, 
M., Bauer, C.S., Pratt, W.S., and Dolphin, A.C. (2010). The alpha2delta 
subunits of voltage-gated calcium channels form GPI-anchored proteins, 
a posttranslational modification essential for function. Proc Natl Acad Sci 
U S A 107, 1654-1659. 
47. Dietrich, A., Fahlbusch, M., and Gudermann, T. (2014). Classical 
Transient Receptor Potential 1 (TRPC1): Channel or Channel Regulator? 
Cells 3, 939-962. 
48. Dietrich, A., and Gudermann, T. (2014). TRPC6: physiological function 
and pathophysiological relevance. Handb Exp Pharmacol 222, 157-188. 
49. Dietrich, A., Kalwa, H., Storch, U., Mederos y Schnitzler, M., Salanova, 
B., Pinkenburg, O., Dubrovska, G., Essin, K., Gollasch, M., Birnbaumer, 
L., et al. (2007). Pressure-induced and store-operated cation influx in 
vascular smooth muscle cells is independent of TRPC1. Pflugers Arch 
455, 465-477. 
50. Dietrich, A., Mederos, Y.S.M., Gollasch, M., Gross, V., Storch, U., 
Dubrovska, G., Obst, M., Yildirim, E., Salanova, B., Kalwa, H., et al. 
(2005). Increased vascular smooth muscle contractility in TRPC6-/- mice. 
Mol Cell Biol 25, 6980-6989. 
51. Dolphin, A.C. (2003). Beta subunits of voltage-gated calcium channels. J 
Bioenerg Biomembr 35, 599-620. 
52. Dolphin, A.C. (2013). The alpha2delta subunits of voltage-gated calcium 
channels. Biochim Biophys Acta 1828, 1541-1549. 
53. Dutton, R.P., and McCunn, M. (2003). Traumatic brain injury. Curr Opin 
Crit Care 9, 503-509. 
54. Eberst, R., Dai, S., Klugbauer, N., and Hofmann, F. (1997). Identification 
and functional characterization of a calcium channel gamma subunit. 
Pflugers Arch 433, 633-637. 
55. Eckel, J., Lavin, P.J., Finch, E.A., Mukerji, N., Burch, J., Gbadegesin, R., 
Wu, G., Bowling, B., Byrd, A., Hall, G., et al. (2011). TRPC6 enhances 
angiotensin II-induced albuminuria. J Am Soc Nephrol 22, 526-535. 
56. Ellis, S.B., Williams, M.E., Ways, N.R., Brenner, R., Sharp, A.H., Leung, 
A.T., Campbell, K.P., McKenna, E., Koch, W.J., Hui, A., et al. (1988). 
Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 
subunits of a DHP-sensitive calcium channel. Science 241, 1661-1664. 
57. Ertel, E.A., Campbell, K.P., Harpold, M.M., Hofmann, F., Mori, Y., Perez-
Reyes, E., Schwartz, A., Snutch, T.P., Tanabe, T., Birnbaumer, L., et al. 
References 
 
Universität des Saarlandes  121 
 
(2000). Nomenclature of voltage-gated calcium channels. Neuron 25, 
533-535. 
58. Fan, D., Grooms, S.Y., Araneda, R.C., Johnson, A.B., Dobrenis, K., 
Kessler, J.A., and Zukin, R.S. (1999). AMPA receptor protein expression 
and function in astrocytes cultured from hippocampus. J Neurosci Res 
57, 557-571. 
59. Fawcett, J.W., and Asher, R.A. (1999). The glial scar and central nervous 
system repair. Brain Res Bull 49, 377-391. 
60. Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H., Tanasa, 
B., Hogan, P.G., Lewis, R.S., Daly, M., and Rao, A. (2006). A mutation in 
Orai1 causes immune deficiency by abrogating CRAC channel function. 
Nature 441, 179-185. 
61. Flockerzi, V. (2007). An introduction on TRP channels. Handb Exp 
Pharmacol, 1-19. 
62. Flockerzi, V., Oeken, H.J., Hofmann, F., Pelzer, D., Cavalie, A., and 
Trautwein, W. (1986). Purified dihydropyridine-binding site from skeletal 
muscle t-tubules is a functional calcium channel. Nature 323, 66-68. 
63. Freichel, M., Almering, J., and Tsvilovskyy, V. (2012). The Role of TRP 
Proteins in Mast Cells. Front Immunol 3, 150. 
64. Freichel, M., Suh, S.H., Pfeifer, A., Schweig, U., Trost, C., Weissgerber, 
P., Biel, M., Philipp, S., Freise, D., Droogmans, G., et al. (2001). Lack of 
an endothelial store-operated Ca2+  current impairs agonist-dependent 
vasorelaxation in TRP4-/- mice. Nat Cell Biol 3, 121-127. 
65. Freichel, M., Tsvilovskyy, V., and Camacho-Londono, J.E. (2014). 
TRPC4- and TRPC4-containing channels. Handb Exp Pharmacol 222, 
85-128. 
66. Freise, D., Held, B., Wissenbach, U., Pfeifer, A., Trost, C., Himmerkus, 
N., Schweig, U., Freichel, M., Biel, M., Hofmann, F., et al. (2000). 
Absence of the gamma subunit of the skeletal muscle dihydropyridine 
receptor increases L-type Ca2+ currents and alters channel inactivation 
properties. J Biol Chem 275, 14476-14481. 
67. Gao, K., Wang, C.R., Jiang, F., Wong, A.Y., Su, N., Jiang, J.H., Chai, 
R.C., Vatcher, G., Teng, J., Chen, J., et al. (2013). Traumatic scratch 
injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/AP-1 
pathway and switch on GFAP expression. Glia 61, 2063-2077. 
68. Gao, Y., Cao, E., Julius, D., and Cheng, Y. (2016). TRPV1 structures in 
nanodiscs reveal mechanisms of ligand and lipid action. Nature 534, 
347-351. 
69. Gautron, S., Dos Santos, G., Pinto-Henrique, D., Koulakoff, A., Gros, F., 
and Berwald-Netter, Y. (1992). The glial voltage-gated sodium channel: 
cell- and tissue-specific mRNA expression. Proc Natl Acad Sci U S A 89, 
7272-7276. 
70. Gregg, R.G., Messing, A., Strube, C., Beurg, M., Moss, R., Behan, M., 
Sukhareva, M., Haynes, S., Powell, J.A., Coronado, R., et al. (1996). 
Absence of the beta subunit (cchb1) of the skeletal muscle 
dihydropyridine receptor alters expression of the alpha 1 subunit and 
eliminates excitation-contraction coupling. Proc Natl Acad Sci U S A 93, 
13961-13966. 
71. Grimaldi, M., Maratos, M., and Verma, A. (2003). Transient receptor 
potential channel activation causes a novel form of [Ca 2+]I oscillations 
References 
 
Universität des Saarlandes  122 
 
and is not involved in capacitative Ca 2+ entry in glial cells. J Neurosci 
23, 4737-4745. 
72. Gross, S.A., Guzman, G.A., Wissenbach, U., Philipp, S.E., Zhu, M.X., 
Bruns, D., and Cavalie, A. (2009). TRPC5 is a Ca2+ activated channel 
functionally coupled to Ca2+ -selective ion channels. J Biol Chem 284, 
34423-34432. 
73. Grynkiewicz, G., Poenie, M., and Tsien, R.Y. (1985). A new generation of 
Ca2+ indicators with greatly improved fluorescence properties. J Biol 
Chem 260, 3440-3450. 
74. Gurkoff, G., Shahlaie, K., Lyeth, B., and Berman, R. (2013). Voltage-
gated calcium channel antagonists and traumatic brain injury. 
Pharmaceuticals (Basel) 6, 788-812. 
75. Harteneck, C., and Gollasch, M. (2011). Pharmacological modulation of 
diacylglycerol-sensitive TRPC3/6/7 channels. Curr Pharm Biotechnol 12, 
35-41. 
76. Hartmann, J., Dragicevic, E., Adelsberger, H., Henning, H.A., Sumser, 
M., Abramowitz, J., Blum, R., Dietrich, A., Freichel, M., Flockerzi, V., et 
al. (2008). TRPC3 channels are required for synaptic transmission and 
motor coordination. Neuron 59, 392-398. 
77. Hirschler-Laszkiewicz, I., Zhang, W., Keefer, K., Conrad, K., Tong, Q., 
Chen, S.J., Bronson, S., Cheung, J.Y., and Miller, B.A. (2012). Trpc2 
depletion protects red blood cells from oxidative stress-induced 
hemolysis. Exp Hematol 40, 71-83. 
78. Hisatsune, C., Nakamura, K., Kuroda, Y., Nakamura, T., and Mikoshiba, 
K. (2005). Amplification of Ca2+ signaling by diacylglycerol-mediated 
inositol 1,4,5-trisphosphate production. J Biol Chem 280, 11723-11730. 
79. Hofmann, F., Biel, M., and Flockerzi, V. (1994). Molecular basis for Ca2+ 
channel diversity. Annu Rev Neurosci 17, 399-418. 
80. Hofmann, T., Obukhov, A.G., Schaefer, M., Harteneck, C., Gudermann, 
T., and Schultz, G. (1999). Direct activation of human TRPC6 and 
TRPC3 channels by diacylglycerol. Nature 397, 259-263. 
81. Hofmann, T., Schaefer, M., Schultz, G., and Gudermann, T. (2000). 
Transient receptor potential channels as molecular substrates of 
receptor-mediated cation entry. J Mol Med (Berl) 78, 14-25. 
82. Iglesias, J., Morales, L., and Barreto, G.E. (2016). Metabolic and 
Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs. Mol 
Neurobiol. 
83. Jun, K., Piedras-Renteria, E.S., Smith, S.M., Wheeler, D.B., Lee, S.B., 
Lee, T.G., Chin, H., Adams, M.E., Scheller, R.H., Tsien, R.W., et al. 
(1999). Ablation of P/Q-type Ca(2+) channel currents, altered synaptic 
transmission, and progressive ataxia in mice lacking the alpha(1A)-
subunit. Proc Natl Acad Sci U S A 96, 15245-15250. 
84. Jungblut, M., Tiveron, M.C., Barral, S., Abrahamsen, B., Knobel, S., 
Pennartz, S., Schmitz, J., Perraut, M., Pfrieger, F.W., Stoffel, W., et al. 
(2012). Isolation and characterization of living primary astroglial cells 
using the new GLAST-specific monoclonal antibody ACSA-1. Glia 60, 
894-907. 
85. Kanemaru, K., Kubota, J., Sekiya, H., Hirose, K., Okubo, Y., and Iino, M. 
(2013). Calcium-dependent N-cadherin up-regulation mediates reactive 
References 
 
Universität des Saarlandes  123 
 
astrogliosis and neuroprotection after brain injury. Proc Natl Acad Sci U 
S A 110, 11612-11617. 
86. Katiyar, R., Weissgerber, P., Roth, E., Dorr, J., Sothilingam, V., Garcia 
Garrido, M., Beck, S.C., Seeliger, M.W., Beck, A., Schmitz, F., et al. 
(2015). Influence of the beta2-Subunit of L-Type Voltage-Gated Cav 
Channels on the Structural and Functional Development of 
Photoreceptor Ribbon Synapses. Invest Ophthalmol Vis Sci 56, 2312-
2324. 
87. Kim, D., Park, D., Choi, S., Lee, S., Sun, M., Kim, C., and Shin, H.S. 
(2003). Thalamic control of visceral nociception mediated by T-type Ca2+ 
channels. Science 302, 117-119. 
88. Kim, M.S., Lee, K.P., Yang, D., Shin, D.M., Abramowitz, J., Kiyonaka, S., 
Birnbaumer, L., Mori, Y., and Muallem, S. (2011). Genetic and 
pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects 
secretory epithelia from Ca2+ -dependent toxicity. Gastroenterology 140, 
2107-2115, 2115 e2101-2104. 
89. Kim, Y.J., and Kang, T.C. (2015). The role of TRPC6 in seizure 
susceptibility and seizure-related neuronal damage in the rat dentate 
gyrus. Neuroscience 307, 215-230. 
90. Kimelberg, H.K., and Nedergaard, M. (2010). Functions of astrocytes and 
their potential as therapeutic targets. Neurotherapeutics 7, 338-353. 
91. Kiselyov, K., van Rossum, D.B., and Patterson, R.L. (2010). TRPC 
channels in pheromone sensing. Vitam Horm 83, 197-213. 
92. Kiyonaka, S., Kato, K., Nishida, M., Mio, K., Numaga, T., Sawaguchi, Y., 
Yoshida, T., Wakamori, M., Mori, E., Numata, T., et al. (2009). Selective 
and direct inhibition of TRPC3 channels underlies biological activities of a 
pyrazole compound. Proc Natl Acad Sci U S A 106, 5400-5405. 
93. Koschak, A., Reimer, D., Huber, I., Grabner, M., Glossmann, H., Engel, 
J., and Striessnig, J. (2001). alpha 1D (Cav1.3) subunits can form l-type 
Ca2+ channels activating at negative voltages. J Biol Chem 276, 22100-
22106. 
94. Kraft, R. (2015). STIM and ORAI proteins in the nervous system. 
Channels (Austin) 9, 245-252. 
95. Latour, I., Hamid, J., Beedle, A.M., Zamponi, G.W., and Macvicar, B.A. 
(2003). Expression of voltage-gated Ca2+ channel subtypes in cultured 
astrocytes. Glia 41, 347-353. 
96. Leuner, K., Kazanski, V., Muller, M., Essin, K., Henke, B., Gollasch, M., 
Harteneck, C., and Muller, W.E. (2007). Hyperforin--a key constituent of 
St. John's wort specifically activates TRPC6 channels. Faseb J 21, 4101-
4111. 
97. Liang, C., Du, T., Zhou, J., Verkhratsky, A., and Peng, L. (2014). 
Ammonium increases Ca(2+) signalling and up-regulates expression of 
TRPC1 gene in astrocytes in primary cultures and in the in vivo brain. 
Neurochem Res 39, 2127-2135. 
98. Liao, M., Cao, E., Julius, D., and Cheng, Y. (2013). Structure of the 
TRPV1 ion channel determined by electron cryo-microscopy. Nature 504, 
107-112. 
99. Liao, Y., Erxleben, C., Yildirim, E., Abramowitz, J., Armstrong, D.L., and 
Birnbaumer, L. (2007). Orai proteins interact with TRPC channels and 
References 
 
Universität des Saarlandes  124 
 
confer responsiveness to store depletion. Proc Natl Acad Sci U S A 104, 
4682-4687. 
100. Lichtenegger, M., and Groschner, K. (2014). TRPC3: a 
multifunctional signaling molecule. Handb Exp Pharmacol 222, 67-84. 
101. Linde, C.I., Baryshnikov, S.G., Mazzocco-Spezzia, A., and 
Golovina, V.A. (2011). Dysregulation of Ca2+ signaling in astrocytes from 
mice lacking amyloid precursor protein. Am J Physiol Cell Physiol 300, 
C1502-1512. 
102. Lintschinger, B., Balzer-Geldsetzer, M., Baskaran, T., Graier, 
W.F., Romanin, C., Zhu, M.X., and Groschner, K. (2000). Coassembly of 
Trp1 and Trp3 proteins generates diacylglycerol- and Ca2+ -sensitive 
cation channels. J Biol Chem 275, 27799-27805. 
103. Lipscombe, D., Helton, T.D., and Xu, W. (2004). L-type calcium 
channels: the low down. J Neurophysiol 92, 2633-2641. 
104. Liu, X., Cheng, K.T., Bandyopadhyay, B.C., Pani, B., Dietrich, A., 
Paria, B.C., Swaim, W.D., Beech, D., Yildrim, E., Singh, B.B., et al. 
(2007). Attenuation of store-operated Ca2+ current impairs salivary gland 
fluid secretion in TRPC1(-/-) mice. Proc Natl Acad Sci U S A 104, 17542-
17547. 
105. Lucas, P., Ukhanov, K., Leinders-Zufall, T., and Zufall, F. (2003). 
A diacylglycerol-gated cation channel in vomeronasal neuron dendrites is 
impaired in TRPC2 mutant mice: mechanism of pheromone transduction. 
Neuron 40, 551-561. 
106. MacVicar, B.A., and Tse, F.W. (1988). Norepinephrine and cyclic 
adenosine 3':5'-cyclic monophosphate enhance a nifedipine-sensitive 
calcium current in cultured rat astrocytes. Glia 1, 359-365. 
107. Malarkey, E.B., Ni, Y., and Parpura, V. (2008). Ca2+ entry through 
TRPC1 channels contributes to intracellular Ca2+ dynamics and 
consequent glutamate release from rat astrocytes. Glia 56, 821-835. 
108. Mangoni, M.E., Traboulsie, A., Leoni, A.L., Couette, B., Marger, 
L., Le Quang, K., Kupfer, E., Cohen-Solal, A., Vilar, J., Shin, H.S., et al. 
(2006). Bradycardia and slowing of the atrioventricular conduction in 
mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res 98, 
1422-1430. 
109. Maragakis, N.J., and Rothstein, J.D. (2006). Mechanisms of 
Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 
2, 679-689. 
110. Miller, B.A. (2014). Trpc2. Handb Exp Pharmacol 222, 53-65. 
111. Miyano, K., Morioka, N., Sugimoto, T., Shiraishi, S., Uezono, Y., 
and Nakata, Y. (2010). Activation of the neurokinin-1 receptor in rat 
spinal astrocytes induces Ca2+ release from IP3-sensitive Ca2+ stores 
and extracellular Ca2+ influx through TRPC3. Neurochem Int 57, 923-
934. 
112. Montell, C., and Rubin, G.M. (1989). Molecular characterization of 
the Drosophila trp locus: a putative integral membrane protein required 
for phototransduction. Neuron 2, 1313-1323. 
113. Montgomery, D.L. (1994). Astrocytes: form, functions, and roles in 
disease. Vet Pathol 31, 145-167. 
114. Muller, C.S., Haupt, A., Bildl, W., Schindler, J., Knaus, H.G., 
Meissner, M., Rammner, B., Striessnig, J., Flockerzi, V., Fakler, B., et al. 
References 
 
Universität des Saarlandes  125 
 
(2010). Quantitative proteomics of the Cav2 channel nano-environments 
in the mammalian brain. Proc Natl Acad Sci U S A 107, 14950-14957. 
115. Munakata, M., Shirakawa, H., Nagayasu, K., Miyanohara, J., 
Miyake, T., Nakagawa, T., Katsuki, H., and Kaneko, S. (2013). Transient 
receptor potential canonical 3 inhibitor Pyr3 improves outcomes and 
attenuates astrogliosis after intracerebral hemorrhage in mice. Stroke 44, 
1981-1987. 
116. Murakami, M., Fleischmann, B., De Felipe, C., Freichel, M., Trost, 
C., Ludwig, A., Wissenbach, U., Schwegler, H., Hofmann, F., Hescheler, 
J., et al. (2002). Pain perception in mice lacking the beta3 subunit of 
voltage-activated calcium channels. J Biol Chem 277, 40342-40351. 
117. Nakao, K., Shirakawa, H., Sugishita, A., Matsutani, I., Niidome, T., 
Nakagawa, T., and Kaneko, S. (2008). Ca2+ mobilization mediated by 
transient receptor potential canonical 3 is associated with thrombin-
induced morphological changes in 1321N1 human astrocytoma cells. J 
Neurosci Res 86, 2722-2732. 
118. Neary, J.T., and Zhu, Q. (1994). Signaling by ATP receptors in 
astrocytes. Neuroreport 5, 1617-1620. 
119. Neely, G.G., Hess, A., Costigan, M., Keene, A.C., Goulas, S., 
Langeslag, M., Griffin, R.S., Belfer, I., Dai, F., Smith, S.B., et al. (2010). 
A genome-wide Drosophila screen for heat nociception identifies 
alpha2delta3 as an evolutionarily conserved pain gene. Cell 143, 628-
638. 
120. Nesin, V., and Tsiokas, L. (2014). Trpc1. Handb Exp Pharmacol 
222, 15-51. 
121. Newton, R.A., Bingham, S., Case, P.C., Sanger, G.J., and 
Lawson, S.N. (2001). Dorsal root ganglion neurons show increased 
expression of the calcium channel alpha2delta-1 subunit following partial 
sciatic nerve injury. Brain Res Mol Brain Res 95, 1-8. 
122. Nicoll, R.A., Tomita, S., and Bredt, D.S. (2006). Auxiliary subunits 
assist AMPA-type glutamate receptors. Science 311, 1253-1256. 
123. Niemeyer, M.I., and Lummis, S.C. (2001). The role of the agonist 
binding site in Ca(2+) inhibition of the recombinant 5-HT(3A) receptor. 
Eur J Pharmacol 428, 153-161. 
124. Nilius, B., and Flockerzi, V. (2014). Mammalian transient receptor 
potential (TRP) cation channels. Preface. Handb Exp Pharmacol 223, v - 
vi. 
125. Nishizuka, Y. (1984). The role of protein kinase C in cell surface 
signal transduction and tumour promotion. Nature 308, 693-698. 
126. Nowak, L., Ascher, P., and Berwald-Netter, Y. (1987). Ionic 
channels in mouse astrocytes in culture. J Neurosci 7, 101-109. 
127. Nowycky, M.C., Fox, A.P., and Tsien, R.W. (1985). Three types of 
neuronal calcium channel with different calcium agonist sensitivity. 
Nature 316, 440-443. 
128. Okada, T., Inoue, R., Yamazaki, K., Maeda, A., Kurosaki, T., 
Yamakuni, T., Tanaka, I., Shimizu, S., Ikenaka, K., Imoto, K., et al. 
(1999). Molecular and functional characterization of a novel mouse 
transient receptor potential protein homologue TRP7. Ca(2+)-permeable 
cation channel that is constitutively activated and enhanced by 
References 
 
Universität des Saarlandes  126 
 
stimulation of G protein-coupled receptor. J Biol Chem 274, 27359-
27370. 
129. Olivera, B.M., Miljanich, G.P., Ramachandran, J., and Adams, 
M.E. (1994). Calcium channel diversity and neurotransmitter release: the 
omega-conotoxins and omega-agatoxins. Annu Rev Biochem 63, 823-
867. 
130. Ong, E.C., Nesin, V., Long, C.L., Bai, C.X., Guz, J.L., Ivanov, I.P., 
Abramowitz, J., Birnbaumer, L., Humphrey, M.B., and Tsiokas, L. (2013). 
A TRPC1 protein-dependent pathway regulates osteoclast formation and 
function. J Biol Chem 288, 22219-22232. 
131. Paez, P.M., Fulton, D., Spreuer, V., Handley, V., and 
Campagnoni, A.T. (2011). Modulation of canonical transient receptor 
potential channel 1 in the proliferation of oligodendrocyte precursor cells 
by the golli products of the myelin basic protein gene. J Neurosci 31, 
3625-3637. 
132. Parpura, V., and Verkhratsky, A. (2012). Astrocytes revisited: 
concise historic outlook on glutamate homeostasis and signaling. Croat 
Med J 53, 518-528. 
133. Paulsen, C.E., Armache, J.P., Gao, Y., Cheng, Y., and Julius, D. 
(2015). Structure of the TRPA1 ion channel suggests regulatory 
mechanisms. Nature 525, 552. 
134. Pereverzev, A., Mikhna, M., Vajna, R., Gissel, C., Henry, M., 
Weiergraber, M., Hescheler, J., Smyth, N., and Schneider, T. (2002). 
Disturbances in glucose-tolerance, insulin-release, and stress-induced 
hyperglycemia upon disruption of the Ca(v)2.3 (alpha 1E) subunit of 
voltage-gated Ca(2+) channels. Mol Endocrinol 16, 884-895. 
135. Phelan, K.D., Shwe, U.T., Abramowitz, J., Birnbaumer, L., and 
Zheng, F. (2014). Critical role of canonical transient receptor potential 
channel 7 in initiation of seizures. Proc Natl Acad Sci U S A 111, 11533-
11538. 
136. Phelan, K.D., Shwe, U.T., Abramowitz, J., Wu, H., Rhee, S.W., 
Howell, M.D., Gottschall, P.E., Freichel, M., Flockerzi, V., Birnbaumer, L., 
et al. (2013). Canonical transient receptor channel 5 (TRPC5) and 
TRPC1/4 contribute to seizure and excitotoxicity by distinct cellular 
mechanisms. Mol Pharmacol 83, 429-438. 
137. Philipp, S., Cavalie, A., Freichel, M., Wissenbach, U., Zimmer, S., 
Trost, C., Marquart, A., Murakami, M., and Flockerzi, V. (1996). A 
mammalian capacitative calcium entry channel homologous to 
Drosophila TRP and TRPL. Embo J 15, 6166-6171. 
138. Philipp, S., Hambrecht, J., Braslavski, L., Schroth, G., Freichel, 
M., Murakami, M., Cavalie, A., and Flockerzi, V. (1998). A novel 
capacitative calcium entry channel expressed in excitable cells. Embo J 
17, 4274-4282. 
139. Platzer, J., Engel, J., Schrott-Fischer, A., Stephan, K., Bova, S., 
Chen, H., Zheng, H., and Striessnig, J. (2000). Congenital deafness and 
sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. 
Cell 102, 89-97. 
140. Reuter, H. (1967). The dependence of slow inward current in 
Purkinje fibres on the extracellular calcium-concentration. J Physiol 192, 
479-492. 
References 
 
Universität des Saarlandes  127 
 
141. Reuter, H. (1983). Calcium channel modulation by 
neurotransmitters, enzymes and drugs. Nature 301, 569-574. 
142. Reuter, H. (1986). Voltage-dependent mechanisms for raising 
intracellular free calcium concentration: calcium channels. Ciba Found 
Symp 122, 5-22. 
143. Rhodes, K.E., and Fawcett, J.W. (2004). Chondroitin sulphate 
proteoglycans: preventing plasticity or protecting the CNS? J Anat 204, 
33-48. 
144. Riccio, A., Li, Y., Moon, J., Kim, K.S., Smith, K.S., Rudolph, U., 
Gapon, S., Yao, G.L., Tsvetkov, E., Rodig, S.J., et al. (2009). Essential 
role for TRPC5 in amygdala function and fear-related behavior. Cell 137, 
761-772. 
145. Riccio, A., Li, Y., Tsvetkov, E., Gapon, S., Yao, G.L., Smith, K.S., 
Engin, E., Rudolph, U., Bolshakov, V.Y., and Clapham, D.E. (2014). 
Decreased anxiety-like behavior and Galphaq/11-dependent responses 
in the amygdala of mice lacking TRPC4 channels. J Neurosci 34, 3653-
3667. 
146. Ruth, P., Rohrkasten, A., Biel, M., Bosse, E., Regulla, S., Meyer, 
H.E., Flockerzi, V., and Hofmann, F. (1989). Primary structure of the beta 
subunit of the DHP-sensitive calcium channel from skeletal muscle. 
Science 245, 1115-1118. 
147. Saadoun, S., Papadopoulos, M.C., Watanabe, H., Yan, D., 
Manley, G.T., and Verkman, A.S. (2005). Involvement of aquaporin-4 in 
astroglial cell migration and glial scar formation. J Cell Sci 118, 5691-
5698. 
148. Saegusa, H., Kurihara, T., Zong, S., Kazuno, A., Matsuda, Y., 
Nonaka, T., Han, W., Toriyama, H., and Tanabe, T. (2001). Suppression 
of inflammatory and neuropathic pain symptoms in mice lacking the N-
type Ca2+ channel. Embo J 20, 2349-2356. 
149. Saotome, K., Singh, A.K., Yelshanskaya, M.V., and Sobolevsky, 
A.I. (2016). Crystal structure of the epithelial calcium channel TRPV6. 
Nature 534, 506-511. 
150. Schachtrup, C., Ryu, J.K., Helmrick, M.J., Vagena, E., Galanakis, 
D.K., Degen, J.L., Margolis, R.U., and Akassoglou, K. (2010). Fibrinogen 
triggers astrocyte scar formation by promoting the availability of active 
TGF-beta after vascular damage. J Neurosci 30, 5843-5854. 
151. Schildge, S., Bohrer, C., Beck, K., and Schachtrup, C. (2013). 
Isolation and culture of mouse cortical astrocytes. J Vis Exp. 
152. Schleifer, H., Doleschal, B., Lichtenegger, M., Oppenrieder, R., 
Derler, I., Frischauf, I., Glasnov, T.N., Kappe, C.O., Romanin, C., and 
Groschner, K. (2012). Novel pyrazole compounds for pharmacological 
discrimination between receptor-operated and store-operated Ca(2+) 
entry pathways. Br J Pharmacol 167, 1712-1722. 
153. Schmitt, A., Asan, E., Puschel, B., and Kugler, P. (1997). Cellular 
and regional distribution of the glutamate transporter GLAST in the CNS 
of rats: nonradioactive in situ hybridization and comparative 
immunocytochemistry. J Neurosci 17, 1-10. 
154. Scimemi, A. (2013). A TRP among the astrocytes. J Physiol 591, 
9-15. 
References 
 
Universität des Saarlandes  128 
 
155. Seisenberger, C., Specht, V., Welling, A., Platzer, J., Pfeifer, A., 
Kuhbandner, S., Striessnig, J., Klugbauer, N., Feil, R., and Hofmann, F. 
(2000). Functional embryonic cardiomyocytes after disruption of the L-
type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem 
275, 39193-39199. 
156. Sell, T.S., Belkacemi, T., Flockerzi, V., and Beck, A. (2014). 
Protonophore properties of hyperforin are essential for its 
pharmacological activity. Sci Rep 4. 
157. Selvaraj, S., Sun, Y., Watt, J.A., Wang, S., Lei, S., Birnbaumer, L., 
and Singh, B.B. (2012). Neurotoxin-induced ER stress in mouse 
dopaminergic neurons involves downregulation of TRPC1 and inhibition 
of AKT/mTOR signaling. J Clin Invest 122, 1354-1367. 
158. Silver, J., and Miller, J.H. (2004). Regeneration beyond the glial 
scar. Nat Rev Neurosci 5, 146-156. 
159. Sofroniew, M.V. (2009). Molecular dissection of reactive 
astrogliosis and glial scar formation. Trends Neurosci 32, 638-647. 
160. Song, X., Zhao, Y., Narcisse, L., Duffy, H., Kress, Y., Lee, S., and 
Brosnan, C.F. (2005). Canonical transient receptor potential channel 4 
(TRPC4) co-localizes with the scaffolding protein ZO-1 in human fetal 
astrocytes in culture. Glia 49, 418-429. 
161. Storch, U., Forst, A.L., Philipp, M., Gudermann, T., and Mederos y 
Schnitzler, M. (2012). Transient receptor potential channel 1 (TRPC1) 
reduces calcium permeability in heteromeric channel complexes. J Biol 
Chem 287, 3530-3540. 
162. Stowers, L., Holy, T.E., Meister, M., Dulac, C., and Koentges, G. 
(2002). Loss of sex discrimination and male-male aggression in mice 
deficient for TRP2. Science 295, 1493-1500. 
163. Streifel, K.M., Gonzales, A.L., De Miranda, B., Mouneimne, R., 
Earley, S., and Tjalkens, R. (2014). Dopaminergic neurotoxicants cause 
biphasic inhibition of purinergic calcium signaling in astrocytes. PLoS 
One 9, e110996. 
164. Striedinger, K., and Scemes, E. (2008). Interleukin-1beta affects 
calcium signaling and in vitro cell migration of astrocyte progenitors. J 
Neuroimmunol 196, 116-123. 
165. Strubing, C., Krapivinsky, G., Krapivinsky, L., and Clapham, D.E. 
(2001). TRPC1 and TRPC5 form a novel cation channel in mammalian 
brain. Neuron 29, 645-655. 
166. Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F., and 
Kraus, J. (2006). A systematic review of brain injury epidemiology in 
Europe. Acta Neurochir (Wien) 148, 255-268; discussion 268. 
167. Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, 
H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. 
(1987). Primary structure of the receptor for calcium channel blockers 
from skeletal muscle. Nature 328, 313-318. 
168. Tang, J., Lin, Y., Zhang, Z., Tikunova, S., Birnbaumer, L., and 
Zhu, M.X. (2001). Identification of common binding sites for calmodulin 
and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp 
channels. J Biol Chem 276, 21303-21310. 
169. Templeton, N.S. (1992). The polymerase chain reaction. History, 
methods, and applications. Diagn Mol Pathol 1, 58-72. 
References 
 
Universität des Saarlandes  129 
 
170. Tong, Q., Chu, X., Cheung, J.Y., Conrad, K., Stahl, R., Barber, 
D.L., Mignery, G., and Miller, B.A. (2004). Erythropoietin-modulated 
calcium influx through TRPC2 is mediated by phospholipase Cgamma 
and IP3R. Am J Physiol Cell Physiol 287, C1667-1678. 
171. Trebak, M., St, J.B.G., McKay, R.R., Birnbaumer, L., and Putney, 
J.W., Jr. (2003). Signaling mechanism for receptor-activated canonical 
transient receptor potential 3 (TRPC3) channels. J Biol Chem 278, 
16244-16252. 
172. Ulbricht, W. (2005). Sodium channel inactivation: molecular 
determinants and modulation. Physiol Rev 85, 1271-1301. 
173. Varga-Szabo, D., Authi, K.S., Braun, A., Bender, M., Ambily, A., 
Hassock, S.R., Gudermann, T., Dietrich, A., and Nieswandt, B. (2008). 
Store-operated Ca(2+) entry in platelets occurs independently of 
transient receptor potential (TRP) C1. Pflugers Arch 457, 377-387. 
174. Venkatachalam, K., van Rossum, D.B., Patterson, R.L., Ma, H.T., 
and Gill, D.L. (2002). The cellular and molecular basis of store-operated 
calcium entry. Nat Cell Biol 4, E263-272. 
175. Vergouwen, M.D., Vermeulen, M., and Roos, Y.B. (2006). Effect 
of nimodipine on outcome in patients with traumatic subarachnoid 
haemorrhage: a systematic review. Lancet Neurol 5, 1029-1032. 
176. Weissgerber, P., Held, B., Bloch, W., Kaestner, L., Chien, K.R., 
Fleischmann, B.K., Lipp, P., Flockerzi, V., and Freichel, M. (2006). 
Reduced cardiac L-type Ca2+ current in Ca(V)beta2-/- embryos impairs 
cardiac development and contraction with secondary defects in vascular 
maturation. Circ Res 99, 749-757. 
177. Weissgerber, P., Kriebs, U., Tsvilovskyy, V., Olausson, J., Kretz, 
O., Stoerger, C., Mannebach, S., Wissenbach, U., Vennekens, R., 
Middendorff, R., et al. (2012). Excision of Trpv6 gene leads to severe 
defects in epididymal Ca2+ absorption and male fertility much like single 
D541A pore mutation. J Biol Chem 287, 17930-17941. 
178. Wes, P.D., Chevesich, J., Jeromin, A., Rosenberg, C., Stetten, G., 
and Montell, C. (1995). TRPC1, a human homolog of a Drosophila store-
operated channel. Proc Natl Acad Sci U S A 92, 9652-9656. 
179. Wu, J., Yan, Z., Li, Z., Yan, C., Lu, S., Dong, M., and Yan, N. 
(2015). Structure of the voltage-gated calcium channel Cav1.1 complex. 
Science 350, aad2395. 
180. Wu, L.J., Sweet, T.B., and Clapham, D.E. (2010). International 
Union of Basic and Clinical Pharmacology. LXXVI. Current progress in 
the mammalian TRP ion channel family. Pharmacol Rev 62, 381-404. 
181. Wycisk, K.A., Zeitz, C., Feil, S., Wittmer, M., Forster, U., 
Neidhardt, J., Wissinger, B., Zrenner, E., Wilke, R., Kohl, S., et al. 
(2006). Mutation in the auxiliary calcium-channel subunit CACNA2D4 
causes autosomal recessive cone dystrophy. Am J Hum Genet 79, 973-
977. 
182. Xu, W., and Lipscombe, D. (2001). Neuronal Ca(V)1.3alpha(1) L-
type channels activate at relatively hyperpolarized membrane potentials 
and are incompletely inhibited by dihydropyridines. J Neurosci 21, 5944-
5951. 
183. Yi, M., Dou, F., Lu, Q., Yu, Z., and Chen, H. (2016). Activation of 
the KCa3.1 channel contributes to traumatic scratch injury-induced 
References 
 
Universität des Saarlandes  130 
 
reactive astrogliosis through the JNK/c-Jun signaling pathway. Neurosci 
Lett 624, 62-71. 
184. Yue, D.T. (2004). The dawn of high-resolution structure for the 
queen of ion channels. Neuron 42, 357-359. 
185. Zeng, S., Li, B., and Chen, S. (2009). Simulation of spontaneous 
Ca2+ oscillations in astrocytes mediated by voltage-gated calcium 
channels. Biophys J 97, 2429-2437. 
186. Zhang, X., and Trebak, M. (2014). Transient receptor potential 
canonical 7: a diacylglycerol-activated non-selective cation channel. 
Handb Exp Pharmacol 222, 189-204. 
187. Zholos, A.V. (2014). Trpc5. Handb Exp Pharmacol 222, 129-156. 
188. Zhu, X., Chu, P.B., Peyton, M., and Birnbaumer, L. (1995). 
Molecular cloning of a widely expressed human homologue for the 
Drosophila trp gene. FEBS Lett 373, 193-198. 
189. Zhu, X., Jiang, M., Peyton, M., Boulay, G., Hurst, R., Stefani, E., 
and Birnbaumer, L. (1996). trp, a novel mammalian gene family essential 
for agonist-activated capacitative Ca2+ entry. Cell 85, 661-671. 
190. Zubcevic, L., Herzik, M.A., Jr., Chung, B.C., Liu, Z., Lander, G.C., 
and Lee, S.Y. (2016). Cryo-electron microscopy structure of the TRPV2 
ion channel. Nat Struct Mol Biol 23, 180-186. 
 
Supplementary Figures 
 
Universität des Saarlandes  131 
 
6 Supplementary Figures 
Figure S1 
 
Figure ‎6-1 TRPC transcripts expression in enriched astrocyte culture. 3 
independent RT-PCRs performed from enriched astrocyte culture RNA showing 
the amplification of TRPC1, TRPC2, TRPC3, TRPC4, TRPC6, TRPC7 and 
HPRT DNA fragments of the expected sizes. 
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Figure S2 
 
Figure ‎6-2 TRPC transcripts expression in GLAST-sorted astrocytes. 13 
independent RT-PCRs performed from GLAST-sorted astrocytes showing the 
amplification of TRPC1, TRPC2, TRPC3, TRPC4 and HPRT DNA fragments of 
the expected sizes. 
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Figure S3 
 
Figure ‎6-3 TRPC transcripts expression in CD11b-sorted microglia. (a and 
b) 3 independent RT-PCRs performed from CD11b-sorted microglia showing 
the amplification of TRPC2, TRPC4 and HPRT DNA fragments of the expected 
sizes. TPRC6 in (b) is shown in (Sell et al., 2014). 
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